### On the cover: Transmission electron photomicrographic image of a dispersed suspension of single-walled carbon nanotubes labeled with 10-nm colloidal gold. This labeling technique allows these nanoparticles to be more easily tracked and visualized in various tissues and organs following exposure. Image courtesy of Robert Mercer, NIOSH.

# Progress Toward Safe Nanotechnology in the Workplace

A Report from the NIOSH Nanotechnology Research Center

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health

### iii 

## This document is in the public domain and may be freely copied or reprinted.



## Disclaimer Mention of any company or product does not constitute endorsement by the National Institute for Occupational Safety and Health (NIOSH). In addition,citations to Web sites external to NIOSH do not constitute NIOSH endorsement of the sponsoring organizations or their programs or products. Furthermore, NIOSH is not responsible for the content of these Web sites. 

## Ordering Information To receive documents or other information about occupational safety and health topics, contact NIOSH at
NIOSH—Publications Dissemination 4676 Columbia Parkway Cincinnati, OH 45226–1998 Telephone: 1–800–35–NIOSH (1–800–356–4674) Fax: 513–533–8573 E-mail: pubstaft@cdc.gov or visit the NIOSH Web site at www.cdc.gov/niosh DHHS (NIOSH) Publication No. 2007–123 ( **R e**  **issued with minor modifications** ) June 2007

safer • healthier • people tm



### ii

### ii 

# Foreword

As with any new technology, the earliest and most extensive exposures to engineered nanoparticles are most likely to occur in the workplace. Workers are currently producing and using nanoparticles. Society requires assessment of whether these exposures present any threat to workers. The National Institute for Occupational Safety and Health (NIOSH) is mandated by law to conductresearch and develop guidance on worker safety and health. NIOSH, in collaboration with partners in other government agencies, countries, academia,industry, labor, and nongovernmental organizations, has been conducting research and developing guidance to address the occupational safety and health of workers exposed to nanomaterials. This document is a report of the progress of the NIOSH Nanotechnology Research Center (NTRC) since its inception in 2004 through 2006. Using only internally redirected resources, the NTRC has begun to make contributions to all the steps in the continuum from hazard identification to risk management. Understanding the occupational safety and health issues of nanotechnology is a comp lex endeavor. The types of nanomaterials and the opportunities for workplace exposure are growing rapidly. The challenge is to effectively address thesafety and health issues of nanotechnology while helping society realize the farreaching potential benefits. NIOSH will continue to respond to this challenge.

John Howard, M.D. Director, National Institute for

Occupational Safety and Health Centers for Disease Control and Prevention

iii

### v 

# Executive Summary

The National Institute for Occupational Safety and Health (NIOSH) is the Federal agency responsible for conducting research and making recommendations to prevent work-related injury, illness, and death. As such, NIOSH is active in (1) identifying critical issues related to possible health hazards of nanomaterial s, (2) p rotecting the safety and health of workers involved in this emerging technology, and (3) implementing a strategic plan to develop and disseminate methods for safely advancing the technology through workplace controls and safe handling procedures, and (4) investigating the possible applications of nanotechnology to solve workplace safety and health issues. Because of theirsmall size and large surface area, engineered nanoparticles may have chemical, physical, and biological properties distinctly different from larger particles of similar chemical composition. Those properties may include the ability to reach the gas exchange regions of the lung, travel from the lung throughout the body, penetrate dermal barriers, cross cell membranes, and interact at the molecular level. NIOSH is investigating all of these properties, as it would with any new technology or material in the workplace, to provide the necessary guidance to ensure a safe and healthy workplace. NIOSH is mandated by the Occupational Safety and Health Act to determine wh et her materials in a workplace constitute any harm and to provide recommendations for preventing injury and illness. NIOSH is taking the first steps in assessing hazards posed by various types of nanoparticles by attempting to understand the mechanisms of action of nanoparticles in living systems and assessing risks to workers. The research being conducted by the NIOSHNanotechnology Research Center (NTRC) was funded by redirecting existing NIOSH programmatic funds: $3.0 million in FY 2005, $3.7 million in FY 2006, and $4.6 million in FY 2007. This budgetary constraint has made a morecomprehensive research program specific to nanomaterials difficult to implement. Even with the budgetary constraints, NIOSH investigators have laid the foundation for an evidence-based strategy for providing safe nanotechnology in the workplace. This effort is consistent with the following guidance from the U.S. Office of Science and Technology Policy (OSTP) and the Office of Management and Budget (OMB): to ensure that nanotechnology research leads to the responsible development of beneficial applications, high priority should be given to research on societal implications, human health, and environmental issues related to nanotechnology and to develop, where applicable, cross-agency approaches to the funding and execution of this research [July 8, 2005 memorandum for the Heads of Executive Departments and Agencies]. Because of

i v

### iv **Executive Summary**



### its mission and the active program of research it has started, NIOSH has been identified as a lead agency in several high priority areas by the Nanotechnology Environmental and Health Implications (NEHI) Working Group within the National Nanotechnology Initiative (NNI). 

## Nanotechnology Research CenterNTRC was established in 2004 to coordinate and facilitate research in nanotechnology and develop guidance on the safe handling of nanomaterials in the workplace. It is a ‘virtual center’ in which NIOSH scientists and engineers at geographically dispersed locations are linked by shared computer networks and other technologies. This approach surmounts the logistical complicationsthat traditionally arise when scientists and engineers collaborating on common research are not physically in the same locations. This approach has also allowed NIOSH to jump-start research and facilitate ongoing studies. The goals for NTRC are as follows:
1. Determine whether nanoparticles and nanomaterials pose risks of inj ur ies and illnesses for workers.
2. Conduct research on applying nanotechnology to the prevention of
wo r k-related injuries and illnesses.
3. Promote healthy workplaces through interventions, recommendations,
an d c apacity building.
4. Enhance global workplace safety and health through national and inte r national collaborations on nanotechnology research and guidance. As evidenced by the full report, progress has been made toward each of these go a ls. The following paragraphs present highlights of each goal.

1. Determine whether nanoparticles and nanomaterials pose risks of injuries and illnesses for workers. S in ce 2004, the NTRC has conducted toxicology research on the properties
an d c haracteristics of nanoparticles that are relevant for predicting whether these particles pose a risk of adverse health effects in workers (see Appendix A for the status of ongoing research and published results). These research projects have involved characterizing occupationally relevant nanoparticles— particularly the toxicity of carbon nanoparticles. Preliminary work by NTRC investigators demonstrated that exposures to specific nanotubes had harmful pulmonary effects (such as a fibrotic response) in mice soon after exposure to relatively low doses. NTRC investigators have evaluated the potential for

v

### vii **Executive Summary NIOSH Nanotechnology Research Center** 



### nanoparticles to enter the bloodstream and move to systemic tissues after being deposited in the lungs. NTRC is also assessing the impact of dermal exposure to nanoparticles. In addition, NTRC established a nanoparticle aerosol generation system and began conducting animal inhalation studies during the summer of 2006. These studies will help scientists determine whether some engineered nanomaterials pose risks to human health in the work setting. They will also help determine the mechanisms by which they operate. Although the results of these studies are preliminary and limited, more research is needed to predict whether they signal a health risk to humans. The data support the need to address that question and provide promising leads for strategic, ongoing studies.NTRC investigators have evaluated exposure-response information and deve l oped quantitative risk assessment methods for nanoscale titanium dioxide; these efforts may serve as a model for assessing the risk of other nanoparticles. To gain further knowledge about exposure and control practices, the NTRChas established a field team (see Appendix B) to conduct assessments of workplaces where exposure to engineered nanoparticles may occur. To date, this team has partnered with various companies that produce or use engineered nanoparticles to obtain useful information about potential worker exposures, control technologies, and risk management practices.

2. Conduct research on applying nanotechnology to the prevention of work-related injuries and illnesses.NTRC has identified various possibilities for applying nanotechnology to occu p ational safety and health, including the application of this technology in fabricating more efficient filters, sensors, and protective clothing. NTRC has also conducted numerous discussions with academia and the private sector on other potential projects. Efforts are underway between NTRC, other CDC personnel, and the Georgia Institute of Technology to identify collaborative projects involving nanotechnology applications to occupational and public health problems.

3. Promote healthy workplaces through interventions, recommendations, and capacity building.NTRC has provided seminal guidance for workers and employers in nanotechno l ogy through the document entitled Approaches to Safe Nanotechnology: An Information Exchange with NIOSH . This document was posted on the NIOSHWeb site in 2005 and updated in August 2006 (see Appendix H for a summary). The document concludes the following:

v i

### vi **NIOSH Nanotechnology Research Center Executive Summary** 



## ■ Given the limited amount of information for determining with confidence whether adverse human health effects may be associated with production and use of engineered nanoparticles, interim precautionary measures should be taken to minimize worker exposures.



## ■ For most processes and job tasks, the control of airborne exposure to nanoaerosols can be accomplished using a wide variety of engineering control techniques (e.g., exhaust ventilation, process enclosure) similarto those used in reducing exposure to other types of aerosolized particulates.



## ■ Implementing a risk management program in workplaces where workers are exposed to nanomaterials can help to minimize the potential for exposure to nanoaerosols. Elements of such a programshould include engineering control techniques and good work practices. Engineering controls such as source enclosure (i.e., isolatingthe generation source from the worker) and local exhaust ventilation systems should be effective for capturing airborne nanoparticles. Current knowledge indicates that a well-designed exhaust ventilationsystem with a high-efficiency particulate air (HEPA) filter should effectively remove nanoparticles. The use of good work practices (e.g.,handling and transfer practices, using wet methods, cleaning of contaminated surfaces), the education and training of workers, and the use of personal protective equipment (PPE) when needed should help reduce the potential for exposure.



## ■ Respirators may be necessary when engineering and administrative controls do not adequately prevent exposures. Currently, there are nospecific exposure limits for airborne exposures to engineered nanoparticles, although occupational exposure limits exist for larger particles of similar chemical composition. Preliminary evidence shows that for respirator filtration media, particulates as small as 2.5 nm in diameter are efficiently captured, in keeping with single fiber filtration theory. Although this evidence needs confirmation, it suggests that it is likely that NIOSH-certified respirators will be useful for protecting workers from nanoparticle inhalation when properly selected and fit tested as part of a complete respiratory protection program.Other information products on the NIOSH Web site include the Nanotechnolog y t opic page (with an extensive section on Frequently Asked Questions) andthe Nanoparticle Information Library (NIL), which is a resource on particle information, including physical and chemical characteristics. In addition, NTRC

v ii

### ix **Executive Summary NIOSH Nanotechnology Research Center** 



### has convened a cross-Federal group to develop a framework document for health surveillance of workers exposed to nanomaterials. This document will also involve the business community to identify the range of issues involved in occupational health surveillance.Nationally and internationally, NTRC has delivered a wide range of prese n tations on occupational safety and health issues associated with nanotechnology. These have included presentations at scientific conferences, trade associations, and professional associations; meetings of government agencies and nongovernmental organizations (NGOs); and special panels convened by government agencies, NGOs, and professional associations (see Appendix A for a listing of NTRC presentations and other activities).NIOSH has cosponsored the three major international meetings on occupational safety and health involving nanomaterials. These research summits furthered the exchange of the latest information among leading scientists and promoted the application of research findings to actual workplace practice for minimizing occupational exposures. The third meeting will be held in Taiwan in 2007, and two NTRC scientists serve on the planning committee. NIOSH also cosponsored a major occupational safety and health research-to-practice (r2p) conference in Cincinnati, Ohio during December 2006, which drewmore than 450 participants from 11 countries. In addition, NTRC is collaborating with the U.S. Environmental Protection Agency (EPA), the Occupational Safety and Health Administration (OSHA), and other government agencies to obtain and evaluate exposure and good work practice information.

4. Enhance global workplace safety and health through national and international collaborations on nanotechnology research and guidance. NTRC has established several national and international collaborations to ad va nce understanding of occupational safety and health for nanotechnologyworkers. NTRC participates in the NNI and has contributed to the nanotechnology strategic plan for the Nation through the working group of NEHI. Occupational Safety and Health has been a major priority of the NEHI effort, and the NIOSH strategic research plan and activities are addressing most of the major issues in the NEHI plan. The NTRC has collaborated with the Organization for Economic Cooperation
an d D evelopment (OECD) to build cooperation, coordination, and communication between the United States and 30 OECD member countries (including the European Union), and with more than 180 nonmember economies as well.

v iii

### viii **NIOSH Nanotechnology Research Center Executive Summary** 



### NTRC is part of the U.S. leadership on the International Organization for Standardization (ISO) TC 229 Nanotechnology Working Group on Health, Safety, and the Environment. NTRC also works with the World Health Organization (WHO) Collaborating Centers on global projects of information dissemination and communication.Together, the research and guidance efforts of the NTRC are expected to enha n ce the safe use of nanotechnology in the workplace and safe work-relatedhandling of nanomaterials. However, until more information becomes available, it is appropriate to take precautions and apply recognized occupational exposure control measures where nanoparticle exposure may occur.


## Steps to Addressing Occupational Safety and Health Implications The NTRC research and guidance effort has been initiated to fill the knowledgegaps in prevention and control of workplace exposures to engineered nanoparticles. To accomplish this, the NTRC has focused its research program on hazard identification and characterization, exposure assessment, risk assessment,and risk management. While research continues, NIOSH partners and stakeholders have urged NIOSH to provide interim guidance for risk management until scientists understand those properties, characteristics, and behaviors of nanomaterials that may pose occupational safety and health risks. NTRC has provided such interim guidance and will continue to do so as research is being conducted. The NTRC research program has identified 10 critical topic areas important fo r un derstanding the potential health risks and developing and disseminating recommendations. The report describes each of these critical topic areas and the research being conducted. These 10 topic areas are the core of the NTRC research program and represent the areas that are most critical to addressing occupational safety and health issues. They include toxcity and internal dose, risk assessment, epidemiology and surveillance, engineering controls and PPE,measurement methods, exposure assessment, fire and explosion safety, recommendation and guidance, communication and education, and applications. By working in these 10 critical areas, NIOSH has comprehensively begun to address the information and knowledge gaps necessary to protect workers and responsibly move nanotechnology forward so that its far-reaching benefits may be realized.

ix

### xi **Executive Summary NIOSH Nanotechnology Research Center** 



## NIOSH Resource Limitations Since its inception in 2004, the NTRC has published more than 70 papers in thepeer-reviewed scientific literature (see specific research projects in the appendices) and provided a broad range of information and guidance. Publications in the area of hazard identification and characterization, exposure assessment, risk assessment, and risk management have provided a framework for beginning to address the potential hazards and risks from engineered nanoparticles. While these accomplishments have contributed significantly to our understanding of the potential health risks to nanoparticles, NIOSH research and subsequent development and dissemination of interim guidance efforts are limited by the amount of funding available. To the best of its ability in allocating limited resources to competing priorities, NIOSH has redirected funds internally over the past 3 years to build modest increases in nanotechnology research programsupport. New infusions of funding beyond the current NIOSH budget, specifically directed toward the program, would be needed for significant expansion of research to address the following research gaps:

1. Although NIOSH toxicology studies have provided better understanding o f t he ways in which some types of nanoparticles may enter the body and interact with the body’s organ systems, the breadth and depth of such research efforts have been limited to a few nanoparticle types. More types of nanoparticles need to be assessed for characteristics and properties relevant for predicting potential health risk. 2	 NIOSH field investigators have assessed exposure to engineered
na n oparticles in some workplaces, but few data exist on the extent and magnitude of exposure to other types of nanoparticles in workplaces that manufacture or use nanomaterials, nanostructures, and nanodevices.
3. NIOSH guidance is a first step toward controlling nanoparticles in the
wo r kplace; however, more research is needed on the efficacy and specificity of engineering and work practice control measures. NIOSH needs support to conduct more field investigations.
4. An increasing number of workers are involved with the research, deve l opment, production, and use of nanomaterials, but there is a lack of specific guidance for occupational health surveillance. NIOSH needs support to conduct research on the short- and long-term potential health risks in nanotechnology workers. This may involve the conduct of large-scale prospective epidemiologic studies and the establishment of exposure registries.

x

### x **NIOSH Nanotechnology Research Center Executive Summary** 



### 5. The utility of nanotechnology to support the development of new technol ogies (such as sensors, more efficient filters, and better protective materials) that can enhance the protection of workers requires further research and development and can be advanced by additional resources.In summary, the NTRC has advanced the scientific knowledge in understanding th e possible health risks of engineered nanoparticles. Continuing research will help to expand this knowledge and provide opportunities for advancing the safe use of nanotechnology.

xi

### xiii xii

### xii 

# Contents

Foreword

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii Executive Summary

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iv Abbreviations

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiv Acknowledgments

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xvii Introduction

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Chapter 1 : Toxicity and Internal Dose

. . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Chapter 2 : Risk Assessment

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Chapter 3 : Epidemiology and Surveillance

. . . . . . . . . . . . . . . . . . . . . . . 23 Chapter 4 : Engineering Controls and Personal Protective Equip ment

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Chapter 5 : Measurement Methods

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Chapter 6 : Exposure Assessment

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Chapter 7 : Fire and Explosion Safety

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 Chapter 8 : Recommendations and Guidance

. . . . . . . . . . . . . . . . . . . . . 47 Chapter 9 : Communication and Education

. . . . . . . . . . . . . . . . . . . . . . . 53 Chapter 10 : Applications

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59 Appendices A. Project-Specific Progress Reports

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 63 B. Field Research Team Progress Report

. . . . . . . . . . . . . . . . . . . . . . . . . 131 C. Occupational Health Surveillance for Nanotechnology Workers

. . 137 D. Review of the NIOSH Extramural Nanotechnology Research Prog ram: Fiscal Years 2001–2006

. . . . . . . . . . . . . . . . . . . . . . . . . . . 139 E. Nanotechnology Information Dissemination

. . . . . . . . . . . . . . . . . . . 151 F. Other NTRC Partnership Activities and Presentations

. . . . . . . . . . . 159 G. Projected Timeframe for Addressing Critical Areas

. . . . . . . . . . . . . 165 H. Executive Summary— Approaches to Safe Nanotechnology: An Information Exchange with NIOSH

. . . . . . . . . . . . . . . . . . . . . . . . . 171

xiii

### xv 

# Abbreviations

AIHA American Industrial Hygiene Association AIHce American Industrial Hygiene Conference and Exposition ANSI American National Standards Institute ASSE American Society of Safety Engineers ASTM American Society for Testing and Materials BIA Berufsgenossenschafliches Institut für Arbeitsschutz CDC Centers for Disease Control and Prevention CIB Current Intelligence Bulletin CMPND Center for Multifunctional Polymer Nanomaterials and Devices CNF ca r bon nanofiber CNT carbon nanotube COPD Chronic obstructive pulmonary disease CPC Condensation Particle Counter CSHEMA Campus Safety, Health and Environment Management Association DART Division of Applied Research and Technology DEP Diesel exhaust particulate DSHEFS Division of Surveillance Hazard Evaluation and Field Studies DRDS D ivision of Respiratory Diseases DSR Division of Safety Research EHS Environmental Health Sciences EID Education and Information Division EPA U.S. Environmental Protection Agency EU European Union FAQs Frequently Asked Questions FMPS Fast Mobility Particle Sizer FY Fiscal year HELD Health Effect Laboratory Division HEPA High-Efficiency Particulate Air Filter

xi v

### xiv **Abbreviations**



### HHE Health Hazard Evaluation HHPC hand-held particle counter IAPA Industrial Accident Prevention Association ICMAT International Conference on Materials for Advanced Technologies ICON International Council on Nanotechnology INRS In s titut National de la Recherche Scientifique ISO Int ernational Organization for Standardization kW kil owatt LDH lac tate dehydrogenase MCE mixe d cellulose ester MIST man-in-simulation test MOU memorandum of understanding MOUDI micro-orifice-uniform-deposit impactor NASA National Aeronautics and Space Administration NATO North Atlantic Treaty Organization NCER National Center for Environmental Research NEHI Nanotechnology Environmental and Health Implications NFPA National Fire Protection Association NGO non-g overnmental organization NIH Nat ional Institutes of Health NIEHS National Institute of Environmental Health Sciences NIL Na n oparticle Information Library NIOSH National Institute for Occupational Safety and Health NIST Nat ional Institute of Standards and Technology

nm nan ometer(s) NNI Nat ional Nanotechnology Initiative NNIN National Nanotechnology Infrastructure Network NORA National Occupational Research Agenda NPPTL National Personal Protective Technology Laboratory NRC Nat ional Research Council NSET Nanoscale Science, Engineering, and Technology

xv

### xvii **NIOSH Nanotechnology Research Center**



### NSF National Science Foundation NTRC NIOSH Nanotechnology Research Center OD Office of the Director OECD Organization for Economic Cooperation and Development OEP Offi ce of Extramural Programs ORC Organization Resource Council OSH occupational safety and health OSHA Occupational Safety and Health Administration PAS passive aerosol sampler PPE personal protective equipment PRL Pittsburgh Research Laboratory PSLT poorly soluble, low toxicity QD quantum dot QRA quantitative risk assessment r2p research to practice REL recommended exposure limit RFA request for application RTI Research Triangle Institute SBIR Small Business Innovative Research SNORA Small National Occupational Research Agenda on personal protective equipment SRL Sa fety Research Laboratory SWCNT single-walled carbon nanotube TEM Transmission Electron Microscopy TEM/EDS Transmission Electron Microscopy/ Energy Dispersive Spectroscopy TERA T oxicology for Excellence in Risk Assessment TiO2 titanium dioxide TSCA Toxic Substances Control Act WHO World Health Organization

xv i

### xvi 

# Acknowledgments

This report was developed by the scientists and staff of the National Institute for Occupational Safety and Health (NIOSH) who participate in the NIOSHNanotechnology Research Center (NTRC). Paul Schulte, Ph.D., is the coordinator of the NTRC. Special thanks go to Vincent Castranova, Ralph Zumwalde, Charles Geraci, Mark Hoover, and Amanda Harney Gust for organizing this report. Other NIOSH staff who conducted or contributed to the work described here include the following: James Antonini, Paul A. Baron, Stephen Berardinelli Jr., Eileen M. Birch, Fred Blosser, George R. Bockosh, Aleksandar D. Bugarski, David W. Chrislip, Keith G. Crouch, Brian D. Curwin, Gregory A. Day, Gregory J. Deye, Ming Ding, Clayton B. Doak, Kevin H. Dunn, Kelley D urst, G. Scott Earnest, Cherie F. Estill, Douglas E. Evans, Michael Galvin, Pengfei Gao, John Howard, Ann Hubbs, DeLon R. Hull, Vijia K.Karra, Bon-Ki Ku, Eileen Kuempel, Pramod S. Kulkarni, Li-Ming Lo, Max Lum, Michael Luster, John McKernan, Walter H. Mengel, Robert Mercer, Mark M. Methner, Paul Middendorf, Arthur L. Miller, Diane B. Miller, Vladimir Murashov, James O’Callaghan, Andrea Okun, Dale Porter, Larry Reed, Dori Reissman, Appavoo Rengasamy, Allen Robinson, Ronald Shaffer, Anna Shvedova, Petia Simeonova, Aleksandr Stefaniak, Virginia Sublet, Douglas Trout, Leonid A. Turkevich, and Mary L. Woebkenberg. NIOSH would also like to acknowledge the seminal contribution of Andrew May nard (formerly with NIOSH) to the NTRC and the early leadership of Mary Lynn Woebkenberg. Vanessa Becks, Gino Fazio, Steve Leonard, and Anne Stirnkorb performed des ktop publishing, and graphic design. Anne Hamilton, Susan Afanuh, andJane Weber edited the report. Brenda Proffitt provided word processing support.

xv ii

# Introduction**Introduction NIOSH Nanotechnology Research Center** 



## Background Nanotechnology is a system of innovative methods to control and manipulate matter at near-atomic scale to produce new materials, structures, and devices. Nanoparticles are a specific class or subset of these new materials that have at least one dimension that is less than 100 nm. They exhibit unique properties because of their nanoscale dimensions. Nanotechnology offers the potential fortremendous improvement and advances in many areas that may benefit society, such as integrated sensors, semiconductors, medical imaging, drug delivery systems, structural materials, sunscreens, cosmetics, coatings, and many others. Nanotechnology is one of the most rapidly growing industries across the world. By 2015, the global market for nanotechnology-related products is predicted to reach $1 trillion and employ 1 million workers in the United States alone. The properties of nanoparticles (e.g., size, surface area, reactivity)that yield many of the far-reaching societal benefits may also pose risks. Currently, increasing numbers of workers are potentially exposed to nanomaterialsin research laboratories, startup companies, production facilities, and operations where nanomaterials are processed, used, disposed of, or recycled. The challenges are to determine whether the nature of engineered nanostructured materials and devices presents new occupational safety and health risks. At thesame time, the need is to realize the benefits of nanotechnology while proactively minimizing the risk.Multiple Federal agencies are fostering the development and use of nanot e chnology. The President’s Council of Advisors on Science and Technology has collaborated with the interagency National Science and TechnologyCouncil to create the National Nanotechnology Initiative (NNI). This initiative supports basic and applied research and development in nanotechnology to create new nanomaterials and to disseminate new technical capabilities to industry. The purpose of NNI is to facilitate scientific breakthroughs and maintain U.S. competitiveness in nanoscience. A stated goal of this interagency program is to ensure that nanotechnology research leads to the responsible development of beneficial applications by giving high priority to research on societal implications, human health, and environmental issues related to nanotechnology.The National Institute for Occupational Safety and Health (NIOSH) is the Fede r al agency responsible for conducting research and making recommendations to prevent work-related injury, illness, and death. NIOSH is a member of the Nanoscale Science, Engineering, and Technology (NSET) Subcommittee of theNational Science and Technology Council. As such, NIOSH is active in (1) identifying critical issues related to possible hazards of nanomaterials, (2) protecting

2**NIOSH Nanotechnology Research Center Introduction** 



### worker safety and health in this emerging technology, and (3) implementing a strategic plan for conducting research and for developing guidance documents. Because of their small size and large surface area, engineered nanoparticles
m a y have chemical, physical, and biological properties distinctly different fromand greater than fine particles of similar chemical composition. Such properties may include a high rate of pulmonary deposition, the ability to travel from the lung to systemic sites, the ability to penetrate dermal barriers, and a high inflammatory potency per mass. At a time when materials and commercial applications are being conceived, NIOSH is well positioned to proactivelyidentify, assess, and resolve potential safety and health issues posed by nanotechnology. NIOSH has 35 years of experience in conducting research and formulating recommendations for occupational safety and health. During thisperiod, NIOSH has developed considerable expertise in measuring, characterizing, and evaluating new processes and new materials by conducting quantitative exposure assessments and evaluating health effects. NIOSH also has expertise in developing control systems and prevention strategies for incidental nanoparticles (for example, diesel exhaust, welding fume, smelter fume, and fire smoke particles). NIOSH is using this experience to address similar issues for engineered nanoparticles. NIOSH has redirected programmatic funds ($3.0 million in FY 2005, $3.7
m i llion in FY 2006, and $4.6 million in FY 2007) to resolve occupational safety and health knowledge gaps in the field of nanotechnology by conducting a broad program of research and guidance development. This report describes the progress of the NIOSH Nanotechnology Research Center (NTRC). The Center is a matrix of activities and projects consisting of and supported by more than 30 scientists from various divisions and laboratories in NIOSH who have developed and implemented a strategic plan (available at www.cdc.gov /
n i osh/topics/nanotech) to address occupational health issues of nanotechnology. See Appendix G for a projected timeline of activities.

The NIOSH Role in Occupational Safety and Health of Nanotechnology W ork ers A complete process for managing occupational safety and health implications d ur ing the development of new technologies and materials consists of a set of progressive elements: identifying and characterizing the hazard, assessing theextent of exposure, characterizing the risk, and developing control and management procedures. As exposure assessment data become available, it can be determined whether an occupational risk exists; if so, the risk can be assessed and characterized. The risk characterization should make it possible to

3**Introduction NIOSH Nanotechnology Research Center** 



### determine whether workplace exposure to a given technology or material (in this case, nanoparticles) is likely to result in adverse health effects. The exposureassessment data will also provide a means to determine what controls are effective in preventing exposure that could cause adverse effects. The NTRC is involved in answering questions posed in each element in the risk management process (Figure 1). Particularly as this report illustrates, the NTRC has begun to answer questions about hazards by assessing exposures to nanoparticles in surrogate animals using well established scientific principles. Toxicological research is one element that forms the foundation for occupational safety and health. The critical routes of exposure (respiratory and skin) and their targets (lungs, cardiovascular, skin, brain, systemic) are being identified, and research is being conducted on the health effects and mechanisms of action of specific nanoparticles. Meanwhile, research is being conducted on measuring nanoparticles in air, d et ermining what measures are appropriate, and using this information in field assessments. Parallel efforts have been undertaken to address the control ofairborne nanoparticles and the strengths and weaknesses of control approaches. Similar efforts are underway for personal protective equipment (PPE) such as respirators and gloves. The findings of field investigations and laboratory research are continually used t o update guidance for thinking about, evaluating, and managing potential nanotechnology risks. This information is being widely disseminated by NIOSH. The problem is that it is difficult to proceed in a classic step-by-step fashion f r om hazard identification to risk management because each day more workers may be exposed to nanomaterials as nanotechnology permeates industrial and commercial sectors. Thus the challenge is to conduct research toaddress knowledge gaps while drawing on all available information to provide interim guidance. Fortunately, a body of knowledge exists on hazards, risks, and controls for particles between 100 nm and 1μm. Nanomaterials that are currently manufactured apparently have no major physical features that would make them behave differently from fine and ultrafine particleswhen controlling them in the workplace. However, the limits of this assumption need continued evaluation. Despite a comprehensive approach, NIOSH research and guidance is limited b y r esource constraints. Workplace applications of nanotechnology are numerous and diverse. At this time, it is difficult to understand whether broad, homogenous classes of nanoparticles can be identified for testing and control purposes. The vast diversity of nanoparticles presents a challenge

4

### 5 Figure 1. Steps to protect workers involved with nanotechnology. Adapted from Gibbs, 2006. **Introduction Introduction**  **NIOSH Nanotechnology Research Center**



### for determining which ones should be the focus of research. NIOSH has primarily been addressing the growing categories of carbon nanotubes, carbon nanofibers, metal oxides, and quantum dots in laboratory and fieldinvestigations. However, within each category is a broad range of combinations, surface characteristics, and physical and chemical parameters that can and are being altered by researchers and manufacturers. Although specific nanoparticles are being assessed in toxicologic research, the NTRC field team is proceeding to identify and assess the growing range of nanoparticles in the workplace. 

## Critical Topic Areas NTRC has identified 10 critical topic areas (Figure 2) to (1) guide its research in areas where knowledge gaps exist, (2) develop strategies, and (3) provide recommendations. Each chapter (1–10) provides a brief description of the research that NTRC is conducting in the topic area and the applications and

Toxicity and internal dose Risk assessment Epidemiology and sur veillance



## Applications Exposure Fire and explosion assessment safety Measurement R ecommendations

methods and guidance Engineering Communication controls and PPE and education

Figure 2. The 10 critical areas identified by the NTRC.



### 6**NIOSH Nanotechnology Research Center Introduction** 



### implications of nanomaterials in the workplace. Research needs for each topic area are listed as follows: 1. Toxicity and Internal Dose



## ■ Investigating and determining the physical and chemical properties (e.g., size, shape, solubility) that influence the potential toxicity of nanoparticles



## ■ Determining what happens to nanomaterials once they enter the body.



## ■ Evaluating short- and long-term effects that nanomaterials may have in organ systems and tissues (e.g., lungs, brain, cardiovascular)



## ■ Determining biological mechanisms for potential toxic effects



## ■ Creating and integrating models to help assess hazards



## ■ Determining whether a measure other than mass is more appropriate for determining toxicity
2. Risk Assessment



## ■ Determining how existing exposure-response data for fine and ultrafine particles (human or animal) may be used to identify and assess occupational hazards and risks



## ■ Developing a framework for evaluating potential hazards and predicting the occupational risk of exposure to nanoparticles
3. Epidemiology and Surveillance



## ■ Evaluating existing epidemiological studies in the workplace where nanomaterials are used



## ■ Identifying knowledge gaps that could be filled by epidemiologicalstudies to advance the understanding of nanomaterials and evaluating the feasibility of conducting new studies



## ■ Integrating nanotechnology safety and health issues into existing hazard surveillance methods and determining whether additional screening methods are needed



## ■ Using existing systems to share data and information about nanotechnology
4. Engineering Controls and PPE



## ■ Evaluating the effectiveness of engineering controls in reducing occupational exposures to nanoaerosols and developing new controls when needed

7**Introduction NIOSH Nanotechnology Research Center** 



## ■ Evaluating the suitability of control banding techniques when additional information is needed, and evaluating the effectiveness of alternative materials



## ■ Evaluating and improving current PPE



## ■ Developing recommendations to prevent or limit occupational exposures to nanomaterials (e.g., recommending respiratory protection)

5. Measurement Methods



## ■ Evaluating methods for measuring the mass of respirable particles in the air and determining whether this measurement can be used to measure nanomaterials



## ■ Developing and field-testing practical methods to accurately measure airborne nanomaterials in the workplace



## ■ Developing, testing, and evaluating systems to compare and validate sampling instruments

6. Exposure Assessment



## ■ Determining key factors that influence the production, dispersion, accumulation, and re-entry of nanomaterials into the workplace



## ■ Determining how possible exposures to nanomaterials differ by work process



## ■ Assessing possible exposure when nanomaterials are inhaled or settle on the skin

NIOSH monitoring of a worker during a nanomaterial powder production and collection.



### 8**NIOSH Nanotechnology Research Center Introduction** 



### 7. Fire and Explosion Safety



## ■ Identifying physical and chemical properties that contribute todustiness, combustibility, flammability, and conductivity of nanomaterials



## ■ Recommending alternative work practices to eliminate or reduce workplace exposures to nanomaterials

8. Recommendations and Guidance



## ■ Using the best available science to make interim recommendations for workplace safety and health practices during the production, use, and handling of nanomaterials



## ■ Evaluating and updating mass-based occupational exposure limits for airborne particles to ensure good, continuing precautionary practices

9. Communication and Education



## ■ Establishing partnerships to allow for identifying and sharing research needs, approaches, and results



## ■ Developing and disseminating training and education materials toworkers, employers, and occupational safety and health professionals

10. Applications



## ■ Identifying uses of nanotechnology for application in occupational safety and health



## ■ Evaluating and disseminating effective applications to workers, employers, and occupational safety and health professionals The remainder of this report provides an update describing the research and guid ance efforts in each of the 10 critical topic areas of the NTRC. In addition,ongoing partnerships and collaborations are identified along with accomplishments and areas where future research is needed. The appendices provide details of each intramural project and they outline published research andpresentations of the NTRC staff. Appendix D provides information regarding the nanotechnology research being funded through the NIOSH Office of Extramural Programs.

9

# Toxicity and Internal Dose 

# 1**Chapter 1 ■ Toxicity and Internal Dose NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Background NIOSH has studied in great detail the toxicity of incidental exposures to nanoparticles generated from processes involving combustion, welding, ordiesel engines. However, less is known about nanoparticles that are intentionally produced (engineered) with diameters smaller than 100 nm. Many uncertainties exist as to whether the unique properties of engineered nanomaterials pose occupational health risks. These uncertainties arise because of gaps in knowledge about the potential routes of exposure, movement of nanomaterials once they enter the body, and the interaction of the materials with the body’sbiological systems. Results from existing animal and human studies of exposure to incidental nanoscale and other respirable particles provide preliminary information about the possible adverse health effects from exposures to similar engineered nanomaterials. The NTRC is conducting research to address the following questions:



## ■ Is particle surface area a more appropriate measure of exposure than particle mass?



## ■ Does a high deposition of nanoparticles in the lungs affect clearance and movement of nanoparticles from airspaces into cells, tissues, and blood vessels?



## ■ Can nanoparticles get into various organs once they are in the bloodstream?



## ■ By what mechanisms do nanoparticles generate reactive oxygen species?



## ■ Do nanoparticles cause adverse health effects in workers if they penetrate the skin?



## ■ How do shape, durability, and chemical composition of nanoparticles affect their biological activity?



## ■ Do nanoparticles that are bound together separate into smaller, possibly more potent structures in biological fluids?



## ■ Are in vitro assays predictive of in vivo responses to nanoparticles?


## NTRC Toxicology and Internal Dose ProjectsThe NTRC has built a comprehensive research program focused on the question of whether nanomaterials pose occupational health risks. Currently, sev12**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 1 ■ T**  **o xic**  **i t**  **y a n**  **d I n**  **t**

**e r**  **n a**  **l D os**  **e**



### eral projects are underway and are primarily studying the effects of inhalation and dermal exposure to nanoparticles. Projects include the following:



## ■ Measuring how nanoparticles deposit in andclear out of the lungs after intratracheal instillation, pharyngeal aspiration, or pulmonary exposure



## ■ Monitoring how nanoparticles move from the airways into tissue and blood through the use of labeled nanoparticles



## ■ Measuring pulmonary damage, oxidantstress, inflammation, and fibrosis after pulmonary exposure to nanoparticles of various compositions and shapes



## ■ Measuring the cardiovascular effects of pulmonary exposure to nanoparticles of various compositions and shapes



## ■ Measuring how nanoparticles move from the lung to brain tissue and determining whether this results in neural effects



## ■ Determining the role of surface area in biological activity



## ■ Determining the ability of lung lining fluid to separate nanoparticles that are bound together



## ■ Determining whether in vitro measurement of the oxidant-generating capacity of nanoparticles predicts in vivo response



## ■ Determining dermal effects of exposure to nanoparticles of various compositions and shapesFor more information about the NTRC nanotoxicolog y projects, see Appendix A, Projects 1 through 10. 

## Collaborations and Partnerships NTRC scientists working in the area of toxicity and internal dose have established external collaborations Transmission electron micrograph (TEM) of dispersed multiwalled carbon nanotubes. Magnification=4,350X 800 nm

20 μm Collagen

SWCNT
Alveolar granulomas containing single-walled carbon nanotube (SWCNT) with collagen detected in granuloma, indicating a fibrotic response. Thetissue sample was collected 7 days following exposure to 40 μg of SWCNT by pharyngeal aspiration in rats.



### 13

### 14 with universities, private industries, and other government agencies. Collaborations are intended to advance knowledge and understanding of the factors that are critical for determining whether nanoparticles pose an occupational risk of harmful effects. NTRC is collaborating with organizations such as the National Aeronautics and Space Administration (NASA), the University ofPittsburgh, West Virginia University, IBM, and Mitsui Incorporated. These collaborations provide a multidisciplinary approach to addressing research needs and ensure high-quality research.


## AccomplishmentsThe NTRC Toxicity and Internal Dose team has had significant accomplishments over the last several years to advance knowledge and understanding of exposure to nanomaterials. The team has accomplished the following:



## ■ Developed a method for improved dispersion of nanoparticles for in vitro and in vivo exposure



## ■ Determined the in vitro effect of single-walled carbon nanotubes or metal oxide nanoparticles on dermal cells in culture



## ■ Determined the pulmonary effect of exposure to single-walled carbon nanotubes



## ■ Labeled single-walled carbon nanotubes and tracked their deposition and migration in the lung in laboratory animals



## ■ Developed systems to generate aerosolized ultrafine titanium dioxide (TiO 2 

### ) particles and single-walled carbon nanotubes (SWNCTs) at a controlled size and concentration



## ■ Determined cardiovascular response in laboratory animals to pulmonary exposure to single-walled carbon nanotubes and TiO 2 

### nanopar

ticles

20 μm 20 μm Right: Microvessel in rat muscle showing a buildup ofpolymorphonuclear neutrophils (PMNs) on the vesselwall 24 hours after intratracheal installation exposure to Ti0 2 . The vessel wall is less responsive to vasodilators and blood flow is restricted. Left: Microvessel from a control rat showing no buildup of PMNs and free-flowing blood cells.**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 1 ■ T**  **o xic**  **i t**  **y a n**  **d I n**  **t**

**e r**  **n a**  **l D os**  **e**



### For more information about the NTRC nanotoxicology accomplishments, see Appendix A, Projects 1 through 10.


## Additional Research Needs and Future Direction Although the NTRC has made significant advancements in understanding the potential harmful effects of exposure to nanomaterials, much more research isneeded. The NTRC is focusing its research efforts in the following four primary areas:
1. Determining the nature and severity of effects on the lung from inhaled
na noparticles 2. Determining whether nanoparticles can move to other parts of the bo dy (e.g., the heart or brain) after the particles are inhaled 3. Determining whether exposure to nanoparticles has any effect on the imm une system 4. Determining whether the unique physical and chemical properties of
na noparticles affect how the body responds when exposed to these particles

200 nm

200 nm Fullerenes—These are TEMs of nanoparticles suspended in water and sonicated.

SWCNTs produced by the high-pressure decomposition of carbon monoxide (HiPCO) method. Arrows note iron contamination of the unpurified SWCNT.


### 15

# Risk Assessment 

# 2**Chapter 2 ■ Risk Assessment NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## BackgroundIn the context of occupational safety and health, risk assessment can be described as a scientific evaluation of the potential for adverse safety and health effects to workers exposed to hazardous substances. When assessing risk, it must be determined whether a hazard is present and the extent to which aworker is likely to be exposed to the hazard. Risk occurs only when a hazardous agent is present and a worker is exposed to that agent. Quantitative and qualitative risk assessment methods are used to evaluate risk.Quantitative risk assessment methods are used when adequate data are availab le concerning the relationship between the amount of exposure received and the reaction to that exposure. This relationship is known as dose-response. Quantitative methods are useful to estimate exposure concentrations that are likely (or unlikely) to cause adverse health effects. The estimates are then used

Risk assessment paradigm. (Based on National Research Council [1983]. Risk assessment in the Federal government: managing the process. Committee on the Institutional Means for Assessment of Risks to Public Health, Commission on Life Sciences, National Research Council. Washington, DC: National Academy Press, 191 pp.)



### 18**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 2 ■ R**  **i s**  **k A s**  **s e**  **s s**  **m e**  **n t** 



### in conjunction with occupational exposure data (1) to characterize the health and safety risk to workers, (2) to form a basis for risk management decisions,and (3) to evaluate the effectiveness of engineering controls and other occupational safety and health measures. When adequate dose-response data are notavailable, qualitative risk assessment methods such as comparative or hazardranking approaches may be used. To develop appropriate risk assessment models and methods, risk assessors work closely with experimental scientists to design laboratory experiments that will provide useful data for estimating risk and uncertainty. They also work with risk managers to provide the analyses needed to develop effective risk reduction strategies. 

## NTRC Risk Assessment Projects The goal of occupational risk assessment is to predict conditions in the workenvironment that could lead to safety and health hazards for workers. This information is used by risk managers to develop appropriate preventive measures

Predicted deposition of inhaled particles in the human respiratory tract— ICRP [1994] model: light exercise, nose breathing; 0.1–5 μm, minimal inertial and diffusion deposition mechanisms. (Source: ICRP, InternationalCommission on Radiological Protection [1994]. ICRP Publication 66: Human respiratory tract model for radiological protection. Elsevier Science, Inc. Tarrytown, NY.)



### 19**Chapter 2 ■ Risk Assessment NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### to reduce or eliminate the risk. In a new industry such as nanotechnology, human data are not yet available for estimating the risk of exposure to engineered nanoparticles. Therefore, NTRC is scientifically extrapolating existing animal data to humans to evaluate dose-response relationships and estimate the risk to workers who are producing or using nanoparticles. To advance understanding of this risk and to provide improved scientific models and methods that assess the risk of exposure to nanoparticles, the NTRC Risk Assessment team is currently focusing its research efforts in the following three
areas: 1. Extending current rodent lung models to describe the fate of inhaled
na n oparticles and their increased potential for translocating to other organs in the body 2. Investigating models to describe biologically based relationships betw e en internal dose and biological response 3. Developing state-of-the-art statistical methods to consolidate risk estima t es from a number of equally plausible dose-response models The NTRC is also investigating quantitative and qualitative risk assessment met h ods for occupational exposure to nanoparticles. Information currentlyavailable includes (1) toxicology and epidemiology studies of respirable airborne particles and fibers and (2) toxicology studies of in vitro and in vivo responses to nanoparticles. Existing studies provide the NTRC with a basis fordeveloping interim occupational safety and health guidance, and for comparing the effects of well-studied materials to the effects of new nanoparticles, as data become available.For more information about the NTRC nanotechnology risk assessment projec ts, s ee Appendix A, Project 12. 

## Collaborations and Partnerships Risk assessors who are part of the NTRC have established both internal and external collaborations with other researchers and organizations. External partners include CIStems Institute of Information Technology (CIIT) Centers for Health Research, the Institute of Occupational Medicine, and Toxicologyfor Excellence in Risk Assessment. Research collaborations are underway in areas such as (1) study design for risk assessment of nanoparticles, (2) evaluation of dose metric, (3) translocation of labeled nanoparticles, (4) region-specific deposition of inhaled nanoparticles, and (5) biomathematical lung modeling of nanoparticle deposition and early biological responses.

20**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 2 ■ R**  **i s**  **k A s**  **s e**  **s s**  **m e**  **n t** 



## Accomplishments Between 2004 and 2006, NTRC risk assessors had significant accomplishments in their research projects. The Risk Assessment Team has accomplished the following:



## ■ Performed quantitative risk assessment using data from existing studies of fine and ultrafine particles



## ■ Developed partnerships with external researchers in an effort to filldata gaps and obtain the scientific information needed to achieve occupational safety and health research objectives



## ■ Published research findings in scientific, peer-reviewed publications



## ■ Presented research findings at scientific meetings More specifically, a quantitative risk assessment of fine and ultrafine TiO 2 

### particles was used as the basis for recommended exposure limits (RELs) in aNIOSH Current Intelligence Bulletin. Modifications to a lung deposition model were completed to provide enhanced capabilities for lung dosimetry modeling and research of nanoparticles. Finally, NTRC researchers were invited to provide expert advice and consultation to national and international working groups evaluating occupational safety and health issues of nanoparticles.



## Additional Research Needs and Future Direction During FY 2007, NTRC risk assessors will initiate research efforts involving nanoparticles in two primary ways:
1. Investigating the application of risk assessment methods using existing da t a to provide a framework for developing preliminary risk management strategies 2. Exploring biomathematical modeling approaches to fill data gaps conce r ning occupational health risks of exposure to nonspherical nanoparticles (i.e., carbon nanotubes) These research efforts, in conjunction with ongoing projects, will provide NTRC wi t h a sound scientific basis for determining interim estimates of the potential safety and health hazards to workers exposed to engineered nanoparticles. It will also assist NTRC in providing prudent interim guidelines for using engineeringcontrols, work practices, and other risk management strategies to protect workers responsible for producing and/or using nanomaterials. These assessments may be refined as research is finalized and new data become available.

21

# 3

Epidemiology and Surveillance**Chapter 3 ■ Epidemiology and Surveillance NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Background Human studies of exposure and response to engineered nanomaterials are not currently available. Gaps in knowledge and understanding of nanomaterials must be filled before epidemiologic studies can be performed. For example, improvements in exposure assessment will allow researchers to identify groups of workers who are likely to be exposed to nanomaterials. In turn, health studies conducted on these worker groups can provide useful information about the health risks associated with nanomaterials. Until such studies can be conducted effectively, studies of humans exposed to other aerosols (e.g., larger respirable particles) can be used to evaluate the health risks of exposure to airborne nanomaterials.The available health data on workplace exposure to airborne respirable part i cles and fibers, and the air pollution data from epidemiology literature may provide valuable insight into the hazards of nanoparticle exposure. However,applying these data to workplace exposures to nanomaterials presents a number of challenges, including the following:



## ■ Determining the relative importance of particle size (less than 100 nm) as a cause of the observed health effect



## ■ Determining whether nanoparticles move throughout the body and potentially affect organ systems other than the one through which they entered the body The NTRC hopes to address these and other challenges as information is g a ined from epidemiologic and other health studies of workers exposed to nanomaterials. 

## NTRC Epidemiology and Surveillance Projects The lack of information about potential effects of workplace exposures to nanomaterials underscores the need for occupational health surveillance to be considered for nanotechnology workers. NTRC is addressing this lack of exposure and health effects data by developing guidance for employers and workers concerning the implementation of occupational health surveillance in workplaces where nanomaterials are handled. Every workplace involved in the production, use, and/or handling of engineered
n a nomaterials should conduct a needs assessment to make a qualitative riskdetermination. The guidance being developed by NTRC will consist of a framework for approaching such a needs assessment and applying existing hazard

24

### 25 and medical surveillance methods in workplaces. It will provide information to improve existing occupational health surveillance programs and methods for initiating programs where none exist. As the field of nanotechnology advances,it is likely that this guidance and framework will need to be revised and updated, as will any existing occupational health surveillance programs.



## Collaborations and PartnershipsThe NTRC has partnered with other Federal agencies to develop guidance related to occupational health surveillance for nanotechnology workers. Partners include the following:



## ■ U.S. Environmental Protection Agency



## ■ U.S. Department of Energy



## ■ U.S. Department of Defense



## ■ Occupational Safety and Health Administration



## ■ Lawrence Berkeley National Laboratory**Chapter 3 ■ Epidemiology and Surveillance NIOSH Nanotechnology Research Center** 



## AccomplishmentsThe NTRC has convened a cross-Federal group to develop guidance for nanotechnology employers and workers on implementing occupational healthsurveillance programs in the workplace. For more information about the development of an occupational health surveillance program for nanotechnology workers, please see Appendix C.



## Additional Research Needs and Future DirectionA well-recognized need exists for an improved ability to assess relevant exposures to nanoparticles (e.g., we need to determine how to appropriately measure nanoparticle exposure and to assess particle size distribution and composition). Improved exposure assessment will involve a series of important first steps and will be closely tied with improvements in identifying worker cohorts likely to be exposed to nanomaterials. These gaps in our current knowledgeabout nanomaterials must be filled before epidemiologic studies can be effectively carried out. In addition, toxicologic and health effects research is neededto identify potential health problems to be addressed through medical surveillance programs.

26

# 4

Engineering Controls and Personal Protective Equipment**Chapter 4 ■ Engineering Controls and Personal Protective Equipment NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## BackgroundBecause of the current lack of exposure standards for nanomaterials, an alternative rationale is required to evaluate the need for and effectiveness of engineering controls. In addition, the success of emerging nanotechnology industries will depend on production and development costs, including the installation of new exposure controls. Minimizing occupational exposure is the most prudent approach to controlling materials of unknown toxicity such as nanomaterials. Typically, these approaches include substituting a less toxic material if possible, enclosing the hazardous process, removing workers from exposure by automating the process, isolating workers from the hazard, and/or using local exhaust ventilation where nanomaterials are handled. Improvedcontrol approaches will become more evident as the risks of exposure to nanomaterials are better understood.When engineering controls are not feasible for reducing exposure to nanopart i cles, PPE such as respirators, protective clothing, and gloves should be considered. The use of PPE should be based on a combination of professional judgment and assessment of the hazard. A concern has been raised that nanoparticles could pass through the protective barrier of PPE at a higher ratethan larger particles because of their smaller size and unique properties. Therefore, NTRC is conducting research to address this concern. 

## NTRC Engineering Controls and PPE Projects Engineering Controls The published literature contains only a limited number of studies on theimplementation and effectiveness of engineering controls in the nanotechnology industry. Therefore, a group of NTRC researchers is assessing multiple approaches for controlling occupational exposure to nanoparticles. As part of this assessment, standard engineering controls are being thoroughly assessed to determine how controlling nanoparticle exposure differs from controllinglarger particle exposure. In addition, a group of NTRC researchers is conducting walk-through technical evaluations at a variety of facilities that handlenanomaterials. Scientists are evaluating the potential for occupational exposure to nanoparticles and the use of engineering controls at these facilities. They also provide interim recommendations on safe work practices and work with the company to evaluate the its engineering controls when applicable. For more information about the field investigations, see Appendix A, Project 13.

28**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 4 ■ E**  **n g**  **i n**  **e e**  **r i**  **n g C**  **o n**  **t r**  **o l**  **s a n**  **d P e**  **r**

**s o**  **n a**  **l P r**  **o t** 

**e c**  **t i**  **v e E**  **q u**  **i p**  **m e**  **n t** 



### pler that will be used in small-scale laboratory studies and testing of human A flat plate test system for measuring respirator filter penetration of 3 to 20 nm silver particles 

## Respirators and Other PPE Scientific information is available to characterize the efficiency of respirator filtration for particles larger than 20 nm in diameter. However, less isknown about smaller particles. To increase knowledge and understanding of these smaller particles, NIOSH funded a study in 2005 at the University of Minnesota’s Center for Filtration Research. Thepurpose of this study was to measure the penetration of nanoparticles between 3 and 20 nm in size through various filter media, including glass fiber, electret, and nanofiber. The respirator filter mediatested in this study effectively collected nanoparticles as small as 3 nm. There was no evidence that particles in this size range pass through filter media at a higher rate than the larger particles. The NTRCis planning studies to validate these findings using NIOSH-approved respirators and to evaluateworker exposures to nanoparticles when respirators do not fit correctly.The NTRC is also developing innovative method s to measure the penetration of nanoparticles through protective clothing and ensembles. TheNTRC developed a prototype passive aerosol samsubjects. The sampler will be used to evaluate the penetration of nanoparticles t h rough commercially available protective ensembles; iron oxide aerosolsdown to 20 nm will be used. Once this study is complete, the NTRC will develop a statistical model based on study results. For more information about the NTRC PPE studies, see Appendix A, Projects 15 a n d 16.


## Collaborations and Partnerships Engineering ControlsNTRC engineers, scientists, and industrial hygienists have established external collaborations to evaluate the effectiveness of engineering controls. These assessments have been conducted by the NTRC Field Research team through

29**Chapter 4 ■ Engineering Controls and Personal Protective Equipment NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### surveys conducted at various types of industries that handle engineered nanomaterials. One such collaboration is being used to evaluate the reduction in airborne exposure to nanomaterials after implementing engineering controls or safe work practices.


## Respirators and Other PPE NIOSH and E.I. du Pont de Nemours & Co. (DuPont) signed an agreement in June 2006 under a memorandum of understanding (MOU). The purpose of the MOU is to establish a formal partnership to conduct research and increaseknowledge and understanding of nanomaterials to reduce potential occupational exposures to nanoparticles. This MOU is effective through December 2007. 

## Accomplishments Engineering Controls In December 2005, NTRC conducted a comprehensive evaluation at a research facility that incorporates carbon-based nanomaterials into composites. NTRCcollected numerous airborne and surface samples and operated a set of realtime aerosol instrumentation as part of a task-based sampling approach. Engineering controls and work practices were observed and qualitatively evaluated. A report has been completed and will be made publicly available.

Checking for fiber release during destructive testing of nanofibers deposited on a substrate using optical andcondensation particle counters.



### 30**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 4 ■ E**  **n g**  **i n**  **e e**  **r i**  **n g C**  **o n**  **t r**  **o l**  **s a n**  **d P e**  **r**

**s o**  **n a**  **l P r**  **o t** 

**e c**  **t i**  **v e E**  **q u**  **i p**  **m e**  **n t** 



### In March 2006, NTRC conducted an extensive study at a primary manufacturer of nanoscale metal oxides. The purpose was to characterize potential occupationalexposure to nanomaterials and evaluate use of engineering controls and safe work practices. An interim report has been prepared for the manufacturing facility that includes results of the evaluation and provides recommendations about where improvements can be made to minimize exposure. NTRC is working with this company to demonstrate the effectiveness of implementing recommended changes to engineering controls and work practices. In July 2006, NTRC conducted a screening survey at amanufacturing facility where quantum dots are produced and encapsulated into small display units. The survey collected basic information about the types of processes employed, exposure control methods, andexposure measurement data. NTRC has drafted a report for the company that includes results from air and surface samples and provides recommendations for improving exposure controls and work practices where necessary. Results obtained from the evaluation of engineering
co ntrol practices at nanomaterial facilities will be usedto update recommendations in the NIOSH draft document Approaches to Safe Nanotechnology: An Information Exchange with NIOSH (available at www.cdc. gov/niosh/topics/nanotech/safenano/).


## Respirators and Other PPE Results of respirator and filtration research were reported in several media outlets and have been presented at national and international conferences. Findings will continue to be shared as the information becomes available. Enclosing hood with HEPA exhaust constructed to control possible emission of nylon nanofibers during destructive testing.

Local exhaust ventilation controlling fugitive emissions during precursor mixing at a primary nanoscale metal oxide production facility.



### 31**Chapter 4 ■ Engineering Controls and Personal Protective Equipment NIOSH Nanotechnology Research Center** 



## Additional Research Needs and Future Direction NTRC will focus its efforts on conducting in-depth field surveys and other research studies that document the effectiveness of various exposure controls and work practices for nanotechnology industries. To assist in developing sampling procedures, NTRC will continue collaborating with researchers who develop measurement protocols. NTRC will also continue its research of the potential for nanoparticles to penetrate respirators and other PPE. Findingswill be used to develop standards and methods to protect workers from exposure to nanomaterials.

32

# Measurement Methods 

# 5**Chapter 5 ■ Measurement Methods NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Background Sound scientific measurement methods are essential to effectively anticipate,recognize, evaluate, and control potential occupational health risks from current and emerging nanotechnologies. Traditional measurement approaches, such as determining total and respirable dust concentrations, may not be adequate for nanomaterials because of their unique physical, chemical, and biological properties.NTRC scientists are conducting research to identify and validate a comprehensi v e set of methods suitable for measuring nanomaterials. This area of research is known as nanometrology. To fill gaps in nanometrology, the Measurement Methods Team within the NTRC has identified three critical measurement goals:

1. Evaluate methods used to measure total and respirable dust concentrati o ns to determine whether the same methods can be used to measure nanomaterials.
2. Develop and field test practical methods to evaluate their accuracy in
me a suring airborne nanomaterials in the workplace.
3. Develop testing and evaluation systems to compare and validate samplin g in struments. 

## NTRC Measurement Methods ProjectsThe Measurement Methods team is focusing its efforts on building a knowledge base of methods suitable for measuring nanomaterials in the workplace. The team has a wide variety of research projects underway; within its projects the team is doing the following:



## ■ Establishing a controlled laboratory environment to generate nanoparticles and evaluate the effectiveness of instruments that measure thesize and morphology (structure and form) of these particles (this laboratory will allow researchers to conduct evaluations existing and new instruments using different nanomaterials)



## ■ Evaluating instruments to monitor nanoparticle aerosols in real time



## ■ Investigating innovative methods to estimate surface area of aerosols and demonstrating that these methods provide comparable results for nanoparticles of different shapes and sizes

34**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 5 ■ M**  **e a**  **s u**  **r e**  **m e**  **n t M**  **e t** 

**h o**  **d s** 



## ■ Evaluating different measurement methods to determine worker exposure to TiO 2 

### particles smaller than 2.5 and 0.1 μm in diameter (fine and ultrafine nanoparticles, respectively).



## ■ Developing new direct-reading instruments to measure size distribution, surface area, and mass concentration of nanoaerosols. In addition, the NTRC Measurement Methods Team supports the activities of the Fi eld Research Team in characterizing exposures to nanomaterials in theworkplace and evaluating the effectiveness of controls used to reduce exposures. The above research activities will provide a better understanding of the nature and e xtent of potential exposure to nanoparticles in the workplace. Results from these activities will help explain how nanoparticles are generated anddispersed. In addition, the results from ongoing research will help the occupational health community develop scientifically sound health protection strategies and provide information necessary for establishing voluntary national and international standards for emerging nanotechnologies. For more information about the NTRC measurement methods projects, see Pro jects 1, 5, 11, 13, 14, and 17 in Appendix A, and the Field Research Project in Appendix B.

Air sampling filter in close proximity during tear-testing of nanofiber coated cellulose.



### 35**Chapter 5 ■ Measurement Methods NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Collaborations and PartnershipsScientists within the NTRC Measurement Methods team are collaborating internally, as well as with external agencies and organizations, to characterize thepotential for nanoparticle exposure in the workplace, evaluate sampling instruments, characterize the physical and chemical properties of nanomaterials, and evaluate methods for controlling exposure. NTRC has established several partnerships with industries conducting research of ultrafine nanomaterials, as well as with national and international government agencies and standards organizations, academia, labor unions, and aerosol instrument manufacturers. External partnerships include the following:



## ■ National Institute of Standards and Technology



## ■ U.S. Environmental Protection Agency



## ■ U.S. Department of Energy



## ■ U.S. Department of Defense



## ■ American National Standards Institute



## ■ ASTM International

Comprehensive aerosols measurements conducted at different production processes within a primary nanoscale metal oxide production facility. A number of aerosol sampling methods and instruments are used simutaneously to better understand particle characteristics.



### 36**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 5 ■ M**  **e a**  **s u**  **r e**  **m e**  **n t M**  **e t** 

**h o**  **d s** 



### In addition, NTRC collaborates with several national and international committees and working groups, as well as with commercial instrument manufacturing companies. Additional partnerships are noted within the specific projects listed in Appendix A. 

## Accomplishments Between 2004 and 2006, scientists within the NTRC Measurement Methods team made significant advancements in characterization, implementation, and evaluation of measurement tools and techniques. The Measurement Methods team has accomplished the following:



## ■ Developed laboratory-based techniques for characterizing nanoparticles



## ■ Evaluated innovative instrumentation for nanometrology in controlled laboratory settings



## ■ Tested a set of measurement methods in nanotechnology workplaces



## ■ Developed nanoparticle reference materials in collaboration with the National Institute of Standards and Technology (NIST)



## ■ Disseminated research findings through scientific peer-reviewed publications, presentations, and the media



## ■ Provided expert advice and consultation to stakeholders through personal interactions and the NIOSH Nanotechnology Web page



## ■ Developed a prototype aerosol sampler that was submitted internally within NIOSH’s technology transfer channels for possible patenting For an expanded account of the accomplishments achieved within the NTRC Mea surement Methods Program, see Appendix A, Projects 1, 5, 11, 13, 14, and 17.


## Additional Research Needs and Future DirectionThe Measurement Methods team will focus its short-term efforts on supporting the field- and laboratory-based research plans outlined in the NTRC projects listed in Appendix A. In addition, the group plans to strengthen NTRC’s capabilities for characterizing nanoparticles (e.g., development of nanoaerosolsamplers), ensure that research findings are incorporated into national and international consensus standards, and expand both field- and laboratory-based research plans developed through the NTRC measurement projects.

37

# Exposure Assessment 

# 6**Chapter 6 ■ Exposure Assessment NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## BackgroundExposure assessment is a critical component in determining whether nanomaterials pose occupational safety or health risks. Therefore, it is necessary to conduct exposure assessments in the workplace to identify the ways that workers may beexposed to nanomaterials, the amount of exposure that may occur, and the frequency of potential exposure. Without workplace exposure data, it is difficult to accurately characterize the work environment, identify sources that are emitting nanomaterials, or estimate the amount of nanoparticle exposure that workers may receive. In addition, exposure data can be beneficial when making decisionsconcerning risk management or evaluating the effectiveness of engineering controls and work practices in reducing worker exposures. The NTRC Exposure Assessment team has initiated workplace evaluations of
wor ker exposure to nanomaterials in industries that produce and handle different types of nanomaterials. Several exposure assessment methods are being used to characterize exposures, including methods that will identify the size, shape, structure, and chemistry of airborne nanomaterials. This information is typically gathered after a walk-through evaluation of the facility. To the extent possible, personal breathing-zone samples are taken to ensure tha t each worker’s exposure is measured accurately. Unfortunately, many of the instruments currently available to detect nanomaterial exposures are too large to attach to the worker to collect breathing-zone samples. Therefore, general area air samples are taken in conjunction with personal samples to estimate the magnitude of nanomaterial exposure in areas occupied by workers.

Sampling for airborne nanoparticles during a drum changing operation in a commercial nanomaterial production facility.



### 40**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 6 ■ E**  **xp os**  **u r**  **e A s**  **s e**  **s s**  **m e**  **n t** 



## NTRC Exposure Assessment ProjectsNTRC is currently conducting both qualitative and quantitative exposure assessment surveys in a variety of producers and end-users of nanomaterials. For more information about these activities, see Appendix B. 

## Collaborations and Partnerships Scientists within the NTRC Exposure Assessment team are collaborating internally and with external agencies and organizations to develop and apply state-of-the-art methods to identify and characterize workplace exposures to nanomaterials, develop estimates of these exposures for exposure-response and risk assessment studies, and evaluate the significance of occupational exposure to nanomaterials and the effectiveness of intervention strategies. NTRC has also established partnerships with national and international gov ernment agencies and standards organizations, aerosol instrument manufacturers, and industries conducting research on nanoscale particles. External partners include the following:



## ■ Exposure Assessment Strategies Committee of the American Industrial Hygiene Association (AIHA)



## ■ Nanotechnology Working Group of AIHA



## ■ American Association for Aerosol Research and its international affiliates



## ■ American National Standards Institute (ANSI)



## ■ International Organization for Standardization (ISO) Technical Committee 229 on nanotechnologies

Sampling and data collection during a mixing operation. 

### 41**Chapter 6 ■ Exposure Assessment NIOSH Nanotechnology Research Center** 



## AccomplishmentsAs part of the NTRC, the Exposure Assessment team has made significant recent accomplishments in characterizing workplace exposures to nanomaterials. In the past year, NTRC has completed four exposure assessment surveys with the following organizations:



## ■ A university composite material research laboratory that integrates carbon nanofibers to strengthen plastic materials



## ■ A manufacturer of TiO 2 

## ■ A research laboratory that handles quantum dots



## ■ A filter manufacturer that applies nylon nanofibers to a cellulose base material to increase filtration efficiency For more information about these exposure assessment surveys, see the Field Re s earch Team Progress Report in Appendix B



## Additional Research Needs and Future DirectionThe NTRC Exposure Assessment team has identified several areas where additional research is needed. NTRC plans to continue its efforts conducting initial onsite exposure assessment surveys using handheld particle size andconcentration instrumentation in various nanotechnology facilities, and investigating work processes and practices that could potentially lead to exposure to nanomaterials. Upon completion of the initial surveys, NTRC plans to conductadditional exposure characterization studies using more sophisticated instrumentation capable of measuring particle size distributions, particle surface area, and the mass of particles for various size ranges. Measurements obtained during the detailed surveys are expected to allow NTRC to determine the extent of workplace exposure to nanomaterials and estimate their potential for causing health effects.In addition, NTRC will continue to work with partners to develop personalsiz e d sampling instruments that are able to measure particle size, shape, surface area, concentration, electrical charge, and other nanoparticle characteristics that may influence the conditions and potential health effects of workplace exposure. The development and validation of small sampling instruments toaccomplish these characterizations are critical to the field of exposure assessment, and in understanding the health effects that exposure to nanomaterials may have on workers.

42

# Fire and Explosion Safety 

# 7**Chapter 7 ■ Fire and Explosion Safety NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Background The field of nanotechnology is relatively new, and therefore little is known about the potential occupational safety hazards that may be associated with engineered nanomaterials. However, the information that is available about theproperties of nanoscale particles indicates that under given conditions, engineered nanomaterials may pose a dust explosion hazard and be spontaneously flammable when exposed to air because of their large surface area and overall small size. Until more specific data become available, NTRC is using findings from research studies involving particles smaller than 100 nm to evaluate the potential risk for fire and explosion of airborne nanoparticles. About 20 dust explosions occur in industry settings each year and result in pr o perty damage, worker injury, and death. Dust explosions burn rapidly and with extreme intensity. During these explosions, settled surface dust may getresuspended in the air and create an environment suitable for further combustion. Processes that generate engineered nanomaterials in the gas phase or use or produce nanomaterials as powders, slurries, suspensions, or solutions, are likely to release nanoparticles into the air and therefore create the greatest risk for fire and explosion. Currently, the primary safety concerns associated with nanomaterials in the workplace are fire and explosion.


## Fire and ExplosionNanomaterials present a safety concern for potential fire and explosion because data show that decreasing the particle size of combustible materials may increase the risk for explosion. For many dust particles, the explosion risk appears to plateau at particle sizes on the order of tens of microns. However,some nanomaterials are designed specifically to generate heat through the progression of reactions at the nanoscale; this too may present a fire hazard that is unique to engineered nanomaterials.The ability of nanomaterials to become electrostatically charged during transpo r t, handling, and processing introduces a unique explosion hazard when dealing specifically with nanopowders. Their tendency to charge has been found to drastically increase as particle surface area increases. As a result, their large surface area may become highly charged and become their own ignition source if the powder is dispersed in the air. Nanoparticles and nanostructured porous materials have been used for many ye a rs as effective catalysts for increasing the rate of reactions or decreasing the necessary temperature for reactions to occur in liquids and gases. Depending

44**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 7 ■ F**  **i r**  **e a n**  **d E xp**  **los io**  **n S a**  **f**

**e t** 

**y**



### on their composition and structure, some nanomaterials may initiate catalyticreactions and increase the fire and explosion potential that would not otherwise be anticipated from their chemical composition alone. 

## NTRC Safety Projects NTRC has not yet begun any research projects to investigate the explosivity and risk of fire from airborne exposures to nanomaterials in the workplace. Atpresent, NTRC has reviewed the relevant literature and has initiated the development of a research study protocol. 

## Collaborations and Partnerships Collaborative efforts are underway to identify stakeholders and organizations(e.g., National Fire Protection Association [NFPA]) with expertise in areas associated with the potential safety hazards of airborne dust exposures (e.g., fire, explosion). Through established collaborations and partnerships, NTRC will develop a research plan to determine the physical and chemical characteristics of nanoscale powders that may pose the greatest risk for fire and explosion in the workplace.


## Accomplishments In the absence of data to predict the risk of fire and explosion from airbornenanoparticles, NTRC has developed and published interim guidance in a document entitled Approaches to Safe Nanotechnology: An Information Exchange with NIOSH . This document can be obtained on the NIOSH Web site at: www. cdc.gov/niosh/topics/nanotech/safenano/.



## Additional Research Needs and Future Direction NTRC has identified several areas within the nanotechnology fire and explosion safetyinitiative where additional research is needed. These areas of research include the following:



## ■ Understanding the chemical, physical, and reactive properties of nanomaterials



## ■ Determining the potential for airborne nanomaterials to cause fire or explosion

45**Chapter 7 ■ Fire and Explosion Safety NIOSH Nanotechnology Research Center** 



## ■ Understanding the extent to which combustible nanomaterials pose ahigher risk of fire and explosion than coarser material of similar composition and quantity



## ■ Determining any chemical and/or physical characteristics of nanomaterials that may initiate catalytic reactions and increase the potential of fire and explosion

46

# 8

Recommendations and Guidance**Chapter 8 ■ Recommendations and Guidance NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## BackgroundNIOSH is responsible for (1) conducting research and making recommendations to protect the safety and health of workers, and (2) providing guidance toworkers and employers on how to control potential occupational health hazards. In addition, NIOSH is dedicated to translating its research findings into recommendations and guidance that are scientifically sound and practical for the workplace.The national and international research community has identified the develo p ment of sound scientific recommendations for nanotechnology workers and employers as a key research priority. These recommendations should help workers and employers better understand the potential risks associated withexposure to nanomaterial and provide guidance on ways to manage and eliminate these risks. NTRC has identified the following goals to ensure that workers are protected from the potential safety and health hazards from exposure to nanomaterials:



## ■ Make interim scientific recommendations for prudent workplace safety and health practice during production and use of nanomaterials based on the best available scientific knowledge.



## ■ Validate experience-based recommendations using scientific, field- and laboratory-based research.



## ■ Develop partnerships with employers, workers, government agencies, and those in academia to disseminate recommendations and solicit feedback for improvement.



## ■ Issue periodic updates and revisit interim recommendations based on new research findings.



## ■ Evaluate Material Safety Data Sheets for informative and precautionarylanguage that reflects current classification, toxicity data, and recommendations for working with nanomaterials.



## ■ Evaluate and update recommended occupational exposure limits (e.g., mass-based airborne particles) to ensure that good prudent practices are used. 

## NTRC Recommendations and Guidance Projects NTRC has several ongoing projects aimed at providing recommendations toemployers, workers, and safety and health professionals involved or interested in the field of nanotechnology. The primary project is a document

48**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 8 ■ R**  **e c**  **o m**  **m e**  **n da**  **t io**  **n s a**  **n d G**  **u ida**  **n c**  **e**



### entitled Approaches to Safe Nanotechnology: An Information Exchange with NIOSH . This document was first issued in October 2005 and updated in July 2006. Currently, this document draws from the ongoing NTRC assessment of the potential health risks from exposure to nanomaterials and the best practices for minimizing worker exposure. This document will continue to be updated as more data become available about the potential safety and healthrisks, as well as measures that can be used to control workplace exposure to nanomaterials. NTRC is also participating in the Nanotechnology Environmental and Health Implications (NEHI) effortto develop national research priorities. NTRC is participating in the following five areas: (1) instrumentation, metrology, and analytical methods; (2) nanomaterialsand human health; (3) nanomaterials and the environment; (4) health and environmental surveillance; and (5) risk management methods.

NIOSH developed this document 

## Collaborations and Partnerships to provide an overview of what is known about nanomaterial hazards 

### NTRC has established internal and external collabora­ and measures that can be taken to 

### tions to gather information necessary to develop sound minimize workplace exposures. 

### scientific recommendations and guidelines concerning the safe handling of nanomaterials. National and international collaborations and partnerships include the following:



## ■ NNI through National Science and Technology Council’s Subcommittee on Nanoscale Science, Engineering and Technology



## ■ Organization for Economic Cooperation and Development (OECD)



## ■ New England Healthcare Institute



## ■ U.S. Environmental Protection Agency



## ■ International Organization for Standardization



## ■ American National Standards Institute



## ■ ASTM International



## ■ U.S. Department of Energy National Laboratories

49**Chapter 8 ■ Recommendations and Guidance NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### In addition, the NTRC is collaborating with academic institutions, manufacturers, and employers to ensure that current recommendations on the potential safety and health hazards of nanomaterials are available to workers in the field of nanotechnology.


## Accomplishments NTRC has developed interim recommendations for workers and employers on the safe handling of nanomaterials, and it continues to publish findings fromongoing research. The Recommendations and Guidance team has accomplished the following:



## ■ Developed and disseminated an interim guidance document for safety and health professionals entitled Approaches to Safe Nanotechnology: An Information Exchange with NIOSH



## ■ Developed a draft Current Intelligence Bulletin with recommended exposure limits for workplace exposure to TiO 2 

### nanoparticles



## ■ Established partnerships with national and international researchers, manufacturers, and industry leaders



## ■ Provided expert advice and consultation as well as disseminated recommendations and guidance through invited participation in national and international working groups and expert panels



## ■ Disseminated research findings and recommendations through peerreviewed journal articles


## Additional Research Needs and Future Direction Currently, few quantitative data are available on occupational exposure tonanomaterials. To fill the gaps in the knowledge and understanding of nanomaterials, NTRC created the Nanotechnology Field Research Team. This team has conducted onsite investigations at facilities that produce and/or handle nanomaterials.NTRC plans to continue its onsite field investigations in order to collect expe r iential data and develop a complete and accurate risk-based approach to managing nanomaterials. However, additional research is needed to fill several remaining information gaps to better understand the occupational safety and health implications of nanomaterials. Additional research and information are needed in the following areas:

50**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 8 ■ R**  **e c**  **o m**  **m e**  **n da**  **t io**  **n s a**  **n d G**  **u ida**  **n c**  **e**



## ■ Overall characterization of nanomaterial processes



## ■ Prudent work practices to minimize and manage exposure to nanomaterials



## ■ Engineering controls and PPE



## ■ Worker training that addresses potential hazards that may be associated with nanomaterials



## ■ Evaluation of analytical instruments and methods used to measure exposure to nanomaterials



## ■ Quantitative and qualitative measurements of exposure to nanomaterialsIn addition, NTRC is developing guidance for the occupational health survei llance of workers exposed to engineered nanomaterials. This guidance willaddress medical and biological monitoring, health record review, and the effectiveness of exposure registries.For more information about recommendations and guidance on the safe handling , use, manufacturing, and processing of nanomaterials, visit the NIOSH nanotechnology Web site at www.cdc.gov/niosh/topics/nanotech

.

51

# 9

Communication and Education**Chapter 9 ■ Communication and Education NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Background Communication and education are integral components infused throughoutthe NTRC research program, and they are closely related to the NIOSH research-to-practice (r2p) program, which is geared towards converting research results into safety and health information useful for workers and employers. As a result, communication and education is one of the 10 critical topic areas inaddressing knowledge gaps, developing strategies, and providing recommendations concerning nanotechnology exposure.NTRC has identified the following goals and deemed them as critical to ensuring t hat relevant and applicable safety and health information is available to various target audiences:



## ■ Establish partnerships to identify and share research needs and findings



## ■ Develop communication materials that provide the target audience with useful and appropriate scientific information

54**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 9 ■ C**  **o m**  **m u**  **n ic**  **a t**  **io n a**  **n d E**  **d uc**  **a t**  **io n** 



## ■ Disseminate research findings through communication methods suitable to the target audience



## ■ Develop effective communication and educational materials to assist in reducing occupational exposure to nanomaterials



## ■ Develop a global collaboration with partners interested in nanotechnology communication and education NTRC communicates with a broad range of audiences including employers,
w o rkers, safety and health professionals, researchers, congressional offices, and the media. Therefore, it is important to ensure that each audience (1) receives information in a way that is appropriate and beneficial and (2) has the potential to increase occupational safety and health within the field of nanotechnology. 

## NTRC Communication and Education Projects Communication and education has a role in each of the critical topic areas. Toadvance knowledge and understanding of the potential impact that nanotechnology and exposure to nanomaterials has in the workplace, NTRC is doing the following:



## ■ Developing and maintaining an in-depth Web page dedicated to nanotechnology research on the NIOSH public Web site



## ■ Creating and disseminating a brochure that describes the NTRC research program and provides general information about nanotechnology



## ■ Establishing and managing an online information library that contains resources about nanoparticles (Nanoparticle Information Library [NIL])



## ■ Sponsoring international symposia on nanotechnology



## ■ Developing documents that contain guidance and recommendations on the applications and implications of exposure to nanomaterials in the workplace



## ■ Publishing research findings in scientific, peer-reviewed publicationsFor more information about communication and education as well as nanot e chnology information dissemination strategies by NTRC, see Appendix E. 

## Collaborations and PartnershipsTo leverage resources and maximize the number of employers and workers who receive information about potential safety and health effects of

55**Chapter 9 ■ Communication and Education NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### nanomaterials, NTRC has built global collaborations with stakeholders andorganizations. These collaborations encourage researchers, industries, government officials, and labor organizations to develop sound communication and education strategies that increase knowledge, awareness, and understanding of emerging nanotechnologies and the potential health implications of exposure to nanomaterials in the workplace. NTRC has built collaborations with groups such as the following:



## ■ Nanoparticle Occupational Safety and Health Consortium



## ■ Nanoscale Science, Engineering, and Technology Subcommittee of the U.S. National Science and Technology Council



## ■ National Toxicology Program



## ■ AIHA



## ■ International Council on Nanotechnology



## ■ ISO



## ■ ASTM International



## ■ World Health Organization (WHO)



## ■ OECDIn addition, NTRC is a member of several national and international committ e es and working groups, including the Organization Resource Council (ORC) Nanomaterials Work Practices Workgroup, the ISO Technical Committee onNanotechnology, the International Advisory Committee for the Third International Symposium on Nanotechnology in Taiwan, and the International Commission on Occupational Health Meeting Session on Nanotechnology in Milan, Italy. 

## Accomplishments NTRC has developed several communication and educational products that provide workers with up-to-date information about nanotechnology and thepotential safety and health risks from exposure to nanomaterials. These products include a nanotechnology topic page on the NIOSH Web site, documentsand brochures, presentations, and an electronic resource that contains information about nanoparticles. The NIOSH Nanotechnology topic page ( www.cdc.gov/niosh/topics/nanotech )
wa s u pdated in 2006 and currently includes the following information:

56**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 9 ■ C**  **o m**  **m u**  **n ic**  **a t**  **io n a**  **n d E**  **d uc**  **a t**  **io n** 



## ■ The NIOSH role in nanotechnology



## ■ Ten critical topic areas for NIOSH nanotechnology research



## ■ Interim recommendations ( Approaches toSafe Nanotechnology: An Information Exchange with NIOSH) that invite the public to provide comments



## ■ Frequently Asked Questions about nanotechnology



## ■ News and events



## ■ A nanoparticle information library (NIL) developed by NTRC in partnership with national and international agencies. NIL isa searchable database that will help occupational health professionals, industry users, worker groups, and researchers organize and share information about nanomaterials. NTRC has conducted training and education courses on occupational safety
an d health within nanotechnology for various national and international organizations. In addition, NTRC has participated in professional development courses with the American Society of Safety Engineers (ASSE), AIHA, theIndustrial Accident Prevention Association (IAPA), and several North Atlantic Treaty Organization (NATO) countries. NTRC staff have also providedpresentations and participated in expert panel discussions at numerous meetings, workshops, and conferences about nanotechnology both nationally andinternationally, and published more than 70 manuscripts in scientific, peerreviewed journals.



## Additional Research Needs and Future Direction NTRC will continue to expand and update its communication and educational products as more data become available on the exposures to nanomaterials inthe workplace, and on the impact that exposure to nanomaterials has on workers. These products will be available to provide information and education to workers, companies, and educational institutions to prevent worker exposure to nanomaterials and reduce potential risk of occupational injury and illness.

57

# Applications 

# 10**Chapter 10 ■ Applications NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Background The unique properties and characteristics of nanomaterials may provide the basis for innovative new devices, products, or processes to reduce risks of work-related injuries and illnesses. Such innovations may have properties or capabilities that cannot be created or manufactured using conventional materials. 

## NTRC Application Projects NIOSH has funded a number of research projects looking at applications ofnanotechnology to develop advanced protective gear and sensors, both intramurally and extramurally. For more information about programs funded through the NIOSH Office of Extramural Programs, see Appendix D. 

## Collaborations and Partnerships To advance the application of nanotechnology in the workplace, NTRC is building and establishing national and international partnerships. Currently, NTRC is collaborating with Carnegie Mellon University to develop a sensor that can be placed in a respirator to warn the user of inward chemical leakage through the respirator filter. NTRC is also working with the Georgia Institute of Technology to develop a thermal warning system to protect firefighters from extreme temperatures, and a sensor that can be used by emergency responders to detect biological threats.


## Accomplishments The NTRC Applications research program is in its early development stages.Research is primarily focused on improving worker safety and health by applying emerging nanotechnologies in the workplace such as sensors to warn workers of a hazardous exposure or develop better materials that can be used in making protective equipment and clothing. Within NTRC and through partnerships and collaborations, the Applications Te a m has accomplished the following:



## ■ Developed a methodology to identify emerging nanotechnologies that may pose a safety and health risk to workers



## ■ Developed a prototype sensor that can detect organic vapors and be embedded into respirator cartridges

60**NIOSH Nanotechnology Research Center Ch**  **a p**  **t**

**e r 10 ■ A**  **p**

**p l**  **ic a**  **t io**  **n s** 



## ■ Developed a noninvasive bio-monitoring capability to evaluate exposure to organophosphorus insecticides



## ■ Developed an extremely sensitive, low-temperature, low-cost, and miniaturized sensor that can be mounted inside a respirator to warn users when toxic organic vapors are inside the respirator



## ■ Designed, developed, and demonstrated improved sensor technology for detecting hydrogen sulfide


## Additional Research Needs and Future Direction NTRC will continue to monitor the emergence of new nanotechnologies and evaluate their implications for improving and/or harming worker safety and health. Such evaluations may lead to new recommendations to protect workers from exposure to nanomaterials.

61

# Appendix A Project-Specific Progress Reports

### 65 **NIOSH Nanotechnology Research Center**



### Table 1 identifies the 10 critical topic areas that are addressed within each ofthe research projects conducted by NTRC. Details about each project (including accomplishments, publications and presentations, and partnership activities) are also described following this table.

64

### 64Table 1. Overview of the 10 critical topic areas addressed in research projectsToxicologyRisk Epidemiol- Engineer- Measure- Exposure Fire and Recommen- CommuniProject number and inter- assess-ogy and ing controls ment assess- explosion dations and cation andand/or category nal dose ment surveillance and PPE methods ment safety guidance education ApplicationsProject 1xxProject 2xProject 3xProject 4xProject 5xxProject 6xProject 7xProject 8xProject 9xProject 10xProject 11xxxxProject 12x xxxProject 13xxxxxProject 14x xProject 15xxProject 16xxProject 17x xxxxNanotechnology inforxxxxmation disseminationOffice of the directorxxpartnership activities­



### 65**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Research Program (Projects 1-10): Nanotechnology Safety and Health Research Program
Program Coordinator: Vincent Castranova, Ph.D., HELD/ NIOSH/CDC Progress Report: FY 2004–FY 2006
Background Nanotechnology is one of the fastest growing emerging technologies in the Un i ted States and across the world. Defined as the manipulation of matter at near-atomic scales to produce new materials, structures, and devices with unique properties, nanotechnology has potential applications for integrated sensors, semiconductors, medical imaging, drug delivery systems, structural materials, sunscreens, cosmetics, and coatings. By 2015, the global market fornanotechnology-related products is predicted to reach $15 trillion and to employ 1 million workers in the United States. Engineered nanoparticles are defined as having one dimension smaller than 100 nm. B e cause of their small size, nanoparticles exhibit unique physical and chemical properties not associated with similar materials in the micrometer scale. These unique properties, small size, and high surface area may result in biological responses to exposure not observed with fine particles of the same composition.
To address the critical need to determine whether workers could be at risk of ad v erse health effects as a result of exposure to nanomaterials, NIOSH funded the Nanotechnology Safety and Health Research Program in February 2004. The original research program included the first six projects listed below:

Project 1



## ■ Generation and Characterization of Occupationally Relevant Airborne Nanoparticles



## ■ Principal Investigators: Bon-Ki Ku, Ph.D., and Doug Evans, Ph.D.
Project 2



## ■ Pulmonary Toxicity of Carbon Nanotube Particles



## ■ Principal Investigators: Anna Shvedova, Ph.D., and Paul Baron, Ph.D.

66**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



### Project 3



## ■ Role of Carbon Nanotubes in Cardiopulmonary Inflammation and COPD-Related Disease



## ■ Principal Investigators: Michael Luster, Ph.D., and Petia Simeonova, Ph.D.
Project 4



## ■ Particle Surface Area as a Dose Metric



## ■ Principal Investigator: Vincent Castranova, Ph.D.
Project 5



## ■ Ultrafine Aerosols from Diesel-Powered Equipment



## ■ Principal Investigator: Aleksander Bugarski, Ph.D.
Project 6



## ■ Nanotechnology Safety and Health Research Coordination



## ■ Principal Investigator: Vincent Castranova, Ph.D.Research activities of this program cover aerosol generation and characterizati o n studies in the laboratory and in the field, toxicity studies investigating the significance of aerosol surface area as a dose metric, and cardiopulmonary toxicity and lung disease related to carbon nanotubes and other nanoparticles.In October 2005, the original research program was augmented with the appr o val of a program expansion “Research Gaps Unaddressed in the Initial Nanotechnology Safety and Health Research Program.” This expansion added the following three projects to the original program:

Project 7



## ■ Systemic Microvascular Dysfunction: Effect of Ultrafine vs. Fine Particles



## ■ Principal Investigator: Vincent Castranova, Ph.D.
Project 8



## ■ Pulmonary Deposition and Translocation of Nanomaterials



## ■ Principal Investigators: Robert Mercer, Ph.D., and James Antonini, Ph.D.

67**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### Project 9



## ■ Dermal Effects of Nanoparticles



## ■ Principal Investigators: Anna Shvedova, Ph.D., and Min Ding, Ph.D. These additional three projects augment the original research program by inve stigating the ability of nanoparticles, once deposited in the lung, to enter the blood and translocate to systemic tissue. Effects on systemic microvascular function and resistance will be evaluated. These new projects will also evaluate effects of nanoparticles on the skin. In FY 2006, a new project was added to investigate the pulmonary and neural effe cts of pulmonary exposure to an incidental nanoparticle welding fume. Project 10



## ■ Neurotoxicity after Pulmonary Exposure to Welding Fumes Containing Manganese



## ■ Principal Investigators: James Antonini, Ph.D.; Diane Miller, Ph.D.; and James O’Callaghan, Ph.D.

1.4 nm in diameter Micrometers in length Unique physical, chemical and electronic properties 

## ■ ■ ■ TEM



### 68**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## Project 1: Generation and Characterization of Occupationally Relevant Airborne Nanoparticles
Accomplishments



## ■ Developed and fully characterized an in-situ nanoparticle generation facility for evaluating instrument response to tightly controlled particle morphology and size.



## ■ Evaluated aerosol instrumentation for monitoring nanoparticle aerosols in real time.



## ■ Evaluated three methods of estimating aerosol surface area (diffusion charging, transmission electron microscopy, and differential mobilityanalysis) and showed that these methods provide comparable measurements of aerosol surface area for particles smaller than 100 nm in diameter over a range of particle shapes.



## ■ Characterized the morphology of SWCNTs in aqueous suspension in support of Project 2.



## ■ Characterized the morphology of a SWCNT aerosol generated for a mouse inhalation study in support of Project 2.



## ■ Selected and obtained various commercially available nanomaterials and performed preliminary screening of physical properties through collaboration with Project 11 and in support of Project 4.



## ■ Developed and conducted preliminary testing of a nanomaterial redispersion system for nanoscale TiO 2 

### in support of Project 4. The system includes a flexible nonradioactive aerosol neutralization device.



## ■ Constructed a flow and humidity control system for the nanomaterial redispersion system above in support of Project 4. Determined that high humidity has a serious adverse effect on redispersion of powdered nanomaterials.



## ■ Completed preliminary testing of an electro-spray aerosol generation system to produce aerosols of nanoparticles in support of Project 4.



## ■ Evaluated the airborne levels of SWCNTs during synthesis and handling in a laboratory setting.



## ■ In collaboration with the University of Minnesota, used real-time new instrumentation (serial measurements of particle mobility and mass)combined with TEM analysis to obtain information about the relationship between particle morphology and particle properties of irregularly shaped nanoparticles.

69**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Observed anomalous behavior in state-of-the-art aerosol measurementinstrumentation. These findings are anticipated to lead to the development of effective monitoring methods and new and improved instrument designs that are needed for accurate characterization of worker exposures.



## ■ Evaluated particle sizing instrument responses to airborne carbon nanotubes and nanofibers.



## ■ In support of a NIOSH extramural project, collaborated with University of Cincinnati researchers in the performance evaluation of a wetelectrostatic precipitator for diesel engine exhaust after-treatment.



## ■ In collaboration with the University of Iowa: 1. Conducted the first workplace study of ultrafine and nanoparti cle mapping. Mapped ultrafine number concentration, active surface area and respirable mass concentration in an engine machining facility. 2. Demonstrated the appropriate selection and use of mobile
sa mpling equipment for effective monitoring of ultrafine and nanoparticles in workplaces. 3. Demonstrated that the contribution of emissions from direct ga s-fired heating systems can dominate ultrafine particle concentrations within a workplace. 4. Mapped ultrafine number concentrations, active surface area,
an d respirable mass concentrations in an automotive foundry and demonstrated some limitations in mapping procedures. 5. Conducted field research to help identify cause of high ultrafine pa rticle concentration formation from direct gas-fired heating systems.

Publications and Abstracts



## ■ Evans DE, Maynard AD, Peters TM, Heitbrink WA [2005]. Estimating aerosol surface area in the automotive industry. 24th Annual AAAR Conference, Austin, TX, October 17–21, p. 293.



## ■ Ku BK, Maynard AD [2005]. Physical characterization of airborne carbon nanofibers. 2nd International Symposium on Nanotechnology and Occupational Health, Minneapolis, MN, October 3–6, p. 119.



## ■ Ku BK, Maynard AD [2005]. Comparing aerosol surface-area measurement of monodisperse ultrafine silver agglomerates using mobility

70**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



### analysis, transmission electron microscopy and diffusion charging. J Aerosol Sci 36 :1108–1124.



## ■ Ku BK, Maynard AD [2006]. Generation and investigation of airbornesilver nanoparticles with specific size and morphology by homogeneous nucleation, coagulation, and sintering. J Aerosol Sci 37 :452–470.



## ■ Ku BK, Emery MS, Maynard AD, Stolzenburg MR, McMurry PH [2006]. In situ structure characterization of airborne carbon nanofibers by a tandem mobility-mass analysis. Nanotechnol 17 :3613–3621.



## ■ Ku BK, Maynard AD, Evans DE [2005]. Methods for measuring the active surface area of ultrafine particles as an exposure metric. 9th International Symposium on Neurobehavioral Methods and Effects in Occupational and Environmental Health, Gyeongju, South Korea, September 26–29, p. 26.



## ■ Ku BK, Maynard AD, Baron PA, Deye G [2005]. Anomalous responses (arcing, electrical discharge) in a differential mobility analyzer caused by ultrafine fibrous carbon aerosols. 24th Annual AAAR Conference, Austin, TX, October 17–21, p. 43.



## ■ Ku BK, Emery MS, Maynard AD, Stolzenburg MR, McMurry PH [2006]. Measurement of airborne carbon nanofiber structure using a tandem mobility-mass analysis. 7th International Aerosol Conference, Minneapolis, MN, September 10–15.



## ■ Maynard AD [2004]. Nanotechnology—a new occupational healthchallenge for a new generation? Int Commission Occup Health Newsletter 2 (3):4–6.



## ■ Maynard AD [2004]. Responsible nanotech at work. Nanotechnology: A Materials Today Supplement, p. 56.



## ■ Maynard AD [2005]. Characterizing exposure to nanomaterials. The Toxicologist 84 :A649.



## ■ Maynard AD, Kuempel ED [2005]. Airborne nanostructured particles and occupational health. J Nanopart Res 7:587–614.



## ■ Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V [2004]. Exposure to carbon nanotube material during the handling of unrefined single walled carbon nanotube material. J Toxicol Environ Health Part A 67:87–107.



## ■ Peters TM, Heitbrink WA, Evans DE, Slavin TJ, Maynard AD [2006]. The mapping of fine and ultrafine particle concentrations in an engine machining and assembly facility. Ann Occup Hyg 50 (3):249–257.

71**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Ramsey D, Ku BK, Maynard AD, Evans DE, Bennett J [2005]. Evaluation of nanoparticle de-agglomeration by disc centrifuge. 2nd International Symposium on Nanotechnology and Occupational Health, Minneapolis, MN, October 3–6, p. 120.



## ■ Stolzenburg M, McMurry PH, Emery MS, Ku BK, Maynard AD [2006].Obtaining dispersion of an intensive particle property from a tandemsizing experiment. 7th International Aerosol Conference, Minneapolis, MN, September 10–15.

Invited Presentations



## ■ Maynard A [2005]. Working with engineered nanomaterials: Towards developing safe work practices. University of Cincinnati. Cincinnati, OH, May.



## ■ Maynard A [2005]. Working with engineered nanomaterials: Towards developing safe work practices. Korean Occupational Safety and Health Agency (KOSHA), Daejeon, South Korea, May 11.



## ■ Maynard A [2005]. Nanotechnology and occupational health—addressing potential health risks. Korean Society of Toxicology Annual Conference, Seoul, Korea, May 13.



## ■ Maynard A [2005]. Nanotechnology: Overview and relevance to occupational health. AIHce, Anaheim, CA, May 24.



## ■ Maynard A [2005]. Nanotechnology and occupational health. AIHce, Anaheim, CA, May 24.



## ■ Maynard A [2005]. Working at the nanoscale: nanotechnology and potential health risk. AIHce, Anaheim, CA, May 24.



## ■ Maynard A [2005]. Nanomaterials and occupational health. Establishing a healthy working environment. The World Environment Center International Environment Forum, New York, NY, March 10.



## ■ Maynard A [2005]. Responsible nanotechnology and the working environment. National Research Council review of the US NNI, Meeting on responsible nanotechnology, Washington, DC, March 24.



## ■ Maynard A [2005]. Generating and characterizing airborne nanoparticles. American Association for the Advancement of Science: Nanoaerosol Exposure, Washington, DC, February 20.

72**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Maynard A [2005]. Understanding the potential impact of nanotechnology on occupational health. University of Cincinnati, Cincinnati, OH, February 23.



## ■ Maynard A [2004]. Working with engineered nanomaterials: Towards developing responsible work practices in an uncertain world. National Nanotechnology Infrastructure Network (NNIN) meeting Nanosafe: A Workshop on Environmental Health and Safety in Nanotechnology Research. Georgia Institute of Technology, Atlanta, GA, December 2.



## ■ Maynard A [2004]. NORA Liaison Committee Meeting. Nanotechnology at NIOSH. Washington DC, December 2.



## ■ Maynard A [2004]. Laboratory safety and disposal issues. Nanotoxicology Workshop. Gainesville, FL, November 3.



## ■ Maynard A [2004]. Working at the nanoscale: nanotechnology and potential health risks. CDC/Environmental & Occupational Health & Injury Prevention Coordination Center, Atlanta, GA, November 9.



## ■ Maynard A [2004]. Nanotechnology: Challenges and Opportunities. OSHA/NIOSH Interagency Health Outcome Conference. Washington, DC, November 16.



## ■ Maynard A [2004]. Nanotechnology and occupational health. Professional Conference of Industrial Hygienists. Montreal, Canada, October 5.



## ■ Maynard A [2004]. Nanotechnology and occupational health. Am. Chemical Council Nanotechnology Workshop, Atlanta, GA, October 20.



## ■ Ku BK [2005]. Physical characterization of ultrafine particles: Nanoaerosol surface area measurement. Korea Occupational Safety and Health Agency (KOSHA), Incheon, Korea, September 22–23.



## ■ Ku BK [2006]. Physical characterization of occupationally relevant nanoparticles. University of Kentucky, Lexington, KY, March 9.



## ■ Evans D [2006]. Field measurement of nano-aerosols. International Conference on Nanotechnology. Occupational and Environmental Health & Safety: Research to Practice. Cincinnati, OH, December 4–7.

73**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Project 2: Pulmonary Toxicity of Carbon Nanotube Particles Accomplishments



## ■ Measured the generation of hydroxyl radicals by unpurified SWCNTs. Determined that this radical generation was due to iron contamination of the nanotubes.



## ■ Measured oxidant stress and injury to human keratinocytes and human bronchial epithelial cells exposed to unpurified single-walled carbon nanotubes in culture.



## ■ Determined that acid treatment removes contaminating iron from SWCNTs. Found that these purified nanotubes do not generate radicals and are not avidly phagocytized by macrophages in culture.



## ■ Exposed mice to purified SWCNTs by pharyngeal aspiration. Observed transient inflammation and damage but a rapid and progressive fibrotic response in the lungs. Agglomerates were associated with fibrosis in granulomatous lesions; while more dispersed structures resulted in progressive diffuse interstitial fibrosis.



## ■ In vitro exposure of macrophages to purified SWCNTs indicates that the nanotubes are not avidly phagocytized and do not stimulate an oxidative burst reaction. In vivo exposure of the lung also supports the lack of avid phagocytosis by the alveolar macrophages that correlates with the absence of persistent inflammation.



## ■ Adsorption of phosphatidylserine (but not phosphatidylcholine) on the SWCNT surface makes them recognizable by macrophages indicating potentially promising approaches to modulating their fate in the lung.



## ■ A generation system was developed to produce aerosols of SWCNTs for an inhalation study. Inhalation exposure studies have been taking place during the summer of 2006.

Publications and Abstracts



## ■ Baron PA [2006]. Description of an aerosol calculator. 7th International Aerosol Conference, Minneapolis, MN, September 10–15.



## ■ Baron PA, Deye GJ, Shvedova AA, Castranova V [2005]. Generation ofvery low density fibrous carbon powders (single-walled carbon nanotubes and Pyrograf III). 24th Annual AAAR Conference, Austin, TX, October 17–21, p. 214.

74**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Baron PA, Deye GJ, Shvedova AA, Castranova V [2005]. Generation ofvery low density fibrous carbon powders (single-walled carbon nanotubes and Pyrograf III). 2nd International Symposium on Nanotechnology and Occupational Health, Minneapolis, MN, October 3–6, p. 40.



## ■ Feng WH, Tyurina YY, Bayir H, Shvedova AA, Kagan VE [2007]. Phosphatidylserine enhances recognition and uptake of single-walled carbon nanotubes by rat microglial cells. The Toxicologist 91 (1).



## ■ Heck DE, Kagan VE, Shvedova AA, Laskin JD [2005]. An Epigrammatic (abridged) recounting of the myriad tales of astonishing deeds and dire consequences pertaining to nitric oxide and reactive oxygen species in mitochondria with an ancillary missive concerning origin of apoptosis. Toxicol 208 (2):259–271.



## ■ Kagan VE, Bayir H, Shvedova AA [2005]. Nanomedicine and nanotoxicology: Two sides of the same coin. J Nanomedicine: Nanotechnol Biol Med 1 (4):313–316.



## ■ Kagan VE, Potapovich AN, Osipov YY, Tyurina ER, Kisin E, Schwegler-Berry D, Mercer R, Castranova V, Shvedova AA [2006]. Direct and indirect effects of single-walled carbon nanotubes on RAW 264.7 macrophages: Role in iron. Toxicol Lett 165 :88–100.



## ■ Kagan V, Tyurina YY, Konduru N, Basova L, Stolz D, Kisin E, MurrayA, Fadeel B, Shvedova A [2007]. Targeted delivery of phosphatidylserine-coated single-walled carbon nanotubes to macrophages. The Toxicologist 91 (1).



## ■ Kisin E, Murray AR, Johnson V, Gorelik O, Arepalli S, GandelsmanVZ, Hubbs AF, Mercer RR, Baron P, Kagan VE, Castranova V, Shvedova AA [2005]. Pulmonary toxicity of carbon nanotubes. The Toxicologist 84 :A1041.



## ■ Kisin E, Murray AR, Castranova V, Kagan VE, Shvedova AA [2006].Single-wall carbon nanotubes induce oxidative stress, acute inflammation, and progressive pulmonary fibrosis. Toxicol 90 (1):A1556.



## ■ Mercer RR, Scabilloni J, Kisin E, Gorelik O, Arepalli S, Murray AR, Castranova V, Shvedova AA [2005]. Responses of lung parenchyma to carbon nanotubes. The Toxicologist 84 :A1042.



## ■ Shvedova AA, Castranova, V, Kisin E, Schwegler-Berry D, Murray AR, Gandelsman VZ, Maynard A, Baron P [2003]. Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health, 66 (Part A):1901–1918.

75**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Shvedova AA, Kisin ER, Murray AR, Schwegler-Berry D, Gandelsman VZ, Baron P, Maynard A, Gunther MR, Castranova V [2004]. Exposureof human bronchial epithelial cells to carbon nanotubes caused oxidative stress and cytotoxicity. Proceedings of the Society for Free Radical Research Meeting. European Section, Ioannina, Greece, June 26–29, 2003, pp. 91–103.



## ■ Shvedova AA, Kisin E, Murray AR, Gorelik O, Arepalli S, Gandelsman VZ, Mercer B, Hubbs A, Kagan VE, Castranova V [2004]. Oxidative stress and pulmonary toxicity of carbon nanotubes. Free Radical Biol Med 37 (1).



## ■ Shvedova AA, Kisin E, Murray A, Maynard A, Baron P, Gunther M, Keshava N, Schwegler-Berry D, Gandelsman V, Gorelik O, Aperalli S,Kagan V, Castranova V [2004]. Assessment of carbon nanotube cytotoxicity using human cells and animal models. Proceedings of TheToxicology Forum’s 29th Toxicology Annual Winter Meeting, Washington, DC, February 2–4.



## ■ Shvedova A, Kisin E, Mercer R, Murray A, Johnson VJ, Potapovich A, Tyurina Y, Gorelic O, Arepalli S, Schwegler-Berry D, Antonini J, Evans DE, Ku B-K, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P [2005]. Unusual inflammatory and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. Am J Physiol: Lung Cell Mol Physiol 289 :L698–L708.



## ■ Shvedova AA [2005]. Comparative toxicity of nanomaterials in vivo and in vitro . 229th American Chemical Society Meeting, San Diego, CA, March 12–16.



## ■ Shvedova AA, Potapovich AL, Osipov AN, Tyurina YY, Kisin E,Schwegler-Berry D, Mercer RR, Castranova V, Kagan VE [2006]. Oxidative interactions of single walled carbon nanotubes with RAW 264.7 macrophages: role of iron. Toxicol 90 (1):A1557.



## ■ Shvedova AA, Kisin ER, Murray A, Gorelik O, Arepalli S, Castranova V, Young S-H, Gao F, Tyurina YY, Oury T, Kagan VE [2007]. Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57B6/L mice. The Toxicologist 91 (1).

Invited Presentations



## ■ Baron P [2006]. Measurement and generation of single-walled carbon nanotubes. Particle Workshop at NIST, Gaithersburg, MD, April 24–26.

76**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Baron P, Schulte P, Evans D [2006]. The nanotechnology program atNIOSH. Presented at the Emerging Needs in Aerosol Research for Occupational Hygiene. INRS, Nancy, France, November 22.



## ■ Castranova V [2005]. Pulmonary response to exposure to carbon nanotubes. Korean Society of Toxicology, Seoul, South Korea, May 13.



## ■ Castranova V [2005]. Pulmonary toxicity of single-walled carbonnanotubes. The Centre for Nanoscience and Nanotechnology. University of Melbourne, Melbourne, Australia, July 14.



## ■ Castranova V [2005]. Pulmonary toxicity of single walled carbon nanotubes. Research School of Physical Sciences and Engineering. The Australian National University, Canberra, Australia, July 27.



## ■ Castranova V [2005]. Pulmonary toxicity of single walled carbon nanotubes. National Industrial Chemicals Notification and Assessment Scheme. Sydney, Australia, July 29.



## ■ Castranova V [2005]. Pulmonary toxicity of single walled carbon nanotubes. Oak Ridge National Laboratory, Oak Ridge, TN, June 24.



## ■ Castranova V [2006]. Pulmonary toxicity of single-walled carbon nanotubes. Material Sciences Conference, San Francisco, CA, April 29.



## ■ Castranova V [2006]. Pulmonary toxicity of single-walled carbonnanotubes. 7th International Conference on the Science and Application of Nanotubes, Nagano, Japan, June 19–23.



## ■ Shvedova A [2004]. Pulmonary toxicity of carbon nanotubes. International Congress on Nanotechnology, San Francisco, CA, November 7–10.



## ■ Shvedova A [2004]. Pulmonary toxicity of SWCNT. National Nanotechnology Infrastructure Network (NNIN) meeting Nanosafe: A Workshop on Environmental Health and Safety in Nanotechnology Research, Georgia Institute of Technology, December 2.



## ■ Shvedova A [2004]. Pulmonary toxicity of carbon nanotubes: whatwe know and what we do not know. National Nanotechnology Infrastructure Network (NNIN): Nanosafe: A Workshop on EnvironmentalHealth and Safety in Nanotechnology Research, Atlanta, GA, December 1–3.



## ■ Shvedova A [2005]. Pulmonary oxidative stress, inflammation, and fibrosis induced by single wall carbon nanotubes. 2nd InternationalSymposium on Nanotechnology and Occupational Health, Minneapolis, MN, October 3–6.

77**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Shvedova A [2005]. Pulmonary toxicity of carbon nanotubes. 8th International Conference on Mechanisms of Action of Inhaled Fibers,Particles, and Nanoparticles in Lung and Cardiovascular Diseases, Research Triangle Park, NC, October 25–28.



## ■ Shvedova A [2005]. Comparative toxicity of nanomaterials in vivo and in vitro. 229th American Chemical Society Meeting. San Diego, CA, March 12–16.



## ■ Shvedova A [2005]. Pulmonary response to carbon nanotubes. 44th Society of Toxicology Meeting, New Orleans, LA, March 6–10.



## ■ Shvedova A [2005]. Unusual pulmonary response to carbon nanoparticles. First Annual Meeting of American Academy of Nanomedicine. John Hopkins University, MD, August 15–16.



## ■ Shvedova A [2005]. Pulmonary oxidative stress, inflammation, and fibrosis induced by single wall carbon nanotubes. 2nd InternationalSymposium on Nanotechnology and Occupational Health, Minneapolis, MN, October 3–6.



## ■ Shvedova A [2005]. Pulmonary toxicity of carbon nanotubes. 8th International Conference on Mechanisms of Action of Inhaled Fibers, Particles, and Nanoparticles in Lung and Cardiovascular Disease, Research Triangle Park, NC, October 25–28.



## ■ Shvedova A [2005]. Oxidative stress and pulmonary toxicity of carbonnanotubes. 1st International Meeting Nanotoxicology: Biomedical Aspects, Miami Beach FL, January 28–February 1.



## ■ Shvedova A [2006]. Single-walled carbon nanotubes induced oxidative stress, acute inflammation and progressive pulmonary fibrosis. 45th Society of Toxicology Meeting, San Diego, CA, March 12–18.



## ■ Shevedova A [2006]. Pulmonary effects of single-walled carbon nanotubes. International Conference on Nanotechnology, Occupational and Environmental Health & Safety; Research to Practice, Cincinnati, OH, December 4–7.



## ■ Shevedova A [2006]. Pulmonary toxicity of single-walled carbon nanotubes. Karolinska Institute Nanotechnology Symposium. Stockholm, Sweden, November 15.

78**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## Project 3: Role of Carbon Nanotubes in Cardiopulmonary Inflammation and COPD-Related Diseases
Accomplishments



## ■ Mice were exposed to purified SWCNTs by pharyngeal aspiration and cardiopulmonary responses at 1, 7, 28, 56, and 180 days post-exposure were monitored.



## ■ At days 7, 28, 56, and 180 post-exposure to carbon nanotubes, observed mitochondrial DNA damage and increased production of reactive oxygen species in aortic tissue.



## ■ Found that pulmonary exposure to carbon nanotubes induced similaroxidative modification in aortic tissue of ApoE-1-mice, an atherosclerosis model.



## ■ Pulmonary exposure to carbon nanotubes induced activation of the oxidative gene, heme-oxygenase-1, in lung, heart, and aortic tissue.



## ■ Chronic exposure of mice (four instillations of 20 μg per mouse every other week for 2 months) to purified SWCNTs induced enhanced atherosclerosis progression in ApoE-/- mice especially if the mice were fed a fat chow.



## ■ The body weights, plasma cholesterol, glucose, and lactate dehydrogenase (LDH) levels were comparable in SWCNT- and vehicle-exposed mice under both diet regimens indicating that the enhanced progression of cardiovascular disease by SWCNTs is not due to altered lipid profiles.



## ■ The plaque area analyzed by aortic morphometric en face analysis demonstrated a significant increase in the atheroma formation in SWCNTexposed mice compared with the control-treated mice.



## ■ Histological assessment of the lesion size in the brachiocephalic arteriesof these mice confirmed that SWCNT exposure accelerated atherosclerosis progression compared with the control treatment.



## ■ Although the plaques were larger in the SWCNT-exposed mice, the cellular composition of the plaques was similar to that of control-exposed mice.



## ■ SWCNT-induced atherosclerosis acceleration was not associated with significant differences in the plasma levels of inflammatory cytokines including IL–6, IL–10, MCP–1, TNF–α, and IFN– y.



## ■ Preliminary data demonstrated that SWCNT-induced atherogenic effects are associated with mitochondrial distress mediated endothelial

79**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### dysfunction and alterations in platelet properties (increased thrombogenic potential).

Publications and Abstracts



## ■ Li Z, Salmen R, Hulderman T, Kisin E, Shvedova A, Luster M, Simeonova P [2004]. Pulmonary carbon nanotube exposure and oxidative status in vascular system. Free Radical Biol Med 37 (1):S142.



## ■ Li Z, Salmen R, Hulderman T, Kisin E, Shvedova AA, Luster MI [2005]. Pulmonary exposure to carbon nanotubes induces vascular toxicity. The Toxicologist 84 :A1045.



## ■ Li ZJ, Chapman R, Hulerman T, Salmen R, Shvedova, A, Luster MI, Simeonova PP [2006]. Relationship of pulmonary exposure to multiple doses of single wall carbon nanotubes and atherosclerosis in APOE-/­ mouse model. The Toxicologist 90 (1):A1555.



## ■ Simeonova PP [2006]. Nanomaterial exposure and risk for systemic effects. Toxicology and Risk Assessment Meeting, Cincinnati, OH, April, p. 59.



## ■ Simeonova P, Li J, Luster MI, Shvedova A, Salmen R [in press]. Carbon nanotube exposure and cardiovascular outcomes. 2nd InternationalSymposium on Nanotechnology and Occupational Health, Minneapolis, MN, 2005.

Invited Presentations



## ■ Luster M [2004]. Nanoparticles toxicity testing issues. Nanotoxicology Workshop, Gainesville, FL, November 3–4.



## ■ Luster M [2005]. Nanoparticles toxicity issues. Ramazzini Collegium, Bologna, Italy, September.



## ■ Luster M [2006]. Nanomaterials workshop, project on emerging nanotechnologies. Woodrow Wilson International Center for Scholars, Washington, DC, March.



## ■ Simeonova P [2005]. Nanoparticles-systemic and vascular effects. Nano-toxicology: Biomedical Aspects, Miami, FL.



## ■ Simeonova P [2005]. Nanoparticles—toxicological approaches. First Annual Scientific Meeting of the American Academy of Nanomedicine, Baltimore, MD, August 15–16.



## ■ Simeonova P [2006]. Nanomaterial exposure and risk for systemic effects. Toxicology and Risk Assessment Conference, Cincinnati, OH, April 24–27.

80**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Simeonova P [2006]. Nanoparticles and cardiovascular toxicity. Allegheny-Erie Chapter, Society of Toxicology (A-E SOT), Pittsburgh, PA, April 7.



## ■ Simeonova P [2006]. Cardiovascular effects of nanoparticles. International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research on Practice, Cincinnati, OH, December 4–7.

81**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Project 4: Particle Surface Area as a Dose Metric Accomplishments



## ■ Measured the particle surface area and mass of ultrafine and fine TiO 2 

### , ultrafine and fine carbon black, and fine and coarse crystalline silica samples.



## ■ Measured the surface area and cell numbers of primary rat alveolar macrophages and a human alveolar type II epithelial cell line in culture.



## ■ Evaluated the toxicity of silica, TiO 2 

### , and carbon black of different particle sizes using a mass-based and a surface-based dose metric with macrophages and type II cells. Found that silica was the most toxic of the particles tested.



## ■ Evaluated the ability of the above particles to stimulate production of an inflammatory chemokine (IL–8 or MIP–2) by human type II cells or rat alveolar macrophages, respectively. Found that silica was the most potent stimulant of chemokine production.



## ■ Evaluated the dose-dependent pulmonary response to intratracheal instillation of ultrafine and fine carbon black 24 hours post-exposure. Found that on an equivalent mass basis ultrafine carbon black was more inflammatory.



## ■ Developed an improved method to disperse nanoparticles using bronchoalveolar lavage fluid for in vitro and in vivo testing.



## ■ Demonstrated that the improved dispersal method increased the inflammatory potency of ultrafine carbon black after intratracheal instillation.

Publications and Abstracts



## ■ Castranova V [2007]. Comparison of pulmonary responses to singlewalled vs. multi-walled carbon nanotubes. The Toxicologist 91 (1).



## ■ Oberdorster G, Maynard A, Donaldson K, Castranova V, FitzpatrickJ, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, MonterioRiviere N, Warheit D, Yang H [2005]. Principles for characterizing the potential human effects from exposure to nanomaterials: elements of screening strategy. Particle Fibre Toxicol 2 :8.



## ■ Oberdorster G, Maynard A, Donaldson K, Castranova V, FitzpatrickJ, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, MonterioRiviere N, Warheit D, Yang H [2005]. Principles for characterizing the potential human effects from exposure to nanomaterials: elements of a screening strategy. Toxicol 90 :A2333.

82**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Sager T, Robinson VA, Poster DW, Schwegler-Berry DE, Lindsley W, Castranova V [2007]. An improved method to prepare suspensions of nanoparticles for treatment of lung cells in culture or in vivo exposure by pharyngeal aspiration or intratracheal instillation. The Toxicologist 91 (1).



## ■ Sager T, Porter DW, Robinson VA, Lindsley WG, Schwegler-Berry DE, Castranova V [2007]. Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicity 1.



## ■ Shvedova AA, Sager T, Murray AR, Kisin E, Porter DW, Leonard SS, Schwegler-Berry D, Robinson VA, Castranova V [2007]. Critical issues in the evaluation of possible adverse pulmonary effects resulting fromairborne nanoparticles. In: Monteiro-Riviere N, Tran L, eds. Nanotechnology: Characterization, Dosing and Health Effects. New York: Taylor and Francis.



## ■ Sriram K, Porter DW, Tsuruoka S, Endo M, Jefferson AM, Wolfarth MG, Rogers GM, Castranova V, Luster MI [2007]. Neuroinflammatoryresponses following exposure to engineered nanomaterials. The Toxicologist 91 (1).

Invited Presentations



## ■ Castranova V [2004]. Nanotechnology safety and health research in NIOSH. First International Conference on Nanotoxicology: Biomedical Applications, Miami, FL, January 29–February 1.



## ■ Castranova V [2004]. Potential toxicity of nanoparticles. 2004 Northwest Occupational Health Conference, Portland, OR, October 14.



## ■ Castranova V [2005]. General toxicological issues of potential concern with nanoparticles, an overview. Nanotechnology Building Block for Tomorrow’s Advanced Technology, Perth, Australia, July 18.



## ■ Castranova V [2005]. Health issues for nanoparticles and nanotubes. Australian National Council Nanotechnology Network, Canberra, Australia, July 25.



## ■ Castranova V [2005]. Nanotechnology safety and health research inNIOSH. Korean Occupational Safety and Health Administration, Daejeon, South Korea, May 12.



## ■ Castranova V [2005]. Toxicity of ultrafine particles. Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Australia, July 14.

83**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Castranova V [2005]. Toxicity of ultrafine particles. Centre for Nanoscience and Nanotechnology, University of Melbourne, Melbourne, Australia, July 14.



## ■ Castranova V [2005]. Toxicity of ultrafine particles. Ian Wark Research Institute, University of South Australia, Adelaide, Australia, July 26.



## ■ Castranova V [2005]. Toxicity of ultrafine particles. NASA Scientific Group, January 19.



## ■ Castranova V [2006]. Nanotoxicology program in NIOSH. NANOMIST Workshop. London, England, November 15.



## ■ Castranova V [2006]. Nanotoxicology research in NIOSH. American Industrial Hygiene Conference, Chicago, IL, May 16.



## ■ Castranova V [2006]. Nanotoxicology research in NIOSH. Nanobusiness 06, New York, May 19.



## ■ Castranova V [2006]. Nanotechnology safety and health research in NIOSH. EPA, Research Triangle Park, NC, July 25.



## ■ Castranova V [2006]. Pulmonary effects of exposure to single-walled carbon nanotubes. Wright Patterson Air Force Research Center. Dayton OH, October 31.



## ■ Castranova V [2006]. Pulmonary toxicology studies with nanoparticles:experimental issues. Informa Learning’s Conference on Nanotoxicology, Cambridge, MA, April 25.



## ■ Castranova V [2006]. Toxicity of ultrafine particles. Nanotechnology Center, Ohio State University, Columbus, OH, February 24.



## ■ Castranova V [2006]. Toxicity of ultrafine particles. Nanotox Consortium, University of Kentucky, Lexington, KY, September 19.



## ■ Porter D [2006]. Overview of NIOSH nanotoxicology research. Michigan Regional Chapter of the National Society of Toxicology, Augusta, MI, May 19.



## ■ Porter D [2005]. Particulate handling in the human lung. Biological Effects of Lunar Dust Workshop, Sunnyvale, CA, March 29–31.



## ■ Porter D [2005]. Toxicity of ultrafine particles. Nanotechnology: Occupational Safety and Health Perspectives. 21st Annual Kentucky Governor’s Safety and Health Conference and Exposition, Louisville, KY, May 11.

84**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## Project 5: Ultrafine Aerosols from Diesel-Powered Equipment Accomplishments



## ■ Developed a diesel and nanoparticle research facility at the Lake Lynn Laboratory. Designed and built 150- and 400-kw engine/dynamometersystems; designed and built downstream, upstream, and tailpipe sampling and measurement stations; designed and built ventilation control and measurement facilities; developed and evaluated particle sampling, measurement, and analysis methodologies.



## ■ Selected, acquired, and evaluated instrumentation for characterization of physical and chemical properties of diesel aerosols and gases.



## ■ Conducted a field study in an underground mine using diesel mining vehicles. The Scanning Mobility Particle Sizer, Tapered Element Oscillating Microbalance, and carbon analysis were used to determine and characterize particulate matter in the mine air downstream of the tested vehicles.



## ■ Developed protocols and conducted preliminary evaluation of the effects of emission controls, clean engines, and fuel formulations on the emission of fine and ultrafine diesel particles.



## ■ Developed methods for sampling and analysis of in vitro mutagenic and DNA and chromosomal damage activity by surfactant dispersion or solvent extract of a diesel aerosols.
Publications and Abstracts



## ■ Bugarski A [2004]. Characterization of diesel aerosols in an underground metal mine. Proceedings of 8th ETH-Conference on Combustion Generated Nanoparticles (CD-ROM), August 16–18.



## ■ Bugarski A, Mischler S, Schnakenberg G [2005]. Affects of alterative fuels on concentrations of nanometer and ultrafine particles in an underground mine. In: Proceedings of 9th ETH-Conference on Combustion Generated Nanoparticles (CD-ROM), Zurich, Switzerland, August 15–17.



## ■ Bugarski A [2006]. Characterization of combustion generated nanometer and ultrafine aerosols emitted in work environment. 10th ETHConference on Combustion Generated Nanoparticles (CD-ROM), Zurich, Switzerland, August 21–23.



## ■ Bugarski AD, Schnakenberg GH Jr., Noll JD, Mischler SE, Patts LD, Hummer JA, Vanderslice SE [2006]. Effectiveness of selected diesel particulate

85**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### matter control technologies for underground mining applications: isolated zone study, 2003. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, NIOSH RI 9667.



## ■ Mischler S, Bugarski A, Schnakenberg G [2005]. Analysis of diesel particulate matter control technologies and measurements in US metal mines. Proceedings of 8th International Mine Ventilation Congress, Brisbane, Queensland, Australia, July 6–8.



## ■ Shi, XC, Keane M, Ong T, Harrison J, Gautam M, Bugarski A, Wallace W [2006]. In vitro mutagenic and DNA and chromosomal damage activity by surfactant dispersion or solvent extract of a reference dieselexhaust particulate material. 12th Diesel Engine-Efficiency and Emission Research (DEER), August 20–24.

86**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## Project 6: Nanotechnology Safety and Health Research Coordination
Accomplishments



## ■ Organized a retreat of NIOSH aerosol scientists August 25–27, 2004 toformulate a strategic plan and discuss research progress in nanotechnology. Dr. Lang Tran from the Institute of Occupational Medicine, Edinburgh, Scotland was the guest speaker.



## ■ Organized a second retreat of NIOSH aerosol scientists August 23–25, 2005 to update the strategic plan and discuss research progress in nanotechnology. Dr. Pratim Biswas from Washington University in St. Louis, Missouri, was the guest speaker.



## ■ Submitted annual reports to the Office of the Director, NIOSH.

87**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Project 7: Systemic Microvascular Dysfunction—Effect of Ultrafine versus Fine Particles
Accomplishments



## ■ Constructed and tested a generator of ultrafine TiO 2 

### for rat inhalation studies. A stable output was achieved.



## ■ Initiated dose-response inhalation studies. Monitored the pulmonaryresponse to the first test concentration. Monitored the systemic microvascular response to the first two test concentrations. Thus far, the systemic microvascular response to ultrafine TiO 2 

### is greater than to fine TiO 2 

### .
Publications and Abstracts



## ■ Nurkiewicz TR, Porter DW, Barger M, Hubbs AF, Millecchia L, Rao K, Chen BT, Frazer D, Castranova V, Boegehold MA [2006]. Peripheralmicrovascular dysfunction follows ultrafine titanium dioxide inhalation. Health Effects Institute Annual Conference, San Francisco, CA, April.



## ■ Nurkiewicz TR, Porter DW, Barger M, Millecchia L, Rao KM, MarvarPJ, Hubbs AF, Castranova V, Boegehold MA [2007]. Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ. Health Perspect. 114 :412–419.



## ■ Nurkiewicz TR, Porter DW, Hubbs AF, Millecchia L, Stone S, Chen BT, Frazer D, Castranova V, Boegehold M [2007]. Inhalation of ultrafinetitanium dioxide augments particle-dependent microvascular dysfunction. FASEB J 21.

Invited Presentations



## ■ Castranova V [2005]. Microvascular dysfunction resulting from pulmonary exposure to particles. Research School of Physical Sciences and Engineering, Australian National University, Canberra, Australia, July 27.



## ■ Castranova V [2005]. Microvascular dysfunction resulting from pulmonary exposure to particles. Asan Medical College, Seoul, Korea, May 16.



## ■ Castranova V [2005]. Microvascular dysfunction resulting from pulmonary exposure to particulate matter. 2005 Conference on the Application of Systems Biology Methodologies to Environmental Research, Morgantown, WV, August 1.

88**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## Project 8: Pulmonary Deposition and Translocation of Nanomaterials Accomplishments



## ■ Developed a method to improve dispersal of SWCNTs for pharyngeal aspiration.



## ■ Developed a method to label SWCNTs with colloidal gold or quantum dots to track their distribution and fate upon pulmonary exposure.



## ■ Demonstrated that low doses of purified and dispersed (sub-micron) SWCNTs are capable of widely distributing in the lungs where they are incorporated into the alveolar interstitium and produce a fibrotic response.



## ■ Demonstrated that iron-rich SWCNTs induce elevated biomarkers of oxidative stress.

Publications and Abstracts



## ■ Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, Osipov AN, Kisin ER, Schwegler-Berry D, Mercer RR, Castranova V,Shvedova AA [2006]. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: Role of Iron. Toxicol Lett 165 :88–00.



## ■ Mercer RR, Scabilloni JF, Wang L, Schwegler-Berry D, Shvedova A, Castranova V [2007]. Dispersion significantly enhances the pulmonary toxicity of single walled carbon nanotubes. The Toxicologist 91 (1).



## ■ Roberts JR, Mercer RR, Young S-H, Porter DW, Castranova V, Antonini JM [2007]. Inflammation and fate of quantum dots following pulmonary treatment of rats. The Toxicologist 91 (1).



## ■ Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P [2005]. Unusual inflammatory and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289 :698–708.
Invited Presentations



## ■ Mercer R [2005]. Lung parenchymal responses to carbon nanotubes. 2nd International Symposium on Nanotechnology and Occupational Health, Minneapolis, MN, October 3–6.

89**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Mercer R [2006]. Distribution of SWCNT in the lungs. Nanotoxicology: Biomedical Aspects, Miami, Fl, January 28–February 1.



## ■ Mercer R [2006]. Inhalation toxicity of single-walled carbon nanotubes. Society for Risk Assessment. Tripartite teleconference, June.



## ■ Mercer R [2006]. SWCNT distribute and injure the lungs in a size dependent manner. New York Occupational Safety and Health Research Center, New York, April.

90**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## Project 9: Dermal Effects of Nanoparticles Accomplishments



## ■ Demonstrated that exposure of human keratinocytes in vitro to unpurified SWCNTs resulted in significant cytotoxicity. Purification of SWCNT to remove the iron catalyst particles resulted in less toxicity.



## ■ Demonstrated that exposure to murine epidermal cells to unpurified SWCNT activated the transcription factor AP–1. Such activation was not seen with purified SWCNT.



## ■ Demonstrated that exposure of mouse skin in vivo to unpurified SWCNT caused oxidant stress and inflammation.



## ■ Demonstrated that in vitro exposure of epidermal cells to nanosized TiO 2 

### generated hydroxyl radicals, and activated AP–1 through phosphorylation of MAP kinase signaling pathways.

Publications and Abstracts



## ■ Ding M, Lu Y, Bowman L, Leonard S, Castranova V, Vallyathan V [2006]. Titanium nanoparticles induces AP-1 activation through ROS and MAPKS pathways. 1st International Toxicology of Nanomaterial: Biomedical Aspects Meeting, Miami Beach, FL, January 29–February 1, p. 101.



## ■ Murray AR, Kisin E, Castranova V, Kommineni C, Kagan VE, Shvedova AA [2006]. Oxidative stress and inflammatory response in dermaltoxicity of single-walled carbon nanotubes. 1st International Toxicology of Nanomaterial: Biomedical Aspects Meeting, Miami Beach, FL, January 29–February 1, p. 50.



## ■ Murray AR, Kisin E, Kommineni C, Kagan VE, Castranova V, Shvedova AA [2007]. Single-walled carbon nanotubes induce oxidative stress and inflammation in skin. The Toxicologist 91 (1).

91**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Project 10: Neurotoxicity after Pulmonary Exposure to Welding Fumes Containing Manganese
Accomplishments



## ■ Characterized the physical and chemical properties of generated welding aerosol.



## ■ Compared the pulmonary, inflammatory, and immune responses after exposure to stainless steel and mild steel welding fumes.



## ■ Designed and constructed a robotic welding fume generator and inhalation exposure system for laboratory animals.



## ■ Initiated animal inhalation toxicity studies.



## ■ Evaluated the translocation of welding fume metals from the lungs to other organ systems (e.g., central nervous system and cardiovascular system).



## ■ Evaluated the potential neurotoxic effects in animals after inhalation of welding fume.

Publications and Abstracts



## ■ Antonini JM, Taylor MD, Zimmer AT, Robert JR [2004]. Pulmonaryresponses to welding fumes: Role of metal constituents. J Toxicol Environ Health 67:233–249.



## ■ Antonini JM, Taylor MD, Millecchia L, Ebeling AR, Robert JR [2004]. Suppression in lung defense responses after bacterial infection in rats pretreated with different welding fumes. Toxicol Appl Pharmacol 200 :206–218.



## ■ Antonini JM, Leonard SS, Robert JR, Solano-Lopez C, Young S-H, Shi X, Taylor MD [2005]. Effect of stainless steel manual metal arc weldingfume on free radical production, DNA damage, and apoptosis induction. Mol Cell Biochem 279 :17–23.



## ■ Antonini JM, Afshari AAA, Stone S, Chen B, Schwegler-Berry D,Fletcher WG, Goldsmith WT, Vandestouwe KH, McKinney W, Castranova, V, Frazer DG [2006]. Design, construction, and characterization of a novel robotic welding fume generation and inhalation exposure system for laboratory animals. J Occup Environ Hyg 3 :194–203.



## ■ Antonini JM, Santamaria A, Jenkins NT, Albini E, Lucchini R [2006]. Fate of manganese associated with the inhalation of welding fumes: Potential neurological effects. Neurotoxicol 27 :304–310.

92**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Antonini JM, O’Callaghan JP, Miller DB, Miller DB [in press]. Development of an animal model to study potential neurotoxic effects associated with welding fume inhalation. Neurotoxicol.



## ■ Santamaria AB, Cushing CA, Antonini JM, Finley BL, Mowat FS [in press]. Potential neurological effects of manganese exposure during welding: a state-of-the-science analysis. J Toxicol Environ Health.



## ■ Solano-Lopez C, Zeidler-Erdely PC, Hubbs AF, Reynolds SH, Roberts JR, Taylor MD, Young S-H, Castranova V, Antonini JM [in press]. Welding fume exposure and associated inflammatory and hyperplastic changes in the lungs of tumor susceptible A/J Mice. Toxicol Pathol.



## ■ Antonini JM, Roberts JR [2007]. Comparison of lung injury and inflammation after repeated treatment with welding fumes collected from different welding processes. The Toxicologist 91 (1).



## ■ Zeidler-Erdely PC, Young S-H, Roberts JR, Antonini JM [2007]. Acutelung inflammatory response following pharyngeal aspiration of stainless steel welding fume or soluble chromium in A/J and C57Bl/6J mice. The Toxicologist 91 (1).

Invited Presentations



## ■ Antonini J [2004]. Effect of workplace particulates on the susceptibility to bacterial infection and the suppression of lung defense responses in rats. Society of Toxicology Annual Meeting, Baltimore, MD, March.



## ■ Antonini J [2004]. Bioavailability of manganese associated with the inhalation of welding fumes: potential neurological effects. Conference on Health Effects, Clinical Research, and Industrial Hygiene Issues in Occupational Exposure to Manganese, New Orleans, LA, April.



## ■ Antonini J [2004]. Bioavailability of manganese associated with the inhalation of welding fumes: potential neurological effects. Conferenceon Welding—Industrial Hygiene and Occupational Health, American Industrial Hygiene Association, Pacific Northwest Section, Spring Meeting, Olympia, WA, April.



## ■ Antonini J [2004]. Effect of welding fume metal composition and solubility on free radical production and lung inflammation and injury. 3rdConference on Molecular Mechanisms of Metal toxicity and Carcinogenesis, NIOSH, September.



## ■ Antonini J [2005]. Health effects on welding. American Industrial Hygiene Association Annual Meeting: AIHce 2005, Anaheim, CA, May.

93**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Antonini J [2005]. Development of an animal model to study the health effects of welding. Health Effects of Welding International Conference, sponsors: NIOSH, NIEHS, and West Virginia University, Morgantown, WV, July.



## ■ Antonini J [2005]. Characterization of welding fumes and their neurotoxic effects. 22nd International Neurotoxicology Conference: Manganese Symposium, Research Triangle Park, NC, September.



## ■ Antonini J [2005]. Development of an animal model to assess the effect of occupational particles on the susceptibility to bacterial lung infection. 8th International Meeting on Effects on Mineral Dusts and Nanoparticles, Research Triangle Park, NC, October.



## ■ Antonini J [2006]. Suppression of lung defense responses after bacterial infection in rats exposed by inhalation to stainless steel welding particles. 1st International Conference on Nanotoxicology: Biomedical Aspects, Miami, FL, January.



## ■ Antonini J [2006]. Characterization of welding fumes and their potential neurotoxic effects. International Workshop: Neurotoxic Metals— Lead, Mercury, and Manganese: From Research to Prevention: Brescia, Italy, June.

94**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## Nanotechnology Safety and Health Research Program (Projects 1–10)

National and International Activities and Conferences

■ Maynard A [2004]. Co-organized the First International Conference First International Symposium on Occupational Health Implications of Nanomaterials from October 12–14 in Buxton, UK. The conference is co-sponsored by the UK Health and Safety Executive and NIOSH.



## ■ Maynard A [2005]. Co-organized the Second International Symposium of Nanotechnology and Occupational Health, Minneapolis, MN, October 3–6.



## ■ Castranova V [2005]. Co-organized the conference Mechanisms of Action of Inhaled Fibers, Particles, and Nanoparticles in Lung and Cardiovascular Disease, Research Triangle Park, NC, October 25–28.



## ■ Castranova V, Maynard A [2005]. Served on an EPA Workgroup through the International Life Sciences Institute to draft a document entitled Screening Protocols for Nanomaterial Toxicity.



## ■ Maynard A [2005]. Served as the NIOSH representative on the Nanomaterial Science Engineering and Technology Subcommittee of the National Science and Technology Council that develops guidance for the direction of Federal research in nanotechnology.



## ■ Castranova V [2005 to present]. Serves on a scientific advisory committee for the Nanotechnology Research Institute at the University of Rochester.



## ■ Castranova V [2006]. Served as an expert panel member: Health andEnvironmental Issues in Nanotechnology. Wilson Institute, Washington, DC, April 6.



## ■ Castranova V [2006]. Served as a participant: National Nanotechnology Coordination Office Workgroup on Public Dissemination, Education, and Outreach. Arlington, VA, May 30–31.



## ■ Shvedova A, Castranova V [2006]. Co-organized the Nanotoxicology: Biomedical Aspects Conference in Miami, FL, January 28–February 1. (The conference was co-sponsored by NIOSH and the University of Pittsburgh).



## ■ Antonini J [2005]. Co-organized a NIOSH-sponsored internationalconference Health Effects of Welding, Morgantown, WV, July. The conference was co-sponsored by the National Institute of Environmental

95**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### Health Sciences (NIEHS), the Association of Occupational and Environmental Clinics, and West Virginia University.



## ■ Antonini J [2006]. Serves as Vice Chair of the Safety and Health Committee for the American Welding Society.



## ■ Simeonova P [2006]. Co-director of a NATO-funded Advanced Research Workshop Nanotechnology-Toxicological Issues and Environmental Security (CBP.EAP.ARW 982043), Varna, Bulgaria, August 12–17.



## ■ Simeonova P [2006]. Co-chaired the Nanoparticles: Toxicology, Health Effects, Hazard Identification Session, Toxicology and Risk Assessment Conference, Cincinnati, OH, April 24–27.



## ■ Simeonova P [2006]. Organized a presentation and discussions with Dr. Hussain, Air Force Laboratory on nanotoxicology risk assessment for NIOSH scientists. June 7.



## ■ Simeonova P, Luster M [2006]. Organized a presentation and discussions on Nanomaterial Safety for NIOSH scientists with Dr. N. Walker, National Toxicology Program, July 12. 

## Dissemination (interviews and articles in lay press) A. Maynard (Project 1), A. Shvedova (Project 2), and/or V. Castranova (Project 6) ha ve been interviewed by the following press concerning NIOSH activities in Nanotechnology:



## ■ Nanobiotech News 2, 20, pp. 2–3 (May 19, 2004)



## ■ Small Times (May 19, 2004)



## ■ CN&E News 82, 24 pp. (June 14, 2004)



## ■ Environmental Health Perspectives 112, pp. A741–A749 (2004)



## ■ Science News: Particular Problems: Assessing Risks of Nanotechnology, May 6, Vol. 169, pp. 280–281 (2006)



## ■ Science News : How ‘toxic’ nanotubes were faking it. Interview with Science News writer from UK Mason Inman on June 3, 2006, published
on NewScientist.com news service (June 5, 2006). J. Antonini has been interviewed by the following press concerning the NIOSH
w e lding project:



## ■ The Courier (Louisiana), Business section (October 27, 2002)



## ■ Science 300 (5621):927 (May 9, 2003)

96**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ National Law Journal 127 (238) 3 (December 10, 2003)



## ■ Forbes , p. 44 (February 2, 2004)



## ■ The Tennessean (Nashville, TN), Business section, p. 1E (July 16, 2005).



## ■ The Synergist 16 (9):48–49 (October 2005)



## ■ The Plain Dealer –Cleveland (June 2, 2006)



## ■ Associated Press (June 12, 2006) P. Simeonova was interviewed by the following press on research being cond u cted with SWCNTs:



## ■ NanoHazard, Science News (March 19, 2005) 

## Partnerships and Collaborations

■ J. Antonini established an interagency agreement with National Toxicology Program (NTP) to aid in the construction of a welding fume generation and animal exposure system to be used for NTP-sponsored chronic animal studies.



## ■ J. Antonini has established a collaboration with the Manganese Health Research Program and Vanderbilt University (funded by the U.S. Department of Defense) to evaluate the effect of manganese in welding fume on neurotoxicity in laboratory animals.



## ■ V. Castranova (Project 4) is collaborating with G. Oberdorster at theUniversity of Rochester on the ability of nanoparticles to generate radical species.



## ■ V. Castranova and D.W. Porter (Project 4) are collaborating with Dr. Chen at Oak Ridge Laboratory to evaluate the pulmonary toxicity of nanoparticles.



## ■ A. Shvedova and V. Castranova (Projects 2 and 4) are collaborating with V. Kagan at the University of Pittsburgh on the toxicity of nanomaterials.



## ■ Dr. Luster (Project 3) is collaborating with NIEHS/NIH and the Department of Defense on nanotoxicology.



## ■ V. Castranova and D.W. Porter (Project 4) and P. Simeonova are collaborating with Mitsui Inc. and Dr. Endo (Japan) on pulmonary and cardiovascular toxicity of multi-walled carbon nanotubes.



## ■ V. Castranova and D. Frazer are co-investigators on the extramural grant Microvascular dysfunction resulting from pulmonary exposure to fine versus ultrafine titanium dioxide funded by the Health Effects Institute, (7/05–6/08). Dr. Nurkiewicz, West Virginia University, PI.

97**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ D. Evans collaborated with the University of Iowa on mapping measurement and characterization of airborne nanoparticles in the workplace.



## ■ D. Evans collaborated with the University of Cincinnati for conducting a performance evaluation of a wet-electrostatic precipitator for diesel engine exhaust after-treatment.



## ■ J. Ku and D. Evans established a partnership with the University of Minnesota on real-time measurement of nanomaterial structure.



## ■ E. Kuempel and R. Mercer are collaborating on a model for nanoparticle deposition with Dr. Owen Price at CIIT, Research Triangle Park, NC.



## ■ NIOSH PRL formed the Metal/Nonmetal Diesel Partnership with the National Mining Association (NMA), the National Stone Sand and Gravel Association (NSSGA), the United Steel Workers of America(USWA), the MARG Diesel Coalition and the Industrial Minerals Association—North America (IMA-NA) with the objective of reducing exposure of underground mines to diesel aerosols and gases.



## ■ NIOSH PRL Diesel team is collaborating with the Mechanical and Aerospace Engineering Department of West Virginia University on modeling dispersion of diesel aerosol plume in underground mining environment.



## ■ A. Shvedova (Project 2) has a MOU with NASA to evaluate the toxicity of single walled carbon nanotubes.



## ■ A. Shvedova is collaborating with Dr. Bengt Fadeel, Karolinska University, Stockholm, Sweden; Dr. Kadiiska, NIEHS, Research Triangle Park, NC; and Dr. P. Quinn, Professor of the Department of Biochemistry,Kings College, University of London, London, UK; on oxidant generation by nanoparticles and resultant oxidant stress in exposed cells.



## ■ A. Shvedova and V. Castranova are co-investigators on the extramural grant Oxidant stress induced by nanomaterials funded by NIOSH (7/05–6/08). Dr. Kagan, University of Pittsburgh, PA.



## ■ P. Simeonova is collaborating with WVU, Medical School and Engineering Department, on nanomaterial toxicity and physicochemical properties.



## ■ P. Simeonova is collaborating with the University of Rochester, Rochester, NY, Department of Environmental Medicine, with Dr. Gunter Oberdorster.

98**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ P. Simeonova is collaborating with NIEHS/NTP, Research Triangle Park, NC, on fullerene toxicity and metal oxide nanomaterials.
NTRC Critical Research Topic Areas Addressed 1. Toxicity and Internal Dose [Projects 2–4 and 6–10] 2. Measurement Methods [Projects 1 and 5]

99**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Research Project 11: Nanoparticles in the Workplace Principal Investigator: Mark Hoover, Ph.D., DRDS/NIOSH/ CDC Project Duration: FY 2004–FY 2009 Background The scope of the NIOSH Nanoparticles in the Workplace project is to foster the de velopment of partnerships, exposure monitoring instrumentation, operational protocols, and a comprehensive and detailed database of nanoparticles and their properties. These activities are intended to provide NIOSH and the occupational safety and health community with a better understanding of the nature and extent of potential occupational exposures to nanoparticles. Theresults from these activities are expected to foster the development of comprehensive and scientifically sound occupational health protection strategies for emerging nanotechnologies. This work also supports NIOSH toxicologystudies of nanomaterials. This project will enable NIOSH and the nanotechnology industries to better anticipate, recognize, evaluate, and control potential occupational exposures to nanoparticles during their manufacturing and use.
Accomplishments



## ■ Partnerships were developed with nanotechnology industries, academia, government agencies, labor, and voluntary consensus standardcommittees to conduct joint research and develop guidelines on working safely with nanomaterials.



## ■ Sampling protocols and safety management guidelines were developed to help characterize the extent of exposure to nanoparticles in the workplace.



## ■ Partnerships were established with a fullerene research facility, an industrial nano-TiO 2 

### production facility, a cosmetics company, an industrial producer of ultrafine beryllium oxide materials, and a university research facility engaged in polymer work with carbon nanofibers to characterize occupational exposure to nanomaterials.



## ■ Assistance was provided to the ISO in creating the new ANSI nanotechnology program, including the establishment of a nanotechnology technical committee.

100**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ A new carbon nanotube reference material was developed and evaluated in collaboration with NIST.



## ■ A new ultrafine beryllium oxide standard reference was developed in collaboration with NIST and the U.S. Department of Energy.



## ■ The in-house capabilities for physico-chemical characterization of nanoparticles, especially as it relates to surface area, were established.



## ■ The NIL Project (Web-based) was initiated to develop a database on nanomaterials.



## ■ Partnership was established with TSI Incorporated on the characterization, under actual industrial field conditions, of the lung-deposited surface area aerosol sampling instrument.

Publications and Abstracts



## ■ Castranova V, Hoover MD, Maynard A [2005]. NIOSH nanotechnology safety and health research program, in nanoparticles: a risk to healthat work? Final Report of the First International Symposium on Occupational Health Implications of Nanomaterials, David Mark, ed., June, p. 117, http://www.hsl.gov.uk/media/1646/nanosymrep_final.pdf

.


## ■ Hoover MD [2005]. Mixed exposure issues for nanotechnology safety,in nanoparticles: a risk to health at work? Final Report of the First International Symposium on Occupational Health Implications of Nanomaterials, David Mark, ed., June, p. 115, http://www.hsl.gov.uk/media/1646/nanosymrep_final.pdf

. 

## ■ Hoover MD, Miller AL, Lowe NT, Stefaniak AB, Day GA, Linch KD [2005]. Information management for nanotechnology safety and health, in nanoparticles: a risk to health at work? Final Report of the First International Symposium on Occupational Health Implications of Nanomaterials, David Mark, ed., June, p. 110, http://www.hsl.gov.uk/media/1646/nanosymrep_final.pdf

. 

## ■ Northage C, Hoover MD [2005]. Report of workshop Group F on regulatory implications, in nanoparticles: a risk to health at work? Final Report of the First International Symposium on Occupational Health Implications of Nanomaterials, David Mark, ed., June, pp. 145–147, http://www.hsl.gov.uk/capabilities/nanosymrep_final.pdf.



## ■ Phalen RF, Hoover MD [2006]. Aerosol dosimetry research needs. Inh Toxicol 18 (7–10):841–843.

101**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Stefaniak AB, Day GA, Scripsick RC, Hoover MD [2005]. Comprehensive characterization strategies for ultrafine particles: lessons from beryllium health and safety studies, in nanoparticles: a risk to health atwork? Final Report of the First International Symposium on Occupational Health Implications of Nanomaterials, David Mark, ed., June, p. 118, http://www.hsl.gov.uk/media/1646/nanosymrep_final.pdf

.


## ■ Stefaniak AB, Hoover MD, Day GA, Ekechukwu AA, Whitney G, BrinkCA, Scripsick RC [2005]. Characteristics of beryllium oxide and beryllium metal powders for use as reference materials. J. ASTM International, 2 (10):doi 10.1520/JAl13174.



## ■ Watters RL, Hoover MD, Day GA, Stefaniak AB [2006]. Opportunitiesfor development of reference materials for beryllium. J. ASTM International, 3 (1):doi 10.1520/JAl13171.

Invited Presentations



## ■ Eshelman JC, Hoover MD, Petsonk EL, Antao VC, Trout DB, SchultePA [2006]. Occupational Medicine Issues for Nanotechnology, American Occupational Health Conference, Los Angeles, CA, May 10.



## ■ Hoover MD [2005]. NIOSH Nanotechnology Informatics Overview,NIOSH—Altair Nanotechnologies, Inc. Information Exchange Meeting, Reno, NV, April 19.



## ■ Hoover MD [2004]. Mixed Exposure Issues for Nanotechnology Safety, 1st International Symposium on Nanotechnology and Occupational Health, Buxton, UK, October 11–14.



## ■ Hoover MD [2004]. NIOSH Approaches to Safe Nanotechnology, 2006 NIST Safety Day Symposium, National Institute for Standards and Technology, Gaithersburg, MD, June 15.



## ■ Hoover MD, Miller AL, Lowe NT, Stefaniak AB, Day GA, Linch KD [2004]. Information Management for Nanotechnology Safety andHealth, 1st International Symposium on Nanotechnology and Occupational Health, Buxton, UK, October 11–14.



## ■ Hoover MD, Hearl FA [2005]. NORA Mixed Exposures Research Agenda, Society of Toxicology Workshop on Contemporary Concepts In Toxicology Charting the Future: Building the Scientific Foundation for Mixtures Joint Toxicity and Risk Assessment, Atlanta, GA, February 16–17.

102**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Hoover MD [2005]. An Introduction to Nanotechnology and the Possible Hazards, Institute of Occupational and Environmental Health Lecture, West Virginia University, Morgantown, WV, March 1.



## ■ Hoover MD [2005]. Lung Dosimetry of Boundary Fire Smoke Samples, Wildfire Symposium, Morgantown, WV, March 31.



## ■ Hoover MD [2005]. Informatics for Nanotechnology Safety and Health,Round Table on the Role of the Occupational Safety and Health Professional in the Emerging Nanotechnology Industry, American Industrial Hygiene Conference and Exposition, Anaheim, CA, May 24.



## ■ Hoover MD [2005]. Nanotechnology: Addressing Potential Health Impact, Council of State and Territorial Epidemiologists, Albuquerque, NM, June 6.



## ■ Hoover MD [2005]. Planning for the Next Decade of NORA: Opportunities to translate Research into Practice through the National Occupational Research Agenda, Annual Meeting of the Health Physics Society, Spokane, WA, July 13.



## ■ Hoover MD [2005]. Nanotechnology: Understanding and Addressing Potential Health Impacts, National Association of Scientific Materials Managers, Reno, NV, July 25.



## ■ Hoover MD [2005]. Nanoparticles in the Workplace, NIOSH NanoAerosols 2005 Workshop, Oglebay, WV, August 24.



## ■ Hoover MD [2005]. Nanotechnology: Understanding and Addressing Potential Health Impacts, Southern California Environmental Safety, Hygiene, and Health Joint Technical Symposium, Long Beach, CA, October 27.



## ■ Hoover MD, Murashov V [2005]. National and International Standards Activities Related to Nanotechnologies, NIOSH NanoAerosols 2005 Workshop, Oglebay, WV, August 25.



## ■ Hoover MD, Murashov V [2005]. Overview of National and International Standards Activities Related to Nanotechnologies and Draft Ideas for Discussion, U.S. Technical Advisory Group Meeting for ISOTC 229 Nanotechnologies, National Institute for Standards and Technology, Gaithersburg, MD, September 8.



## ■ Hoover MD [2006]. Exposure Assessment for Nanotechnology, American Industrial Hygiene Conference, Chicago, IL, May 13–18.



## ■ Hoover MD [2006]. Characterization of Nanoparticles in the Workplace, Ask the Expert session on the NIOSH Nanotechnology Research

103**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### Program, American Industrial Hygiene Conference, Chicago, IL, May 13–18.



## ■ Hoover MD [2006]. NIOSH Approaches to Safe Nanotechnology, 2006NIST Safety Day Symposium, National Institute of Standards and Technology, Gaithersburg, MD, June 15.



## ■ Hoover MD [2006]. Nanoparticles in the Workplace, Campus Safety Health and Environmental Management Meeting, Anaheim, CA, July 19.



## ■ Miller AL, Hoover MD [2006]. Building a Nanoparticle InformationLibrary, National Occupational Research Agenda Symposium, Washington, DC, April 18–20.



## ■ NIOSH NTRC [2006]. Approaches to Safe Nanotechnology: An Information Exchange with NIOSH. Conference on Commercialization of NanoMaterials 2006, Pittsburgh, PA, September 18–20.



## ■ Schulte P, Geraci C, Zumwalde R, Hoover M, Castranova V, MurashovV, Howard J [2006]. Occupational Safety and Health Issues in Nanotechnology, 28th International Congress on Occupational Health, Milan, Italy, June 8–16.



## ■ Miller AL, Hoover M [2005]. Building a Nanomaterial InformationLibrary. Second International Symposium on Nanotechnology and Occupational Health, Minneapolis, MN, October 3–6.



## ■ Birch ME, Evans DE, Methner MM, McCleery RE, Crouch KG, Ku B-K,Hoover MD [2006]. Workplace Assessment of Potential Exposure to Carbonaceous Nanomaterials. Second International Symposium on Nanotechnology and Occupational Health, Minneapolis, MN, October 3–6.



## ■ Stefaniak AB, Day GA, Hoover MD [2006] Measurement Issues forEvaluating and Relating Nanoparticle Surface Properties to Bioaccessibility and Health. Workshop on Instrumentation, Metrology, and Standards for Nanomanufacturing, Gaithersburg, MD, October 17.



## ■ Miller AL, Hoover MD [2006]. Building a Nanoparticle Information Library. Workshop on Instrumentation, Metrology, and Standards for Nanomanufacturing, Gaithersburg, MD, October 17.



## ■ NIOSH NTRC [2006]. Approaches to Safe Nanotechnology: An Information Exchange with NIOSH. Workshop on Instrumentation, Metrology, and Standards for Nanomanufacturing, Gaithersburg, MD, October 17.

104**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ NIOSH NTRC [2006]. NIOSH Nanotechnology Safety and Health Research Program. Workshop on Instrumentation, Metrology, and Standards for Nanomanufacturing, Gaithersburg, MD, October 17.



## ■ NIOSH Control Banding Working Group [2006]. Potential Application of “Control Banding” for Safe Handling of Engineered Nanoparticles inthe Workplace. Workshop on Instrumentation, Metrology, and Standards for Nanomanufacturing, Gaithersburg, MD, October 17.



## ■ Hoover MD, Stefaniak AB, Methner MM, Ku BK, Geraci CL, Maher TV, Singh M [2006]. Evaluation of a Real-Time Surface Monitor in aNanotechnology Workplace, International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 4–7.



## ■ Hoover MD [2006]. Science and Research Issues for NanoparticleMeasurements and Control, International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 7.



## ■ Hull MS, Hoover MD, Geraci CL [2006]. Update on Understanding and Assessing an Emerging Technology in Practice: Continuation of anInnovative Industry/Government Partnership. International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 4–7.



## ■ Miller AL, Hoover MD [2006]. Building a Nanoparticle Information Library. International Conference on Nanotechnology Occupationaland Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 4–7.



## ■ Stefaniak AB, Day GA, Hoover MD [2006] Measurement Issues forEvaluating and Relating Nanoparticle Surface Properties to Bioaccessibility and Health. International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 4–7.



## ■ Birch ME, Evans DE, Methner MM, McCleery RE, Crouch KG, Ku BK, Hoover MD [2006] Workplace Assessment of Potential Exposure toCarbonaceous Nanomaterials. International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 4–7.

105**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ NIOSH NTRC [2006]. Approaches to Safe Nanotechnology: An Information Exchange with NIOSH. International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 4–7.



## ■ NIOSH NTRC [2006]. NIOSH Nanotechnology Safety and HealthResearch Program. International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 4–7.



## ■ NIOSH Control Banding Working Group [2006]. Potential Application of “Control Banding” for Safe Handling of Engineered Nanoparticlesin the Workplace. International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 4–7.
Future Presentations



## ■ Hoover MD [2007] Characterizing and Controlling Exposures toNanoparticles in the Workplace, American Industrial Hygiene Association Teleweb Nanoparticle Update: Measuring, Evaluating, and Managing Exposures, March 8.



## ■ Hoover MD [2007] Measurement of Nanoparticles in the Workplace, Ask the Experts: An Update on NIOSH Research in Nanotechnology, American Industrial Hygiene Conference and Exposition, Philadelphia, PA, June 4.



## ■ Hoover MD [2007] Exposure Assessment and Sampling Issues for Nanotoxicology and Safe Handling of Nanoparticles in the Workplace, American Industrial Hygiene Conference and Exposition, Philadelphia, PA, June 4.
National and International Activities



## ■ Participated in the formation and activities of the ANSI Nanotechnology Standards Steering Panel, including activities resulting in the formation of the new ISO Technical Committee 229 on Nanotechnologies.



## ■ Participating in the American Industrial Hygiene Association Nanotechnology Working Group, which is bringing together industrialhygiene expertise to develop educational programs, develop best practices, and share lessons learned.



## ■ Participated on the organizing committee for the Frontiers in Respiratory Dosimetry meeting, which was held at the National Academies Center at the University of California, Irvine, CA, October.

106**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Co-organized the Nanotechnology and Health Symposium for the 2006 International Aerosol Conference in St. Paul, MN.



## ■ Participated in the writing group to develop the new American Societyof Testing and Materials (ASTM) International Committee E56 standard on Safe Handling of Unbound Nanoparticles. Dissemination (interviews and articles in lay press) Project participants were interviewed by the press for the following journals
a n d articles concerning NIOSH activities in nanotechnology:



## ■ Inside OSHA , 12 (16):10–11 (August 8, 2005)



## ■ Journal of the American Medical Association (September 2005).



## ■ National Journal Technology Daily (September 2005)



## ■ BNA Daily Report for Executives , Nanotechnology: Small Nanotechnology Firms can be Leaders on Health, Safety Issues, Advisory Firm Says, 205 :A8 (October 25, 2005)



## ■ The Synergist



## ■ Small Times



## ■ Washington Post Partnerships and Collaborations



## ■ Partnership with NIST to develop new standard reference materials for nanoparticles



## ■ Partnership with Luna Innovations to characterize fullerenes in a nanotechnology research facility.



## ■ Partnership with a primary nanoscale metal oxide manufacturer to characterize nanometal oxides in a commercial manufacturer setting.



## ■ Partnership with a commercial cosmetics manufacturer to characterize and control exposures to nanomaterials in the production of cosmetics. NTRC Critical Research Topic Areas Addressed 1. Exposure Assessment 2. Measurement Methods 3. Communication and Education 4. Applications

107**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Research Project 12: Nanoparticles—Dosimetry and Risk Assessment
Principal Investigator: Eileen D. Kuempel, Ph.D., EID/ NIOSH/CDC Project Duration: FY 2004–FY 2009 Background Risk assessment of occupational exposure to nanoparticles is needed to protect
wo r kers’ health. Human data are limited on exposure, dose, and response to nanoparticles. However, data from studies in rodents are available to evaluate the dose-response relationships and estimate the exposures in workers thatwould be unlikely to cause adverse health effects. Using these data in risk assessment requires a scientifically reasonable approach to extrapolating the animal data to humans. One such approach is the use of biologically based lung dosimetry models. However, these models have not been fully evaluated and validated for predicting the deposition and clearance of inhaled nanoparticles. Furthermore, these models currently have limited capability to describe the translocation of nanoparticles beyond the lungs, as observed in rodent studies. In this project, a current rat lung dosimetry model will be extended to include bi o logically relevant paths for the transport of nanoparticles to the blood and other organs as well as excretion. Data from the literature will be used to calibrate this model, and data from new studies at NIOSH and elsewhere will be used to validate the model. The model will be extrapolated to humans using human data where available (e.g., physiological parameters), and biologically based approaches to interspecies extrapolation will be applied to estimate fromthe rat model the parameter values not available in humans. These lung dosimetry models will be used in conjunction with rodent dose-response data to estimate risk of adverse health effects in workers and working lifetime exposure concentrations that are not expected to cause adverse health effects. Specific objectives include the following:
1. Evaluate the dose-response relationships of inhaled particles by size
an d t ype and estimate the lung disease risks in workers using available data from existing studies. 2. Revise and extend a current rat lung dosimetry model to include par ticle size-specific clearance and translocation beyond the lungs.

108**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



### 3. Validate the extended rat model using in vivo and in vitro data from ongoing studies at NIOSH and elsewhere. 4. Quantify variability and uncertainty in parameter values of the human l un g dosimetry models. 5. Extrapolate the validated rat model to humans. 6. Perform quantitative risk assessment for occupational exposure to
n a noparticles. Accomplishments



## ■ Performed quantitative risk assessment (QRA) of working lifetime exposure to various poorly-soluble particles using dose-response data from chronic and subchronic inhalation studies in rats (ED Kuempel, M Wheeler, D Dankovic, AJ Bailer) (Objective 1). 	 Performed QRA for a NIOSH “Current Intelligence Bulletin: E va luation of Health Effects Data on Occupational Exposure toTitanium Dioxide,” which provided the scientific basis for developing particle size-specific RELs for fine and ultrafine TiO 2 

### .	 Presented findings at scientific conferences and in published pap e rs in peer-reviewed journals. Excess risk estimates for poorlysoluble nanoparticles were greater than those for larger respirable particles of similar composition; thus lower workplace exposure concentrations were estimated to be necessary for the nanoparticles evaluated to protect workers’ health. 	 Stimulated a related project to develop quantitative methods for
s um marizing and interpreting multiple models fit to quantal response data using Bayesian model averaging (M Wheeler and J Bailer).



## ■ Initiated research project, Develop and Extend a Biomathematical Model in Rats to Describe Particle Size-Specific Clearance and Translocation of Inhaled Particles and Early Biological Responses (Objectives 2 and 3). 	 Awarded research contract in 2005 to Dr. Lang Tran, Institute
o f O ccupational Medicine, Edinburgh, United Kingdom.	 Designed extended rat dosimetry model for inhaled nanopartic l es with clearance and translocation pathways based on biological and kinetic data from the scientific literature.	 Currently planning the calibration and validation of the ext e nded rat model.

109**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Initiated and managed research project, Development of Specific Modifications to Multi-path Particle Deposition Model and Software Interface (Objectives 2–5). 	 Awarded in 2005 to Drs. Bahman Asgharian and Owen Price, CIIT Centers for Health Research, Research Triangle Park. 	 Completed in 2006 the beta version of the new model, which
e n ables batch runs, variable exposure scenarios, lung regionspecific deposition estimates, and model predictions output in aformat compatible with other models or software. Provides detailed deposition estimates for the rat and human lung models being developed for nanoparticles. Currently finalizing model for public release.	 Identified need for additional region-specific deposition est im ates in the nasal region and initiated follow-on research contact to extend this capability, with Drs. Julie Kimbell and Bahman Asgharian, CIIT Centers for Health Research, in 2006.



## ■ Developed research proposal, Development and Application of Methods to Quantify Variability and Uncertainty in Lung Dosimetry Models for Use in Risk Assessment of Nanoparticles (Objectives 4 and 5). Awarded in 2006 to Dr. Eric Hack, Toxicology for Excellence in Risk Assessment (TERA).



## ■ Developed research proposal, Development of a Method for Predicting the Inhalability and Internal Dose of Airborne Carbon Nanotubes in Workers (Objective 4). Awarded in 2006 to Dr. Bahman Asgharian, CIIT Centers for Health Research, Research Triangle Park.



## ■ Results from research in Objectives 1–5 will be used in Specific Aim 6.

Publications and Abstracts



## ■ Dankovic D, Kuempel E, Wheeler M [2006]. An approach to risk assessment for TiO 2 

### . In: Proceedings of the 10th International Inhalation Symposium on Airborne Particulate Matter: Relevance of Particle Components and Size for Health Effects and Risk Assessment, held in Hannover, Germany, May 31–June 3.



## ■ Kuempel ED, Tran CL, Castranova V, Bailer AJ [2006]. Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal Toxicol 18 (10):717–724.



## ■ Kuempel ED, Wheeler M, Smith R, Bailer AJ [2005]. Quantitative risk assessment in workers using rodent dose-response data of fine

110**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



### and ultrafine titanium dioxide. [Abstract]. In: Nanomaterials: a risk to health at work? First International Symposium on Occupational HealthImplications of Nanomaterials,12–14 October 2004, Buxton, Derbyshire, UK, Report of Presentations at Plenary and Workshop Sessions and Summary of Conclusions. Buxton: Health and Safety Executive, UK, p. 111.



## ■ Kuempel ED, Aitken RJ [2005]. Regulatory implications of nanotechnology: summary of discussion and recommendations from Workshop G. In: Nanomaterials: A Risk to Health at Work? 1st International S y mposium on Occupational Health Implications of Nanomaterials,12­ 14 October 2004, Buxton, Derbyshire, UK Report of Presentations at Plenary and Workshop Sessions and Summary of Conclusions. Buxton: Health and Safety Executive, UK, pp. 142–143.



## ■ Maynard AM, Kuempel ED [2005]. Airborne nanostructured particles and occupational health. J Nanoparticle Res 7 (6):587–614.



## ■ Maynard AM, Kuempel ED [2006]. Addressing the potential environmental and human health impact of engineered nanomaterials. In: The Symposium Q. Proceedings of the 3rd International Conference on Materials for Advanced Technologies (ICMAT), Singapore, July 3–8.

Invited Presentations



## ■ Dankovic DA [2006]. An approach to risk assessment for TiO 2 

### , byD Dankovic, E Kuempel, and M Wheeler. 10th International Inhalation Symposium on Airborne Particulate Matter: Relevance of ParticleComponents and Size for Health Effects and Risk Assessment. Hannover, Germany, June 3.



## ■ Kuempel ED [2004]. Assessing the health risks of nanomaterials in workers: current knowledge and research gaps. National Research Council, Board on Environmental Science and Toxicology. Woods Hole, MA, October 12.



## ■ Kuempel ED [2005]. Lung dosimetry and risk assessment for nanoparticles: use of in vitro and in vivo data to extend current models in rats and humans, by Kuempel E, Tran C, Bailer AJ, Castranova V. Frontiers in Aerosol Dosimetry Research Conference. Irvine, CA, October 24–25.



## ■ Kuempel ED [2006]. Quantitative risk assessment methods for nanoparticles: strategies and data needs. Nanotoxicology: Biomedical Aspects. Miami, FL, February 1.

111**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Kuempel ED [2006]. Estimating nanoparticle dose in humans: issues and challenges. Overcoming obstacles to effective research design in nanotoxicology. Cambridge, MA, April 25.



## ■ Kuempel ED [2006]. Risk assessment approaches and research needsfor nanoparticles: an examination of data and information from current studies, by E Kuempel, C Geraci, P Schulte. NATO Advanced Research Workshop on Nanotechnology: Toxicological Issues and Environmental Security, Varna, Bulgaria, August 14.



## ■ Kuempel ED [2006]. Risk assessment approaches for nanoparticles.International Conference on Nanotechnology Occupational and Environmental Health & Safety: Research to Practice. Cincinnati, OH, December 6.

National and International Activities and Conferences



## ■ Kuempel ED [2006]. Served as an invited working group participant and contributor to the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 93: Carbon Black, Titanium Dioxide and Non-Asbestiform Talc , Lyon, France, February 7–14. The carbon black and TiO 2 

### evaluated include ultrafine or nanoparticle forms.



## ■ Kuempel ED [2006]. Served as an invited participant and presenter atthe NATO Advanced Research Workshop on Nanotechnology: Toxicological Issues and Environmental Security, in Varna, Bulgaria, August 12–17. The scientific presentations, summary of workgroup discussions and recommendations will be published.
Dissemination (interviews and articles in the lay press) ED Kuempel was interviewed for two magazine articles concerning NIOSH
a c tivities in nanotechnology:



## ■ Parsons J [2004]. Small wonders, big questions. Am Ind Hyg Assoc J, The Synergist 15 (10):36–39.



## ■ Agencies publishing, generating data to protect against nanoparticle exposure [2004]. Occupational Safety and Health Reporter 34 (42):1069– 1070.
Partnerships and Collaborations



## ■ ED Kuempel is collaborating with Dr. Lang Tran at the Institute of Occupational Medicine, in Edinburgh, U.K., on a research project to

112**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



### develop and extend a biomathematical lung dosimetry model in rats to describe clearance and retention of nanoparticles.



## ■ ED Kuempel and RR Mercer are collaborating with Drs. Bahman Asgharian, Owen Price, and Julie Kimbell at the CIIT Centers for Health Research, Research Triangle Park, NC, on research projects to develop specific software modifications to the Multi-path Particle DepositionModel to enable integration of deposition estimates into the lung clearance and retention models for nanoparticles, to extend current modelsto include region-specific deposition of nanoparticles in the nasal region, and to explore deposition models for nonspherical nanoparticles.



## ■ ED Kuempel is collaborating with Dr. Eric Hack at Toxicology Excellence for Risk Assessment (TERA) to develop and apply methods to quantify the variability and uncertainty in lung dosimetry models for use in risk assessment of nanoparticles.
NTRC Critical Research Topic Areas Addressed 1. Exposure Assessment 2. Toxicity and Internal Dose 3. Risk Assessment 4. Recommendations and Guidance

113**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Research Project 13: The Measurement and Control of Workplace Nanomaterials
Principal Investigators: Doug Evans Ph.D., and Kevin Dunn M.S., CIH, DART/NIOSH/CDC Co-investigators: Eileen Birch, Keith Crouch, Bon-ki Ku, and Paul Baron Project Duration: FY 2006–FY 2009 BackgroundThe current version of this project was initiated in FY 2006 to address key res e arch gaps in the NIOSH, CDC-NORA, and NIOSH-NTRC research portfolios on engineered nanomaterials. A shift in focus of a previous NTRC-approved and funded project ( An Ultrafine Particle Intervention Study in Automotive Production Plants , approved February 2005) was made following suggestions from the NIOSH-NTRC steering committee (the funding source of this research).This project will provide a fundamental basis for understanding how nanomaterials are released and dispersed into the workplace, demonstrate the way nanomaterials can be monitored, and the way nanomaterial exposure can be controlled. Furthermore, this work provides NIOSH with the tools for making recommendations for reducing workers’ exposures to nanomaterials. Specific goals include the following: Conduct detailed nanomaterial workplace evaluations to provide the following:



## ■ A comprehensive workplace characterization of airborne nanomaterial release and exposure.



## ■ A determination of nanomaterial migration within the workplace.



## ■ A comprehensive qualitative and quantitative (where possible) assessment of engineering controls, ventilation systems, and work practices.



## ■ Recommendations for improvements in engineering controls and work practices where applicable.



## ■ Quantitative assessments of the efficacy of implemented engineering controls and work practices, where applicable, through workplace monitoring.

114**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



### Accomplishments (FY 2006)



## ■ A NIOSH Health Hazard Evaluation (HHE) was conducted at a nanomaterial research facility in December 2005, where carbon-based nanomaterials were incorporated into polymers and resins to produce novelnanocomposites. On the basis of extensive experience gained from previous activities supported by Project 1, the exposure characterization, engineering control, and work practice evaluation were conducted by participants supported under this project. An HHE report of the study is available at: www.cdc.gov/niosh/hhe/reports



## ■ A large comprehensive exposure characterization, engineering control, and work practice evaluation was conducted at a primary manufacturer of nanoscale metal oxides in March 2006. An interim report has beenprepared detailing observations, engineering controls, and work practice evaluations together with recommendations for improvements. A full report, detailing the comprehensive exposure characterization (size distributions, number concentrations, active surface area, massconcentrations, particle morphology, and material migration) is being prepared. Work continues with this company to demonstrate the efficacy of implemented recommended changes to engineering controls and work practices.



## ■ A screening survey was conducted at a quantum dot manufacturingfacility in July 2006, where quantum dots were produced and encapsulated into small display units. The survey involved the collection ofsome basic information about the types of processes employed, exposure control methods, and exposure measurement data. A limited number of samples were collected for characterizing the nanomaterials in the workplace. A report of the survey is being prepared.
Publications and Abstracts



## ■ Birch ME, Evans DE, Methner MM, McCleery RE, Crouch KG, Ku B-K, Hoover MD [2006]. Workplace assessment of potential exposure to carbonaceous nanomaterials. Poster presentation at the International Aerosol Conference. St. Paul, MN, September.



## ■ Dunn KH, Methner MM, Evans DE, Crouch KG, Stefaniak A, Ku B-K, Hoover MD, Curwin BD [2006]. Interim site survey report for a metal oxide and ceramic nanomaterials manufacturer.
Invited Presentations



## ■ Dunn KH [2006]. Nanotech exposure controls and best practices. Presented at the International Conference on Nanotechnology,

115**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### Occupational and Health & Safety: Research to Practice. Cincinnati, OH, December 4–7.



## ■ Dunn KH, Evans DE, Ku B-K, Baron PA Birch ME, Crouch KG [2006]. Overview of NIOSH research on nanomaterial characterization and control technology. Presented at the 2006 American Industrial Hygiene Conference and Exposition, Chicago, IL, May 14–18.



## ■ Evans DE, et al. [2006]. Field measurement of aerosols at the nanoscale.Presented at the International Conference for Nanotechnology. Occupational and Environmental Health & Safety; Research to Practice. Cincinnati, OH, December 4–7.

National and International Activities and Conferences



## ■ DE Evans is collaborating with researchers at the Health and Safety Laboratory (United Kingdom), at INRS (France) and BIA (Germany) on issues related to nanomaterial/ultrafine exposure measurement in workplaces.
Dissemination (interviews and articles in the lay press) Washington Post Staff Writer, Rick Weiss, spoke at length with project particip a nts during a site survey. The survey was the subject of a Post article by Mr. Weiss, which was published soon thereafter.



## ■ The DART project Measurement and Control of Workplace Nanomaterials was highlighted in the March 2006 edition of NIOSH eNews . Thesummary article discussed goals of the field project and issued a request for potential collaborators.



## ■ An article appeared in Occupational Hazards [2006]. This latter article covered results of related research identifying direct-fired, natural gas heating systems as sources of high concentrations of ultrafine particlesin workplaces. The study was conducted with collaborators at the University of Iowa, ( www.occupationalhazards.com/articles/14139 ).
Partnerships and Collaborations NIOSH researchers are working with the three nanomaterial manufacturers/ p r ocessors mentioned above, The University of Iowa, The University of NorthCarolina, The Woodrow Wilson International Center for Scholars, International Truck and Engine Corporation, and the United Auto Workers Union.

116

### 117 NTRC Critical Research Topic Areas Addressed 1. Exposure Assessment 2. Measurement Methods 3. Engineering Controls and Personal Protective Equipment 4. Fire and Explosion Safety 5. Recommendations and Guidance**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Research Project 14: TiO 2 

## Exposure Assessment Study Principle Investigator: Brian Curwin, DSHEFS/NIOSH/CDC Project Duration: FY 2006–FY 2009 Background TiO 2 

### , a poorly soluble, low-toxicity (PSLT) white powder, is used extensively in many commercial products, including paint, cosmetics, plastics, paper, and food as an anti-caking or whitening agent. Production in the United States was an estimated 1.43 million metric tons per year in 2004 [DOI 2005]. Ultrafine particles are hypothesized to penetrate the epithelial lining and lung int e rstitial spaces to a greater extent, more readily enter cells, and cause greaterlung inflammation and oxidative stress compared with larger particles. Furthermore, it is hypothesized that the dose of particles, expressed as particle surface area, is associated with lung responses and this relationship is similar across PSLT particles. Persistent inflammation, tissue damage, fibrosis, and lung cancer have been observed in rats at doses of PSLT particles that impairlung clearance. Particle surface area dose has been shown to be a better predictor of lung clearance inhibition. NIOSH has identified critical research needs for workers exposed to ultrafine
an d fin e TiO 2 

### , including measuring workplace airborne exposures to ultrafine TiO 2 

### in manufacturing and end-user facilities and evaluating the exposure response relationship between TiO 2 

### and human health effects. The goal of this study is to measure workplace exposure to fine and ultrafine TiO 2 

### in both manufacturing and end-user facilites. The specific objectives are to (1) quantify the airborne particle size distribution of TiO 2 

### by job or process in manufacturing and end-user facilities and (2) obtain quantitative estimates of exposure in workers to fine and ultrafine TiO 2 

### particle sizes in manufacturing and end-user facilities. A task-based sampling scheme consisting of various real-time and mass based area and personal aerosol sampling will be employed. In addition,each participant will be asked to provide information about their work practices and PPE use.
Accomplishments



## ■ Protocol for TiO 2 

### study has been written and is undergoing review.

118**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Critical exposure assessment equipment has been purchased including a TSI 3007 condensation particle counter and an Ecochem DC2000 CE portable diffusion charger.



## ■ A contract has been awarded to assist in identifying companies for study.

Publications and Abstracts The field work has not begun and no data have been collected. Therefore, no pub lications or abstracts have been published.

Invited Presentations This project is in its early stages and therefore no invitations to present results fro m this project have been offered.

National or International Activities and Conferences No national or international activities have occurred or are planned at this time

.
Dissemination (interviews and articles in the lay press) This project is in its early stages. No results are available for dissemination.

Partnerships and Collaborations



## ■ Consultations were held with Dr. Dirk Brouwer, Netherlands Organization for Applied Scientific Research (TNO), Netherlands, on study protocol development.



## ■ Collaboration with a manufacturer and an end user of ultrafine TiO 2 

### has been established for conducting possible exposure characterization studies.
NTRC Critical Research Topic Areas Addressed 1. Exposure Assessment 2. Measurement Methods

119**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Research Project 15: Evaluation of Nanoparticle Penetration Through Respirator Filter Media Principle Investigator: Samy Rengasamy, Ph.D., NPPTL/ NIOSH/CDC Project Duration: FY 2005–FY 2008 Background The objective of this project is to evaluate the penetration of nanoparticles th r ough respirator filter media. Nanoparticles smaller than 100 nm in size canbehave differently from larger particles of the same material. NIOSH has initiated research projects on nanoparticle exposure, health effects, and respiratory protection. For respiratory protection against various particles, particulaterespirators are commonly used in different workplaces. Although NIOSH-approved respirators efficiently capture particles greater than 20 nm, few dataexist on their efficiency for particles smaller than 20 nm. Some studies suggest the penetration of smaller particles through filters by a thermal reboundmechanism. The results will be confirmed by testing NIOSH-approved respirators against particles smaller than 20 nm. This study will ensure that respirators provide adequate protection for workers in the nanotechnology industries.

Accomplishments In 2005, the research proposal was approved for a pilot project study, and a
co n tract was awarded to the University of Minnesota. Preliminary results fromthe project were presented at the 2nd International Symposium on Nanotechnology and Occupational Health in Minneapolis, MN, October 2005. Silver nanoparticles of 3-20 nm in diameter were generated for testing respirator filter media. Preliminary results indicated that filtration efficiency increasedwith decreasing particle size as expected according to the Brownian deposition theory. No evidence for thermal rebound of nanoparticles was observed. The results of this study suggest that respirator filters may efficiently capture nanoparticles greater than 3 nm in diameter. To confirm these results, further studies with silver and/or sodium chloride aerosol particles will be used to test for penetration through particulate filtering facepieces and cartridges.

Publications and Abstracts



## ■ Kim SC, Harrington M, Rengasamy S, Pui D [2005]. Collection efficiency of filter media for nanoscale particles. Presented at the 2nd International

120**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



### Symposium on Nanotechnology and Occupational Health in Minneapolis, MN.



## ■ Gardner P, Rengasamy S, Richardson A [2005]. Efficiency of respirator filters against nano-aerosols under high flow rate conditions

. Presentedat the 2nd International Symposium on Nanotechnology and Occupational Health in Minneapolis, MN, October 3–6.



## ■ Kim SC, Harrington M, Rengasamy Samy, Pui D [2006]. Collection efficiency of filter media for nanoscale particles

. Presented at the American Industrial Hygiene Conference and Exposition, Chicago, IL, May 14–18.



## ■ Shaffer R, Gao P, Rengasamy S [2006]. Penetration of nanoparticles through protective clothing and respirator filters. Presented at the Elevated Wind Studies International Conference, Arlington, Virginia, September 25–26.



## ■ Shaffer R, Rengasamy S, Gao P [2006]. Penetration of nanoparticles through protective clothing and respirator filter media. Presented at the International Conference on Nanotechnology, Occupational and Environmental Health & Safety: Research to Practice. Cincinnati, OH December 4–7.

National and International Activities and Conferences S. Rengasamy arranged a Round Table meeting on Nanotechnology and PPE i s s ues for the 2006 AIHCE meeting in Chicago. For this session, PPE experts from academic, industrial, and nongovernmental organizations were invited. Highlights of the presentations include studies on nanoparticle penetrationthrough filter media and respirator filters. Other presentations included developing highly adsorbent and reactive nanoparticles for protective clothing for chemical and biological warfare agents and the evaluation of protective gloves and PPE for handling nanomaterials.

Dissemination (interviews and articles in the lay press)



## ■ S. Rengasamy and R. Shaffer had an interview with Occupational Hazards magazine and discussed nanoparticle filtration. An article entitled NIOSH-funded Study Looks at Filter Efficiency for Nanoparticles was published in September 2005 ( 67 :42). The growth of nanotechnology across different industries and the effects of nanoparticles on respiratory protection and were discussed. Single fiber theory and the mechanisms of penetration of different size particles through respirator

121**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### filters were also shared. The lack of knowledge about the penetration of nanoparticles smaller than 20 nm sizes and the importance of this research were highlighted. NIOSH collaboration with the University of Minnesota to study the penetration of particles smaller than 20 nm wasshared. This interview highlighted current understanding of nanoparticles, and the importance of NIOSH nanoparticle filtration research work with the University of Minnesota.



## ■ S. Rengasamy and R. Berryann of NPPTL had an interview with theBureau of National Affairs (BNA), Inc. in October 2005, and highlighted the current developments on respiratory protection against nanoparticles. An article entitled NIOSH Planning More Respirator Studies after Nanoparticle Tests Find Penetration was printed in a BNA publication, October 19, pp. 8–22.



## ■ S. Rengasamy and R. Shaffer of NPPTL had an interview with the AIHA publication The Synergistin October 2005, and discussed current nanotechnology research activities in NPPTL that address worker safety and issues. An article entitled Accelerating Research Sizes up the Implications of Nanotechnology in the Workplace was published in The Synergist [2005] 17 (1):37–39.



## ■ S. Rengasamy and R. Shaffer of NPPTL were interviewed by Chemical and Engineering News in April 2006. The aim of the interview was to better understand the current developments in respiratory protection against nanoparticles. An article entitled How Well do Gloves and Respirators Block Nanoparticle was published in the May 1 issue of Chemical and Engineering News, pp.14–15.



## ■ K. Williams and A. Maynard were interviewed by The Synergist and highlighted the lack of complete information about nanoparticles andthe performance of personal protective equipment against nanomaterials. An article titled Small Wonders, Big Questions was published in The Synergist [2004] 15 (10):37–39.
Partnerships and Collaborations



## ■ In January 2005, K. Williams assisted the EPA by reviewing a manufacturer’s application to manufacture a nanosized product that was submitted to EPA for approval under the Toxic Substances Control Act (TSCA). He provided input regarding the selection of appropriate PPE for the manufacturing process that was valuable to the EPA in the evaluation and approval of the manufacturer’s application.

122**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## ■ Partnership with the ISEA Filter Research Task Group was establishedto achieve the goals of this project. ISEA Filter Research critically reviewed the proposal in January 2005. The proposal was revised taking into consideration the comments and suggestions of the ISEA Filter Research Task Group.



## ■ S. Rengasamy, R. Shaffer, and P. Gao are actively participating in the DuPont Nanoparticle Occupational Safety and Health Consortium. The objectives of this consortium include the generation of nanoparticles, the measurement, filter penetration, and development of a portable device to measure nanoparticles in workplaces to provide safety and health to workers. An MOU between NIOSH/NPPTL and DuPont was officially executed in June 2006. This will allow NIOSH to collaborate with the DuPont Consortium and exchange information about PPE (clothing and respirators) and nanoparticles research. NTRC Critical Research Topic Areas Addressed 1. Engineering Controls and PPE 2. Recommendations and Guidance

123**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Research Project 16: Development of Bench andMist Protocols for Particulate Penetration Measurements of Protective Clothing and Ensembles
Principle Investigator: Pengfei Gao, Ph.D., C.I.H., NPPTL/ NIOSH/CDC Project Duration: FY 2006–FY 2009
Background Protective clothing and ensembles are critically important items for workers wh e n exposed to hazardous conditions. In order to determine how well ensembles protect wearers, it is necessary to test the entire suit system while itis worn to measure potential leakage through seams, closures, areas of transition to other protective equipment, and any leakage due to movement and activities. The objective of this project is to develop innovative methodology for standardizing both bench-scale testing and man-in-simulant test (MIST) procedures for aerosol particle penetration through protective clothing and ensembles. A test method for aerosol particles including nanoparticles that does not depend on filtration will be developed. A passive aerosol sampler (PAS) using magnetic force will be developed and iron (II, III) oxide particleswill be used to generate challenge aerosols. An aerosol chamber will be fabricated for evaluating the particulate penetration for particle sizes between 20 and 500 nm; a wind tunnel will be used for larger particles up to 10 μm. Iron oxide collected on the PAS will be quantified using a colorimetrical method or TEM. Performance of the PAS will be evaluated under various test conditions, including particle size, particle concentration, wind speed, exposure duration, relative humidity, and sampler orientation. A disposition velocity model willbe developed to calculate sampling rates of the PAS. Penetration of nanoparticles through fabrics and protective clothing swatches will be measured with other reference samplers to compare the performance of the PAS. The researchfindings will be used for revised and new American Society for Testing Materials (ASTM) and NFPA standards. The project duration is proposed to last for 4 years (FY 2006–FY 2009).

Accomplishments



## ■ A prototype passive aerosol sampler using magnetic force has been developed at NPPTL to more accurately determine aerosol particle

124**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



### penetration including nanoparticle penetration through ensembles. Preliminary evaluation of the sampler performance indicates the ability to collect nanoparticles down to 20 nm by the sampler. Appropriatesampler coatings were identified to facilitate analysis of collected aerosol. Experiments to allow an improved assessment of sampler performance were completed.



## ■ An Employee Invention Report (I–015–05) for the passive aerosol sampler was submitted to CDC Technology Transfer Office in March 2005.



## ■ A research proposal has undergone external peer review.

Publications and Abstracts



## ■ King WP, Gao P, Shaffer R [2006]. Review of chamber design requirements for testing of personal protective clothing ensembles. Submitted to the Journal of Occupational and Environmental Hygiene for publication.

Invited Presentations



## ■ Shaffer R, Rengasamy S, Gao P [2006]. Penetration of nanoparticles through protective clothing and respirator filter media. Presented at the International Conference on Nanotechnology, Occupational and Environmental Health & Safety: Research to Practice. Cincinnati, OH, December 4–7.



## ■ Shaffer R, Gao P, Rengasamy S [2006]. Penetration of nanoparticlesthrough protective clothing and respirator filters. Presented at the Elevated Wind Studies International Conference. Arlington, VA, September 25–26.



## ■ Geraci C, Castranova V, Hoover M, Dunn K, Gao P [2006]. Ask the Expert—An update on NIOSH research in nanotechnology. Presented at a roundtable section at the American Industrial Hygiene Conference and Exposition, Chicago, IL, May 16.



## ■ King B, Gao P [2005]. A passive aerosol sampler for evaluation of personal protective ensembles. Presented at the Advanced Personal Protective Equipment: Challenges in Protecting First Responders Conference. Blacksburg, VA, October16–18.



## ■ King WP, Gao P [2006]. Coating evaluation for a newly developed passive aerosol sampler based on magnets for determination of particle penetration through protective ensembles. Presented at the American Industrial Hygiene Conference and Exposition, Chicago, IL, May 17.

125**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### Partnerships and Collaborations



## ■ Efforts have been initiated to establish research collaborations between NPPTL and the Research Triangle Institute (RTI) in North Carolina, Battelle in Columbus, OH, and the Center for Health-Related Aerosol Studies at the University of Cincinnati. The project officer visited RTI in May 2006 to discuss possible collaborative efforts.



## ■ A partnership has been arranged with the DuPont Nanoparticle Occupational Safety and Health Consortium. An MOU between NIOSH/ NPPTL and DuPont was officially executed in June 2006. The MOU provides a formal mechanism for exchanging information on PPE (clothing and respirators) and nanoparticles research.
NTRC Critical Research Topic Areas Addressed 1. Engineering Controls and PPE 2. Recommendations and Guidance

126**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



## Research Project 17: Web-based Nanoparticle Information Library Implementation
Principal Investigator: Arthur Miller, Ph.D., SRL/NIOSH/ CDC Project Duration: FY 2004–FY 2008 Background The primary objective of this project is to design, build, and implement the We b-b ased NIL. The NIL is being developed as a global source for information concerning the properties and associated health and safety implications of the myriad nanomaterials that are being developed. This work also supports efforts ongoing in the Nanoparticles in the Workplace project. It is intended to provide NIOSH and the occupational safety and health community with access to knowledge as to the variety and extent of nanomaterials being produced worldwide, along with information concerning their physical and chemical properties, processes of origin, and possible health effects.
Accomplishments



## ■ Collaborated with the International Council on Nanotechnology (ICON) for the development of a knowledge management hub for nanotechnology.



## ■ Participated in the planning of the nanotechnology field team investigation effort and assisted with developing protocols.



## ■ Provided input for redesigning the nanotechnology topic page on the NIOSH Web site.



## ■ EIR document (patent application) titled, A Portable Hand Held Electrostatic Precipitator for Particle Sampling.



## ■ Developed two protocols for analyzing workplace aerosol samplesusing Transmission Electron Microscopy/Energy Dispersive Spectroscopy (TEM/EDS).



## ■ Provided consultation on the characterization of welding fume and worker exposure to the welding fume.



## ■ Based on preliminary work conducted by participants under Project 1, developed a protocol for nano-aerosol characterization fieldwork at a metal refinery, including real time mapping of particle concentrations in the workplace.

127**Appendix A ■ Project-Specific Progress Reports NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Developed a project to map concentrations of airborne particles in the workplace using the Fast Mobility Particle Size (FMPS) instrument.This work includes the preliminary design of a (non-GPS) spatial mapping system to be used in indoor environments.



## ■ Built and tested an instrumentation cart for evaluating a prototype system for quasi-real-time spatial mapping of nanoparticles in the workplace.



## ■ Incorporated a mailing interface and a newsletter interface in the design of the nanoparticle information library.



## ■ Launched the nanoparticle information database on the NIOSH Web site. The prototype version went live in February 2006.

Publications and Abstracts



## ■ Donggeun L, Miller A, Park K, Zachariah MR [in press]. Effects of tracemetals on particulate matter formation in a diesel engine: metal contents from ferrocene and lube oil. Int J Automotive Technology.



## ■ Lee D, Miller A, Kittelson DB, Zachariah MR [2005]. Characterizationof metal-bearing diesel nanoparticles using single particle mass spectrometry. J Aerosol Sci 37 (2):88–110.



## ■ Lee D, Miller A, Zachariah M, Kittelson DB [2004]. Single particlemass spectrometry of metal-bearing diesel nanoparticles. ACS Symposium Series No. 890–Nanotech and the Environment: Applications and Implications. Chapter 17, pp.142–151, ISBN: 0–8412–3877–4. Papers Submitted for Publication



## ■ Miller A, Ahlstrand G, Kittelson DB, Zachariah MR [2006]. The fate of metal (Fe) during diesel combustion: morphology, chemistry and formation pathways of nanoparticles. Unpublished. Submitted to the journal of Combustion and Flame, March.



## ■ Miller AL, Habjan MC, Park K [2006]. Real-time estimation of elemental carbon emitted from a diesel engine: a preliminary study. Unpublished. Submitted to Environmental Science and Technology , August.



## ■ Ng A, Miller A, Ma H, Kittelson DB [2006]. Comparing measurements of carbon in diesel exhaust aerosols using the aethalometer, NIOSH Method 5040, and SMPS. Unpublished. Submitted to the SAE journal for publication as a Technical Paper, June.

128**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix A ■ P r**  **o j**  **e c**  **t-S p**  **e c**  **i fic P**  **r o** 

**g**

**r**

**e s**  **s R e**  **p o**  **r ts** 



### Posters



## ■ Miller AL, Hoover M [2005]. Nanotechnology—assessing and controlling potential health impacts. Poster session for the XVIIth World Congress on Safety and Health at Work, Orlando, FL, September 19–22.



## ■ Maher TV, Omaye ST, Geraci CL, Zumwalde RD, Miller All, Hoover MD [2006]. A case study in partnering to develop a nanotechnologyoccupational safety program in a nanotechnology manufacturing environment. Poster session at the 2006 NORA Symposium.



## ■ Miller AL [2004]. Novel techniques for characterization of ultrafinemetal aerosol formation: lessons from diesel combustion. Poster session at the first annual international symposium, Occupational Health Implications of Nanomaterials, co-sponsored by NIOSH, Buxton, UK, October.
Invited Presentations



## ■ Miller AL [2005]. NIOSH’s role in improving health and safety in nanotechnology workplaces. Presentation given as part of a multi-agency panel session on nanotechnology at the SAMPE–2005 conference in Seattle, WA, November 3.



## ■ By special invitation, attended the 2006 the spring meeting of the ICON and gave two presentations: 	 Development of a Web-based NIL	 Working Toward an Integrated Management Tool for Nanotec hnology-related EHS Data



## ■ By invitation, gave a presentation in 2006 to the NanoIGERT members at the University of Minnesota, covering the proposed NIOSH work to build a nanomaterial information library, and solicited input to same.
National and International Activities and Conferences



## ■ Miller AL, Hoover M [2005]. Building a Nanomaterial Information Library. Presentation for the Second International Symposium on Nanotechnology and Occupational Health, co-sponsored by NIOSH, Minneapolis, MN, October 3–6. Dissemination (interviews and articles in the lay press) TEM images of nanoparticles prepared by Art Miller were highlighted in the T S I 2005 a erosol instrumentation catalogue, which won an award sponsored by the Society for Technical Communication in 2006.

129**Appendix A ■ Project-Specific Progress Reports NIOSH Nanotechnology Research Center** 



### Partnerships and Collaborations



## ■ Sunshine Metal Refinery, WA, hosted a 2006 field study in which NIOSH staff characterized nanoparticles in the workplace.



## ■ NIOSH is collaborating with researchers in the Atmospheric Science Division at the Desert Research Institute (DRI), regarding instrumentcomparisons and measurement methods for airborne carbon particulates.



## ■ NIOSH is collaborating with EPA to study nano-fuel additives and their influence on particle generation by internal combustion engines.



## ■ Art Miller provided instruction to engineering students at GonzagaUniversity on the design, building, and testing a novel hand-held electrostatic nanoparticle sampler.



## ■ Assistance was provided by the following companies and Universities in designing the NIL:  Altair Nano  University of Minnesota  Washington University at St. Louis  Seattle University  Rice University/ICON consortium  A pr imary nanoscale metal oxide manufacturer
NTRC Critical Research Topic Areas Addressed 1. Toxicology and Internal Dose 2. Risk Assessment 3. Fire and Explosion Safety 4. Communication and Education 5. Recommendations and Guidance

130

# Appendix B Field Research Team Progress Report**Appendix B ■ Field Research Team Progress Report NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Summary of Field Research Progress
Prinicpal Investigators: Mark Methner, PH.D., CIH; Charles L. Geraci, PH.D., CIH; Mark Hoover, PH.D., CIH
Evaluation of Carbon Nanofiber Composite Material at a Polymer Research Facility Following a series of walk-through and planning visits, an in-depth survey was
c o nducted on December 6, 2005 at a research facility evaluating the incorporation of nanomaterials into polymers. The purpose of the survey was todetermine whether fugitive emissions and subsequent nanomaterial migration occurred during various laboratory processes involving both raw carbon nanofibers (CNF) and CNF bound within a composite matrix. Task-based airand surface sampling was conducted using a vacuum method. Real-time aerosol instrumentation was used to measure particle number, active surface area, mass concentration, and particle size distribution. In addition, air and surface samples were collected by NIOSH Method 5040 for subsequent total carbon analysis, as were air samples for analysis by TEM. A qualitative evaluation ofengineering controls and work practices was also conducted and recommendations were made to the company. Preliminary results indicate that some release of CNF occurred during raw fiber transfer to a rotary-stirred mixing vessel. In addition, material was released during a cutting operation of CNF-laden epoxy polymer using a wet saw. A poster describing the methodology used to collect filter-based air and surface samples was presented in September 2006 at the International Aerosol Conference in St. Paul, Minnesota. Interim results have been provided to the facility. A final report has been issued (See http://www. cdc.gov/niosh/hhe/reports/pdfs/2005-0291-3025.pdf). Research activities were
s u pported under Projects 11 and 13.

Preliminary Screening Survey Using Handheld Direct Reading I n strumentation and Air Filter/Wipe Samples at a Quantum Dot Research and Development Laboratory A site survey was conducted on July 10, 2006, at a research and development l a boratory engaged in the development of optical products with Quantum Dot (QD) coatings after several detailed conference calls. The purpose of the survey was to determine whether QD between 2 nm and 8 nm (monodisperse) were released during various laboratory treatments and processes. All processes were very well controlled by ventilation (i.e., laboratory hoods, glove boxes, Class 10,000 Clean Rooms). A total of 13 surface wipe samples were collected

132**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix B ■ F ie**  **ld R e**  **s e**  **a r**  **c h T**  **e a**  **m P r**  **o**

**g**

**r**

**e s**  **s R e**  **p o**  **r t** 



### using Ghostwipe® substrates and 8 high-volume air samples were collected on mixed cellulose ester (MCE) filters. The surface and air samples are currently being analyzed for elemental metals in accordance with NIOSH Method 7300.Direct reading instruments (condensation particle counter [CPC] and handheld particle counter model HHPC-6; ART instruments) were also used to assess airborne particle concentrations in the work areas. No noticeable releases of QD were noted during any process. A final report has been submitted to the company. Research activities were supported under Project 13.

Evaluation of Nanoscale Metal Oxide Release at a Commercial Technology Development and Powder Production FacilityA comprehensive survey was conducted from March 12–17, 2005, at a comm e rcial nanoscale metal oxide development and powder production facility following a series of walk-through and planning visits. The purpose of the survey was to assess the adequacy of engineering controls and work practices, characterize particle releases in the work area, and evaluate the performance of a range of nanoparticle characterization instruments and approaches. A series of recommendations for improved particle control and worker protection were provided to the facility. Detailed evaluation of particle size distribution, surface area, morphology, and other results are underway. Research activities were supported under Projects 11, 13, and 14.

Evaluation of Nanoscale Nylon 6 Fiber Deposition and Potential R elease during Engine Filter Media Manufacturing A r ecent survey (September 2006) of a filter manufacturer (electro-spinning d ep osition of nanoscale Nylon 6 onto cellulose substrate) has been completed. The final report is being drafted.

Preliminary Evaluation of Nanomaterial Handling Practices at a R esearch F acility Engaged in State-of-the-Art Materials Characterization A series of walk-through visits have been made to a state-of-the-art materials
c h aracterization facility to assess the nature and adequacy of control practices being implemented in a newly developing nanotechnology research program at the facility. Presentations were also made to the industrial hygiene professional staff and to workers about the need for, and the nature of, good work practices for safe handling of nanomaterials. Collaborative work on documenting and improving work practices is underway.

133**Appendix B ■ Field Research Team Progress Report NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r** 

# The Many Faces of Nanotechnology

134**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix B ■ F ie**  **ld R e**  **s e**  **a r**  **c h T**  **e a**  **m P r**  **o**

**g**

**r**

**e s**  **s R e**  **p o**  **r t** 



### Assessment of Work Practices in a Facility Developing Specially Formulated Fullerenes for Biomedical Applications A walk-through survey was conducted on July 28, 2005, at a research and development laboratory engaged in the development of specially formulatedfullerenes for biomedical applications. Through collaboration with a local university, a detailed industrial hygiene survey was conducted and then presented at the International Aerosol Conference in September 2006, in St. Paul, MN. Inaddition, results of the survey and detailed observations of nanomaterial handling work practices were presented jointly by NIOSH and the company at the October 2005 International Symposium on Nanotechnology and Occupational Health in Minneapolis, MN. Frequent communication between NIOSH andthe company are continuing to develop further recommendations on comprehensive management and work practice approaches to safe handling of nanomaterials. Involvement was supported under Project 11.
Assessment of Work Practices at Universities Engaged in Research on NanomaterialsA series of walk-through investigations have been conducted at two universitie s engaged in materials science, aerosol science, and biomedical research on nanomaterials. The purpose of the investigations has been to learn more about the actual research and work practices underway, and to advise industrial hygiene professionals, researchers, and students about effective measures forcontrolling nanomaterials and preventing exposure. Opportunities for additional collaborative research are being discussed.
Evaluation of the Performance of the State-of-the-Art Nanoparticle Sam pling Equipment in a Nanoparticle Aerosol Generation Laboratory In July 2006, NIOSH and a commercial instrumentation company collaborated to e valuate the performance of a new nanoparticle real-time surface areaanalysis instrument under actual conditions of particle generation in an aerosol inhalation toxicology facility (supported by Project 11). Valuable lessonswere learned about instrument performance, maintenance and trouble-shooting requirements, and comparison of instrument results with conventional nanoparticle characterization instrumentation. Data reduction and report writing are underway. Collaboration efforts were supported by Project 11.

Invited Presentations



## ■ Methner MM [2006]. NIOSH nanoparticle exposure characterizationand assessment. Society of Advanced Material Processing and Engineering (SAMPE). Dallas, TX.

135**Appendix B ■ Field Research Team Progress Report NIOSH Nanotechnology Research Center** 



## ■ Methner MM [2006]. Health hazard evaluations of engineered nanoparticle exposures. Presented at the International Conference on Nanotechnology, Occupational and Environmental Health & Safety: Research to Practice. Cincinnati, OH, December 4–7.



## ■ Hoover MD, Stefaniak AB, Methner MM [2006]. Evaluation of a realtime surface area monitor in a nanotechnology workplace. Presented at the International Conference on Nanotechnology, Occupational and Environmental Health & Safety: Research to Practice. Cincinnati, OH, December 4–7.



## ■ Methner MM, Zimmer A, Baron P [2005]. Nanotechnologies: Occupational health considerations and controls. Presented at the United States Air Force Institute of Technology (AFIT), Wright-Patterson Air Force Base, Dayton, OH.

136

# Appendix C Occupational Health Surveillance for Nanotechnology Workers**NIOSH Nanotechnology Research Center**



## Research Program: Occupational Health Surveillance For Nanotechnology Workers
Program Coordinator: Douglas Trout, M.D., DSHEFS/ NIOSH/CDC Program Duration: FY 2005–Present The unique physical and chemical properties of nanomaterials, the increasing growth of nanotechnology in the workplace, and information suggesting that engineered nanomaterials may pose a safety and health hazard to workers all underscore the need for medical and hazard surveillance for nanotechnology. Every workplace dealing with engineered nanomaterials and nanotechnologyshould consider an occupational health surveillance program. NTRC has convened a cross-Federal group to develop a document as a framework for using existing medical and hazard surveillance mechanisms to create occupational health surveillance programs for nanotechnology workers. This guidance is not a prescriptive recommendation for a specific type of surveillance program, but rather is provided to present information that can be used to create appropriate occupational health surveillance to fit the needs of workers and organizations involved with nanotechnology. This framework presents information to help initiate occupational health surveillance where none exist. It is likely that as thefield of nanotechnology changes over time modifications to any initial surveillance program will need to be considered periodically.

138

# Appendix D Review of the NIOSH Extramural Nanotechnology Research Program: FY 2001–FY 2006**Appendix D ■ Review of the NIOSH Extramural Nanotechnology Research Programs FY 2001–FY 2006 NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## NIOSH Nanotechnology Research Program Review for FY 2001–FY 2006
Office of Extramural Research Programs Program Administrator: W. Allen Robison, Ph.D., NIOSH Office of Extramural Programs
Background During 2001–2006, the Office of Extramural Programs (OEP) funded
n a notechnology-related research through R01 and R43/44 mechanisms. Since FY 2005, OEP has participated in two collaborative requests for applications(RFA) for nanotechnology research grants investigating environmental and human health issues. The U.S. EPA National Center for Environmental Research (NCER) and the National Science Foundation (NSF) participated in FY 2005. NIEHS joined in FY 2006. Funding was available to support Research (R01) grants for 3 years and Exploratory (R21) grants for 2 years.

Purpose OEP funding of nanotechnology-related research has been undertaken to help incr ease the knowledge of nanotechnology and manufactured nanomaterials as they relate to occupational safety and health. Research areas supported by NIOSH/OEP include assessment methods for nanoparticles in the workplace, toxicology of manufactured nanomaterials, and the use of nanotechnology for improved workplace monitoring.

Status and ProgressFrom FY 2001 to FY 2004, OEP funded three R43/44 projects for a total fundin g c ommitment of almost $950K (Table 1). In FY 2005, OEP began participating in the nanotechnology-related RFAs previously mentioned. For the first RFA, 83 applications were received; 19 of these were recommended for funding. Fourteen met NIOSH criteria for relevance to occupational safety and health, five were in the competitive range for funding consideration, and two were funded by NIOSH (Table 1). In FY 2005, EPA funded 14 projects and NSF funded 2 projects under this RFA. NIOSH also funded a nanotechnology research application through the R01 Program Announcement (Table 1) in FY 2005.

140**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix D ■ R e**  **v ie**  **w o f t**  **h e NI**  **OS H E**  **xt r**  **a m**  **u r**  **a l N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h P**  **r o** 

**g**

**r a**  **m s**  **FY 2001–FY 2006 FY 2001–FY 2006** 



### In FY 2006, 81 applications were received in response to the RFA; 29 of these were recommended for funding. Six of the 29 met NIOSH criteria for relevance, three were in the competitive range for funding consideration, and one of these was funded by NIOSH (Table 1). EPA funded 21 projects, NSF funded four, andNIEHS funded three projects under this RFA. NIOSH also funded a nanotechnology research application through the Small Business Innovative Research (SBIR) Program Announcement. Summaries of projects funded by NIOSH/OEP are described below.To date, NIOSH/OEP has committed about $3.5 million dollars to nanotechnologyrelated research. Projects have been funded on applications and implications of nanotechnology. Contact information for the principal investigators of the projects funded by NIOSH/OEP is provided in Table 2. Next Steps In FY 2007 and FY 2008, NIOSH/OEP will continue collaborative efforts with EP A/N CER, NSF, NIH/NIEHS, and other international agencies to support nanotechnology research with occupational safety and health implications. OEPwill confer with the NTRC regarding issues, knowledge gaps, and future directions.
Additional Information Extramural investigators interested in pursuing nanotechnology studies related t o o ccupational safety and health can learn more about the interests of NIOSH in this area by visiting the following Web pages:



## ■ http://www.cdc.gov/niosh/topics/nanotech /



## ■ http://www.cdc.gov/niosh/topics/nanotech/NIL.html



## ■ http://es.epa.gov/ncer/rfa/2005/2005_star_nano.html



## ■ http://es.epa.gov/ncer/rfa/2004/2004_manufactured_nano.html Information about the NIOSH goal to transfer research findings, technologies,
a n d information into prevention practices and products in the workplace can be found at http://www.cdc.gov/niosh/r2p /. The emphasis on r2p is intended to red u ce occupation-related illness and injury by increasing the use of findings from NIOSH-funded research in the workplace.NIOSH conducts a wide range of efforts in the areas of research, guidance, inf o rmation transfer, and public service. Additional information about the diverse activities of NIOSH can be found at the NIOSH home page ( http://www.cdc

. g o v/niosh/homepage.html) and the program portfolio Web site ( http://www.cdc

. g o v/niosh/programs/).

141Table 1. Extramural nanotechnology research funded by NIOSH*, 2001–20061styear Total projectedGrant number Investigator InstitutionProject titleStart Endfunding fundingBefore FY 2004 NIOSH/SBIR:1R43OH007471–01 Hooker	 Nanomaterials Research Novel Hydrogen Sulfide Sensors for Portable 9/30/2001 3/31/2002 $100,000 $100,000LLC, Longmont, CO Monitors2R44OH007471–02 Williams Synkera Technologies Novel Hydrogen Sulfide Sensors for Portable 9/16/2003 9/15/2006 $373,430 $749,995Inc., Longmont, CO MonitorsPre-FY 2004 total:$473,430 $849,995FY 2004 Exposure assessment (NIOSH/SBIR):1R43OH007963–01A1 Rajagopalan	 Nanoscale Materials,From Nanoparticles to Novel Protective 9/1/2004 5/15/2005 $100,000 $100,000Inc., Manhattan, KS GarmentsFY 2005 Emerging technologies (NIOSH program announcement):1R01OH008282–01A Kagan University of PittsburghLung Oxidative Stress/Inflammation by 7/1/2005 6/30/2009 $363,975 $1,458,862Carbon NanotubesFY 2005 Emerging technologies RFA (EPA STAR–2005–B1):1R01OH008806–01 O’Shaughnessy University of Iowa Assessment Methods for Nanoparticles in 7/1/2005 6/30/2008 $132,903 $392,574the Workplace1R01OH008807–01 Xiong New York UniversityMonitoring and Characterizing Airborne 8/1/2005 7/31/2008 $158,185 $396,401School of Medicine Carbon Nanotube ParticlesFY 2005 total:$655,063 $2,247,837FY 2006 Nanotechnology RFA (EPA G2006–STAR F1 to F7):1R01OH009141–01 Dutta Ohio State University	 Role of Surface Chemistry in the Toxicological 9/1/2006 8/31/2009 $119,700 $359,100Properties of Manufactured NanoparticlesFY 2006 Nanotechnology (NIOSH/SBIR):1R43OH008939–01 Deininger Synkera TechnologiesNew Nanostructured Sensor Arrays for 8/1/2006 2/28/2007 $99,998 $99,998Inc., Longmont, CO Hydride DetectionFY 2006 total—————$219,698 $459,098Grand total:$3,556,932FY 2007 Nanotechnology (NIEHS RFA–ES–06–008):Release date	 September—Set aside $500K; maximum project $300K;29, 2006maximum length 4 yearsFY 2008 Nanotechnology RFA (EPA)—U.S./Europe:AnticipatedApril 2007—Set aside $500K; maximum project $250K;release datemaximum length 3 years*Abbreviations: EPA=Environmental Protection Agency; NIEHS=National Institue of Environmental Health Sciences; NIOSH=National Institute for Occupational Safety and Health;RFA=request for application; SBIR=small business innovative research; STAR= science to achieve results.



### 142**Appendix D ■ Review of the NIOSH Extramural Nanotechnology Research Programs FY 2001–FY 2006**



## Extramural Nanotechnology Research Project Summaries These brief project summaries were excerpted from the project descriptions. For additional information, please contact the identified investigator(s) for thespecific project. Investigator contact information is provided in Table 2; however, information for Dr. Hooker was not available.


## Hooker 7471 (R43), Williams 7471 (R44) Novel Hydrogen Sulfide Sensors for Portable MonitorsThe primary objective for this project is the design, development, and demon s tration of better sensor technology for the detection of hydrogen sulfide. Hydrogen sulfide is a highly toxic, colorless, flammable gas that reacts with enzymes that inhibit cell respiration. At high concentrations hydrogen sulfide can literally shut off the lungs, while lower levels can burn the respiratory tract and cause eye irritation.This gas is encountered in a wide range of industries, and a number of standa r ds have been established for occupational exposure. The OSHA Permissible Exposure Limit (PEL) is 10 parts per million (ppm), the Short Term Exposure Limit (STEL) is 15 ppm, and exposures of 300 ppm or greater are considered immediately dangerous to life and health (IDLH). Because of the potential for adverse health effects at low concentrations, the industrial hygiene community is continually seeking improved performance from hydrogen sulfide sensors. Specific requirements include reliable and accurate detection in real-time, quantitative measurement capabilities, low purchase and life cycle costs, and low power consumption for portability. Sensors meeting these requirements will find numerous applications within the safety and health field. In addition, there are several potential spin-off opportunities in leak detection, emission monitoring, and process control. Alternative ceramic oxide materials and a unique multi-layer fabrication process to accomplish the objectives of thisproject will be used. The work plan includes optimization of the sensor materials, sensor element fabrication, sensor element packaging, in-house and external evaluation of the sensors, and establishing the foundation for new instrument development. The ultimate aim is a low-cost, low-power sensor that can be used in a new type of personal monitor. The envisioned monitor is a low-profile, credit card sized “smart-card” that cannot only alert the wearer when unsafe concentrations have been encountered but also track cumulative individual worker exposure to a particular toxic gas species.

143**Appendix D ■ Review of the NIOSH Extramural Nanotechnology Research Programs FY 2001–FY 2006 NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### ProgressThe early portions of this project focused on developing nano-structured sensor materials and morphologies targeted toward chemiresistive-based sensors. This work resulted in a commercial sensor that is being incorporated into thefixed-system H2S detection products of multiple partnering instrument manufacturers. The middle portion of the project focused on developing solid-state electrochemical sensors utilizing micro and nano-sized morphologies and structures. This has resulted in a working sensor currently being incorporated into an inexpensive, portable personal monitor as described above. 

## Rajagopalan (7963) From Nanoparticles to Novel Protective Garments The overall objectives of this collaborative Phase I research between NanoScale
an d G entex Corp. are to (1) investigate the use of highly adsorbent and reactive nanoparticles in protective garments and (2) create and test new materials for use in the production of protective clothing. During routine chemical use it is not always apparent when exposure occurs. Many chemicals pose invisible hazards and offer no warnings. More importantly, terrorists and saboteurs use a variety of toxic industrial chemicals to create improvised explosives, chemical agents, and poisons. When dealing with hazardous materials released either by accident or intentionally, protective clothing is critical in guarding against the effects of toxic or corrosive products that could enter the body by inhalation or skin absorption and cause adverse effects.This project seeks to (1) establish the feasibility of incorporating highly adsorbe n t and reactive nanoparticles into lightweight, permeable textiles and (2) evaluate the utility of the resultant fabric as protective clothing using standard industry testing procedures. These novel protective garments will be tailored specifically toward personnel associated with Federal, State, or local emergency agencies as well as fire fighters and civilian first responders.To achieve the overall objective, reactivity of selected nanoparticle formulati o ns to various toxic industrial chemicals will be explored by use of a quartz spring balance to determine adsorption capacity. Based on the outcome of this research, a single reactive nanoparticle formulation will be chosen for use in fabrics. The selected nanoparticle formulation will then be incorporated into suitable fabrics using two established techniques. Next, fabric test swatches will be evaluated for a number of criteria using industry recognized ASTM test methods. Finally, the top four nanoparticle embedded fabrics will be tested forphysical and chemical resistance against two representative toxic chemicals using a standard ASTM procedure.

144**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix D ■ R e**  **v ie**  **w o f t**  **h e NI**  **OS H E**  **xt r**  **a m**  **u r**  **a l N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h P**  **r o** 

**g**

**r a**  **m s**  **FY 2001–FY 2006 FY 2001–FY 2006** 



## Kagan (8282) Lung Oxidative Stress/Inflammation by Carbon Nanotubes Background Specific Aim 1: E s t ablish the extent to which SWCNTs alone are pro-inflammatory to lung cells and tissue and characterize the role of iron in these effects using genetically manipulated cells and animals as well as antioxidant interventions. Specific Aim 2: Determine the potential for SWCNTs and microbial stimuli to sy n ergistically interact to promote macrophage activation, oxidative stress, and lung inflammation. Specific Aim 3: Reveal the extent to which SWCNTs are effective in inducing a p optosis and whether apoptotic cells exert their macrophage-dependent anti-inflammatory potential during in vitro and in vivo SWCNT exposure. The project involves a team of interdisciplinary scientists with expertise in redox chemistry and biochemistry, cell and molecular biology of inflammation and its interactions with microbial agents, and pulmonary toxicology of nanoparticles. Progress Two types of SWCNTs were used (iron-rich and iron-stripped) to study their int e ractions with RAW 264.7 macrophages. Following ultrasonication of theSWCNTs to separate strands, neither type was able to generate intracellular production of superoxide radicals or nitric oxide by macrophages observed by flowcytometry and fluorescence microscopy. SWCNTs with different iron content displayed different redox activity in a cell-free model system. In the presence of microbial (zymosan) stimulated macrophages, nonpurified iron-rich SWCNTs were more effective in generating hydroxyl radicals than purified SWCNTs. The presence of iron in SWCNTs may be important in determining redox-dependent responses of macrophages. Dose and time-dependence studies of inflammatory responses in mice using pharyngeal aspiration of SWCNTs demonstrated that they elicited unusual pulmonary effects in C57BL/6 mice that combined a robustbut acute inflammation with early onset yet progressive fibrosis and granulomas. It was demonstrated that occupationally relevant dose-dependent effects of SWCNTs may exert toxic effects in the lungs of exposed animals in vivo.SWCNT-induced inflammation and exposure caused altered pulmonary function. Microbial stimulation and clearance from the lungs of SWCNT-exposed mice were compromised. An unusual and robust inflammatory and fibrogenicresponse was correlated with the progression of oxidative stress and apoptotic signaling. The toxic effects of SWCNTs were important to consider, and also the role of transitional metals, particularly iron, should be investigated.

145**Appendix D ■ Review of the NIOSH Extramural Nanotechnology Research Programs FY 2001–FY 2006 NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## O’Shaughnessy (8806) Assessment Methods for Nanoparticles in the Workplace BackgroundThe primary objectives are to (1) provide the scientific community and practicin g in d ustrial hygienists with verified instruments and methods for accuratelyaccessing airborne levels of nanoparticles and (2) assess the efficacy of respirator use for controlling nanoparticle exposures.Objectives will be satisfied through a combination of laboratory and field studie s c entered on the following aims: identify and evaluate methods to measure airborne nanoparticle concentrations; characterize nanoparticles using a complementary suite of techniques to assess their surface and bulk physicaland chemical properties; and determine the collection efficiency of commonlyused respirator filters when challenged with nanoparticles.
**Progress** Several methods were used to aerosolize nanoparticles from bulk powders in t h e l aboratory. An apparatus was developed to inject the aerosol into a mainflow of dry, filtered air through a charged neutralizing device. The amount and size distribution of the aerosol in the chamber is sampled with a scanning mobility particle sizer. Samples from the chamber are also being analyzed by TEM. While the primary particle size of these powders average 20 nm, anaerosol with a median size of 120 nm is generated. These findings have significance in occupational settings since agglomeration of the particles in this sizerange will have consequences in pulmonary deposition and respirator filtration. Nanosized particles were also found as contaminants in the water used. A variety of instruments are being compared for use in the field studies of nanoparticle exposure concentrations in two facilities; one in Minnesota and one in Texas. 

## Xiong (8807) Monitoring and Characterizing Airborne Carbon Nanotube (CNT) Particles Background The proposed research will develop a comprehensive yet practical method for
sa m pling, quantification, and characterization of CNT particles in air. This method will be capable of (1) classifying sampled particles into three categories:

146**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix D ■ R e**  **v ie**  **w o f t**  **h e NI**  **OS H E**  **xt r**  **a m**  **u r**  **a l N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h P**  **r o** 

**g**

**r a**  **m s**  **FY 2001–FY 2006 FY 2001–FY 2006** 



### tubes, ropes (bundles of single-walled CNT bounded by Van der Waals attraction force), and nontubular particles (soot, metal catalysts, and dust, etc.), and (2) measuring the number concentrations, size distributions for each type, and the s hape characters (diameter, length, aspect ratio and curvature) of CNT. The method will use available instrumentation to build an air monitoring sy s tem that is capable of sampling and sizing airborne CNT particles in a wide size range by using a 10-stage Micro-Orifice Uniform Deposit Impactor (MOUDI) and an Integrated Diffusion Battery previously developed in this laboratory. Successful completion of this project will produce (1) a validated method for
sa m pling airborne CNT in the workplace and (2) a practical method to classify sampled CNT particles by type through quantifying and characterizing each type separately using Atomic Force Microscopy image analysis technology. These methods are needed to determine potential health risks that may result from worker exposure to the various types (CNTs, nanoropes, and nontubular nanoparticles). The results will also provide a foundation for field and personal sampling devices for CNT.
Progress Instrumentation and materials are essentially ready. Years 2 and 3 will focus on met h od development for sampling, quantifying, and characterizing airborne CNT aerosol particles.


## Dutta (9141)Role of Surface Chemistry in the Toxicological Properties of Manufactured Nanoparticles Background The objectives of this program are to verify two hypotheses: (1) the quantifiable diffe r ences in surface reactivity of nanoparticles, as measured by acidity, redoxchemistry, metal ion binding and Fenton chemistry as compared with micronsized particles of similar composition cannot be explained by the increase in surface area alone, and (2) the oxidative stress and inflammatory response induced by nanoparticles upon interaction with macrophages and epithelial cells depends on their surface reactivity. The basis of these hypotheses is that nanoparticles contain a significantly higher number of “broken” bonds on the surface that provide different reactivity as compared to larger particles.

147**Appendix D ■ Review of the NIOSH Extramural Nanotechnology Research Programs FY 2001–FY 2006 NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### The experimental approach focuses on three classes of manufactured nanoparticles; catalysts (aluminosilicates), titania, and carbon. For the catalysts and titania samples, nanoparticles (<100 nm) and micron-sized particles of similar bulk composition will be studied. For carbon, carbon black and single-walledCNTs are chosen. Nanoparticles of aluminosilicates and titania will be synthesized, whereas the other particles will be obtained from commercial sources. Characterization will involve electron microscopy, surface area, and surface and bulk composition. Reactivity of well-characterized particles in regards to their acidity, reaction with antioxidants simulating the lung lining fluid, coordination of iron, and Fenton chemistry will be carried out using spectroscopic methods. Particularattention will be paid to surface activation as may exist during manufacturing and processing. In vitro oxidative stress and inflammatory responses upon phagocytosis of the particles by macrophages and pulmonary epithelial cells will form the toxicological/biological end points of the study. Methods includegene array techniques, assays for reactive oxygen species, and adhesion molecules on endothelial cells.


## Deininger (8939) New Nanostructured Sensor Arrays for Hydride Detection BackgroundThe goal of the proposed project is to develop improved sensors for the detect i o n of hydrides (including arsine, phosphine, and diborane) for protection of worker safety and health. Current sensors suffer from severe limitations including lack of selectivity and limited accuracy and lifetime. An electronic sensor system, capable of automatically warning workers of the presence of one of these toxic gases, would provide a substantial benefit for worker safety and health.This project will take advantage of advances in nanotechnology, ceramic micro m achining, and materials chemistry to create sensors that are substantially better than current state of the art. These improved sensors will be the basis forimproved personal and permanent monitors for increased protection of workers in the semiconductor industry.

148**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix D ■ R e**  **v ie**  **w o f t**  **h e NI**  **OS H E**  **xt r**  **a m**  **u r**  **a l N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h P**  **r o** 

**g**

**r a**  **m s**  **FY 2001–FY 2006 FY 2001–FY 2006** 



### Table 2. Nanotechnology principal investigators funded by NIOSH/OEP; FY 2001–FY 2006

Debra J. Deininger Synkera Technologies, Inc. 2021 Miller Drive, Suite B Longmont, CO 80501 (720) 494–8401 (T)/(720) 494–8402 (F) ddeininger@synkera.com 1R43OH008939–01 (2006)
Prabir K. Dutta The Ohio State University Department of Chemistry 1960 Kenny Road Columbus, OH 43210 (614) 292–4532 (T)/(614) 292–1685 (F) dutta.1@osu.edu 1R01OH009141 (2006) Professor Valerin E. Kagan, Ph.D., D.Sc. University of Pittsburgh Department of Environmental and

Occupational Health Bri dgeside Point 100 Technology Drive, Suite 350 Pittsburgh, PA 15129 (412) 624–9479 (T)/(412) 624–9361 (F) kagan@pitt.edu 1R01OH008282–01A (2005) Patrick Thomas O’Shaughnessy University of Iowa Department of Occupational

and Environmental Health 100 Oak dale Campus, 137 IREH Iowa City, IA 52242–5000 (319) 335–4202 (T)/(319) 335–4225 (F) Patrick-Oshaughnessy@uiowa.edu 

### 1R01OH008806–01 (2005) Shymala Rajagopalan NanoScale Materials, Inc. 1310 Research Park Dr. Manhattan, KS 66502 (785) 537–0179 (T)/(785) 537–0226 (F) srajagopalan@nanoactive.com www.nanoactive.com 1R43OH007963–01A1 (2004) Stephen Williams Synkera Technologies, Inc. 2021 Miller Drive, Suite B Longmont, CO 80501 (720) 494–8401 (T)/(720) 494–8402 (F) swilliams@synkera.com 2R44OH007471–02 (2003) Judy Xiong New York University School of Medicine

Environmental Medicine 57 Old F orge Road Tuxedo, NY 10987 (845) 731–3627 (T)/(845) 351–5472 (F) xiongj@env.med.nyu.edu 1R01OH008807–01 (2005)



### 149

# Appendix E Nanotechnology Information Dissemination**Appendix E ■ Nanotechnology Information Dissemination NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Research Project: Nanotechnology Information Dissemination
Prinicipal Investigator: Charles L. Geraci, Ph.D., C.I.H., EID/NIOSH/CDC Project Duration: FY 2006–FY 2010 Background Guidance and recommendations for managing and preventing occupational expo sure to nanoparticles is needed to protect the health of workers. This project will produce and disseminate educational information about current best practices for minimizing occupational exposure risks during the various phases of nanomaterial research, development, production, and use. The types of communication products and vehicles to be used include the following:



## ■ Interim recommendations on the NIOSH Web site to provide a vehicle for presenting the latest information about nanotechnology, and to provide customers a means to provide feedback, ask questions, and provide examples of work; a Nanoparticle Information Library (NIL) that contains chemical and physical properties of specific nanoparticles



## ■ A Current Intelligence Bulletin on Working with Engineered Nanomaterials that will present NIOSH’s current knowledge and recommendations on health effects, exposure limits, exposure monitoring, PPE, respiratory protection, and engineering controls



## ■ Educational materials that will be used to teach the safety and health components of nanotechnology and nanomaterial processing at the graduate and undergraduate level



## ■ Nano-safe training tool kits that can be used as part of an overall risk management program by nanotechnology companies or companies who incorporate nanomaterials into their productsThis information will be valuable to the much larger population of secondar y u sers of nanomaterials who may not be producing the materials, but are incorporating them into existing products. In addition to materials developed by NIOSH, partnerships with universities and businesses will be developed to incorporate their experience and share practices they have developed that have been effective. This project will allow for a direct translation of r2p by

152**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix E ■ N a**  **n o**  **t e**  **c h**  **n o**  **lo g** 

**y I n**  **f**

**o r**  **m a**  **t io**  **n D i**  **s s**  **e m**  **i n**  **a t**  **io n** 



### communicating NIOSH research and field observations in training documents and tools. The time frame for this project extends into FY 2010 and will be theprimary means to communicate NIOSH research results to the nanotechnology industry, and to maintain an active dialogue with that community.

Accomplishments



## ■ Collected and assembled NTRC information and research results into the original version of Approaches to Safe Nanotechnology: An information Exchange with NIOSH. This document was posted on the NIOSH Web site on October 3, 2005.



## ■ Developed a Nanotechnology Information Development and Dissemination project as part of the WHO coordinating centers portfolio.



## ■ Developed an initial sampling protocol as part of the TiO 2 

### CIB to address possible contribution of nano-sized particles to workplace exposure.



## ■ Established a working partnership with a metal oxide nanoparticle production facility to evaluate work practices and develop protocols to assess workplace exposures.



## ■ Produced an update to Approaches to Safe Nanotechnology and posted it on the NIOSH Web site on June 4, 2006.



## ■ Updated the NIOSH Nanotechnology Web topic page to highlight the ten critical research areas identified in the Strategic Research Plan.



## Charles L. Geraci’s activities in the NIOSH Nanotechnology Research Program Accomplishments



## ■ National and international promotion of NIOSH leadership in the area of nanotechnology occupational safety and health research



## ■ Member of ISO TC 229 on Nanotechnologies, Working Group 3 in Health, Safety and Environment



## ■ Expert reviewer to the ORC Nanotechnology Workgroup developing best practices for nanomaterial processes



## ■ Nanotechnology expert contact for the memorandum of understanding between NIOSH and AIHA

153**Appendix E ■ Nanotechnology Information Dissemination NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Project officer on the NIOSH project Nanotechnology Information Dissemination



## ■ Developer and co-leader of the NIOSH Nanotechnology Field Research team



## ■ Facilitated visits to three nanomaterial facilities

Invited Presentations



## ■ Regulatory and risk overview [2006]. International Conference on Nanotechnology, Occupational and Environmental Health and Safety: Research to Practice. Cincinnati, OH, December 4–7.



## ■ Managing nanomaterials along the product life cycle [2006]. International Conference on Nanotechnology, Occupational and Environmental Health and Safety: Research to Practice. Cincinnati, OH, December 4–7.



## ■ Evaluation of a real-time surface area monitor in a nanotechnology workplace [2006]. Co-author on a poster presented at the International Conference on Nanotechnology, Occupational and Environmental Health and Safety: Research to Practice. Cincinnati, OH, December 4–7.



## ■ Update on understanding and assessing an emerging technology inpractice: continuation of an innovative industry/government partnership [2006]. Co-author on a poster presented at the International Conference on Nanotechnology, Occupational and Environmental Health & Safety; Research to Practice. Cincinnati, OH, December 4–7.



## ■ Health issues associated with nanotechnology [2006]. Continuing Medical Education Seminar Series, College of Medicine, University of Cincinnati, November 29.



## ■ Managing nanomaterials in the workplace: what do we know? [2006]. The American Society of Safety Engineers’ Solutions in Safety Through Technology Symposium, Scottsdale, AZ, November 16–17.



## ■ What is nanotechnology and should you be concerned? [2006]. Fall meeting of the Building Environment Council of Ohio, Columbus, OH, October 26.



## ■ What every industrial hygienist should know about nanotechnology[2006]. Ohio Valley Section—American Industrial Hygiene Association, Cincinnati, OH, October 24.



## ■ Risk based approach to nanoparticle management [2006]. Greater St. Louis Safety and Health Conference, St. Louis, MO, October 1.

154**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix E ■ N a**  **n o**  **t e**  **c h**  **n o**  **lo g** 

**y I n**  **f**

**o r**  **m a**  **t io**  **n D i**  **s s**  **e m**  **i n**  **a t**  **io n** 



## ■ The NIOSH field effort to evaluate practices in nanotechnology [2006]. Commercialization of Nanomaterials, Pittsburgh, PA, September 20.



## ■ The NIOSH nanotechnology research program: applicability to nanocomposites [2006]. Center for Multifunctional Polymer Nanomaterials and Devices, Board of Advisors Meeting, National Composites Center, Kettering, OH, August 15.



## ■ The NIOSH nanotechnology research program: overview with emphasison areas of industry collaboration [2006]. Joint Memorandum of Understanding Meeting: NIOSH and DuPont, NIOSH National Personal Protective Technology Laboratory (NPPTL), Pittsburgh, PA, August 3.



## ■ Nanotechnology in the workplace: promoting innovation through better risk management [2006]. Campus Safety, Health and Environment Mangers Association Annual Conference, Anaheim, CA, July 19.



## ■ Nanotechnology in the workplace: the NIOSH research program[2006]. NPE International Plastics Exposition, Special Educational session on Nanotechnology, Chicago, IL, June 20, 2006



## ■ Occupational health risks of nanoparticles in the workplace [2006].Nanocomposites 2006, Special Forum on Health Issues of Nanotechnology, Chicago, IL, June 19.



## ■ Nanotechnology: ensuring workplace health and safety through betterrisk management [2006]. Nanotechnology in Food and Agriculture, Inaugural Conference by Food Chemical News, Washington, DC, June 7.



## ■ The NIOSH nanotechnology research program: progress through industry partnerships [2006]. NanoBusiness Alliance, New York, NY, June 19.



## ■ Nanotechnology research at NIOSH and applications to the pharmaceutical industry [2006]. AIHA Pharmaceutical Forum, American Industrial Hygiene Conference and Exposition, Chicago, IL, May 17.



## ■ NIOSH nanotechnology program update: ask the experts—(arrangedthe session and presented updates): NIOSH information resources update and NIOSH Field Research Activities [2006]. American Industrial Hygiene Conference and Exposition, Chicago, IL, May 16.



## ■ Nanotechnology: government initiatives [2006]. Special Symposium on Occupational Safety and Health Issues of Nanotechnology in the Workplace, American Industrial Hygiene Conference and Exposition, Chicago, IL, May 13.

155**Appendix E ■ Nanotechnology Information Dissemination NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ Nanotechnology health and safety professional development course[2006]. Health and Safety Canada, Industrial Accident Prevention Association Conference, Toronto, Canada, May 4. Delivered the following modules: 	 Physical and chemical characteristics, metrology, and exposure
as s essment 	 Risk management, work practices, safety, PPE 	 Information resources



## ■ Overview of key NIOSH nanotechnology research projects: Building a nanoparticle information library, Potential application of control banding to nanotechnology, Nanotechnology information resources on the NIOSH Web, and Nanotechnology: a coordinated NIOSH research program [2006]. National Occupational Research Agenda Symposium, Washington, DC, April 18–20.



## ■ Health and safety practices for nanotechnology [2006]. Special Panel Session, the Ohio Nanotechnology Summit 2006, Columbus OH, March 4.



## ■ The NIOSH nanotechnology research program: an overview for Ohio [2006]. Nanotechnology Primer Session, the Ohio Nanotechnology Summit, Columbus, OH, March 4.



## ■ A case study in partnering to develop a nanotechnology occupationalsafety and health program in a nanotechnology manufacturing environment [2006]. Co-author on poster presented at the Second International Symposium Nanotechnology and Occupational Health, Minneapolis, MN, October 4.

Future Presentations



## ■ Nanotechnology: current knowledge for effective risk management [2007]. Oregon Governor’s Occupational Safety & Health Conference, Salem, OR, March 12–15.



## ■ Nanotechnology: what do we know for effective hazard communication? [2007]. Society for Chemical Hazard Communication, San Antonio, TX, April 25.



## ■ NIOSH nanotechnology research update: ask the experts [2007]. Philadelphia, PA, June 5.

156**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix E ■ N a**  **n o**  **t e**  **c h**  **n o**  **lo g** 

**y I n**  **f**

**o r**  **m a**  **t io**  **n D i**  **s s**  **e m**  **i n**  **a t**  **io n** 



## ■ Developing information for effective exposure evaluation and risk management in the production of nanoparticles [2007]. ASSE National Conference, Special Symposium on Developing Business Models for Managing Nanotechnology, Orlando, FL, June 2–7.

National and International Activities



## ■ C. Geraci is a member of the ISO Technical Committee 229 on Nanotechnologies, Work Group 3 Technical report on current safe practices in occupational settings relevant to nanotechnologies.



## ■ C. Geraci was the Co-Organizer of the Conference Planning Committee and Co-Chair of the Applications Session of the International Conference on Nanotechnology, Occupational and Environmental Health and Safety: Research to Practice, Cincinnati, OH, December 4–7, 2006.



## ■ C. Geraci is the U.S. member of the International Advisory CommitteeMember for the U.S. for the Third International Symposium on Nanotechnology: Occupational and Environmental Health, Taipei, Taiwan, August 29 to September 1, 2007.



## ■ C. Geraci is a member of the American Industrial Hygiene Association Nanotechnology Working Group.



## ■ C. Geraci served as an Expert Peer Reviewer to the ORC Nanomaterials Work Practices Workgroup.
Partnerships and Collaborations



## ■ Developed a partnership with an international cosmetic product manufacturer to evaluate exposures, work practices, and controls during the introduction of nanoparticle materials.



## ■ Ongoing partnership with a primary metal oxide manufacturer: characterization of exposures to metal oxide nanoparticles; develop work practices and controls; evaluate effectiveness of controls; develop areturn-on-investment study for controls and health safety and environmental improvements.



## ■ Planned investigations in the nanocomposites industry through a partnership with the Center for Multifunctional Polymer Nanomaterials and Devices (CMPND) and the University of Dayton Research Institute.



## ■ Participated in an inaugural workshop on nanotechnology with the Campus Safety, Health and Environment Management Association (CSHEMA) and developed a strategy for Web-casting workshops.

157**Appendix E ■ Nanotechnology Information Dissemination NIOSH Nanotechnology Research Center** 



### NTRC Critical Research Topic Areas Addressed 1. Exposure Assessment 2. Communication and Education 3. Recommendations and Guidance 4. Measurement Methods

158

# Appendix F Other NTRC Partnership Activities and Presentations**Appendix F ■ Other NTRC Partnership Activities and Presentations NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Other NTRC Staff, Activities in the NIOSH Nanotechnology Research Program
John Howard, M.D.
Presentations



## ■ The NIOSH nanotechnology initiative: ensuring a safe and healthful workforce in a changing environment. Kansas City Safety and Health Conference, ASSE, Kansas, MO, July 14–15.



## ■ The NIOSH nanotechnology initiative: ensuring a safe and healthfulworkforce in a changing environment. The Art of Safety: the 10th Anniversary Commemorative Safety & Health Congress and Expo, Isla Verde, PR. The NIOSH Nanotechnology Initiative: Ensuring a safe and healthful workforce in a changing environment, July 30–August 5.



## ■ The NIOSH nanotechnology initiative: ensuring a safe and healthful workforce in a changing environment [2005]. OSHA Health Forum, Denver, CO, August 31.



## ■ Perspectives on nanotechnology ‘[2006]. NIOSH and Nanotechnology, Woodrow Wilson International Center for Scholars, Washington, DC, February 23.



## ■ National CleanRooms Contamination Control [2006]. Nanotechnologyand Risk: The NIOSH Perspective. Technology Conference & Exposition on 15 March, Boston MA, March 15.



## ■ Mt. Sinai annual ERC meeting on toxicity and control issues [2006]. Nanotechnology and risk: the NIOSH perspective. April 7.



## ■ NIOSH at 5 years of NNI [2006]. International Nanotechnology Conference on Communication and Cooperation. Arlington, VA, May 15–17.



## ■ Nanotechnology and risk: the NIOSH perspective [2006]. Congressof Nanobiotechnology and Nanomedicine (NanoBio 2006). San Francisco, CA, June 19–21. 

## Vladimir Murashov, Ph.D.
Publications and Abstracts



## ■ ISO/TC 229/WG3 Summary of U.S. research and development activities on nanotechnology related to environmental health and safety [2006]. NANO TAG N 221–2006, ANSI.

160**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix F ■ O t**  **h e**  **r NTR C P**  **a r**  **t n**  **e r**  **s h**  **i p A**  **c t**  **i v**  **i t**  **ie s a**  **n d P**  **r e**  **s e**  **n t**  **a t**  **io n**  **s**



## ■ Report of the OECD workshop on the safety of manufactured nanomaterials building Co-operation, Co-ordination, and Communication[2005]. Washington DC, December 7–9. Environment Directorate, Organisation for Economic Cooperation and Development, Paris [2006].



## ■ Murashov VV [2006]. Comments on Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles (by Yang L and Watts, DJ, published in Toxicol Lett [2005] 158 :122– 132). Toxicol Lett 164 :185–187.

Presentations



## ■ Nanotechnology: preparing for public health assessment [2006]. GeorgeWashington University, School of Public Health. Introductory environmental and occupational health course, Washington, DC, June 5.



## ■ Nanotechnology: research perspective/current knowledge [2006]. National Response Team Worker Safety and Health Technical Conference, Washington, DC, May 31.



## ■ Nanotechnology: government initiatives [2006]. Nanotechnology Symposium: Nanoparticles in the Workplace, Chicago, IL, May 13.



## ■ Safe nanotechnology [2006]. NSTI Nanotech 2006, Boston, MA, May 9.



## ■ NIOSH nanotechnology program: funding [2006]. International Conference on Nanotechnology. Technical Association for the Pulp and Paper Industry, Atlanta, GA, April 28.



## ■ NIOSH nanotechnology program: research [2006]. International Conference on Nanotechnology. Technical Association for the Pulp and Paper Industry, Atlanta, GA, April 26.



## ■ NIOSH nanotechnology program [2006]. Office of Extramural Programs, NIOSH, Atlanta, GA, April 25.



## ■ Nanotechnology and risk: NIOSH perspective [2006]. RIMS 2006 Annual Conference and Exhibition. Honolulu, HI, April 24.



## ■ Nanotechnology: ensuring a safe and healthful workplace [2006]. PDC Piedmont Chapter of the ASSE, SC, March 16.



## ■ NIOSH Nanotechnology Program [2006]. NanoBusiness Alliance, Washington, DC, February 17.



## ■ NIOSH Nanotechnology Program [2006]. American Insurance Association, Washington, DC, February 8.

161**Appendix F ■ Other NTRC Partnership Activities and Presentations Appendix F ■ Other NTRC Partnership Activities and Presentations**  **NI OS**  **H N a**  **n o**  **t e**  **c h**  **n o**  **lo g** 

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## ■ NIOSH Current Intelligence Bulletin on TiO 2 

### [2006]. Particles and Cancer, MIT Conference, San Juan, PR, January 11.



## ■ Nanotechnology: ensuring a safe and healthful workplace [2005]. 2005 MRS Fall Meeting, Symposium S: Nanomaterials and the Environment, Boston, MA, December 1.



## ■ Occupational safety and health and nanotechnology: knowns and unknowns, Nanotechnology: are the health and safety concerns as smallas the particles? [2005].AIHA Texas Hill Country Section 2005 Symposium, Austin, TX, November 3.



## ■ NIOSH Nanotechnology Research Program [2005]. Nanotechnology and the Environment: Applications and Implications Progress Review Workshop III, Arlington, VA, October 26–28.



## ■ NIOSH and National Nanotechnology Initiative [2005]. Aerospace Industries Association ES&H Fall 2005 Meeting, Redondo Beach, CA, October 12–14.



## ■ NIOSH Nanotechnology Research Program [2005]. American Chemistry Council Nanotechnology Panel, Arlington, VA, September 20.
National and International Activities



## ■ Member of NSET Subcommittee of the National Science and Technology Council’s Committee on Technology and its working groups.



## ■ Member of the NNI-Chemical Industry Consultative Board for Advancing Nanotechnology.



## ■ Member of the National Electrical Manufacturers Association’s Nanotechnology Advisory Council.



## ■ Member of the external peer-review panel for EPA White Paper on Nanotechnology, June 2006. 

## Paul Schulte, Ph.D.
Publications



## ■ Schulte PA, Salamanca-Buentello F [2006]. Ethical and scientific issues of nanotechnology in the workplace. Environmental Health Perspectives

. available at http://www.ehponline.org/docs/2006/9456/abstracts.html
Invited Presentations



## ■ Occupational Safety and Health Issues in Nanotechnology [2006]. International Commission on Occupational Health. Milan, Italy, June 12.

162**NIOSH Nanotechnology Research Center NIOSH Nanotechnology Research Center**  **A p** 

**p e**  **n d**  **ix F ■ O ix F ■ O**  **t h**  **e r NTR**  **C P a**  **r t**  **n e**  **r s**  **h i**  **p A c**  **t i**  **v i**  **t ie**  **s a n**  **d P r**  **e s**  **e n**  **t a**  **t io**  **n s** 



## ■ NIOSH Nanotechnology Research [2005]. Nanoparticle Occupational Health and Safety Workshop sponsored by the Massachusetts ToxicsUse Reduction Institute and the Center for High-Rate Nanomanufacturing. Westborough, MA. December 2.

Presentations



## ■ Nanotechnology and Occupational Safety and Health and Ethical/ Medical Issues [2006]. Presentations at the International Conference on Nanotechnology Occupational and Environmental Health and Safety: Research to Practice. Cincinnati, OH. December 4–7.



## ■ Nanotechnology [2006]. Health and Safety Professional DevelopmentCourse, Health and Safety Canada 2006, Industrial Accident Prevention Association Conference, Toronto, Canada, May 4. Delivered the following modules: 	 Overview 	 Toxicology 	 Risk Assessment 	 Medical Surveillance 	 Ethical Issues



## ■ Panel Member. Ethical and legal aspects of nanomaterials and environmental regulation [2005]. Materials Research Society Fall Meeting, Boston, MA, December 1.
NTRC Critical Research Topic Areas Addressed 1. Communication and Education
2. Recommendation and Guidance

163

# Appendix G Projected Timeframe for Addressing Critical AreasProjected timeframe for addressing critical areasCalendar yearNIOSH10 critical areas20052006200720082009Exposure assessmentToxicity and internal doseDEP*generation and Data and preliminary Nanoparticle evaluations Dosimetry lung model incharacterization studies dosimetry for DEP (HELD in an automotive plant rats and humans, begin(NORA-PRL, HELD base) base, NORA-PRL) (NTRC-DART)phase II: calibration andvalidation with transloWildfire ultrafine aerosol Data and preliminary TiO2 workplace expo-cation data (NTRC-EIDand firefighter exposure dosimetry for firefighters sure assessment reportpending)studies (SNORA-DRDS) (SNORA-DRDS)(DSHEFS unfunded)Continue evaluationDosimetry lung model in Continue evaluationand characterization ofrats and humans, begin and characterization ofnanoparticle exposuresphase I: structure and nanoparticle exposuresin workplaces handlingcalibration w/ existing in workplaces handlingnanomaterialsdata (NTRC-EID)nanomaterialsInitiate TiO2workplaceexposure assessment(DSHEFS unfunded)Initiate field surveys ofworkplaces handlingnanomaterialsPreliminary results from Hazard ID information Preliminary cardiovas- Complete dose and timetoxicity testing in labora- on carbon nanotubescular endpoints (NORA-information on carbontory animal and in vitro (NORA-HELD)HELD pending)nanotubes (NORA-HELD)systems (NORA-HELD)Surface area-mass met- Nanometal hazard IDric results (NORA-HELD) (NORA-HELD)Dose-response data for Dermal informationdiesel exhaust particles(NORA-HELD)(HELD)Neurological effects(HELD base)Translocation results inlaboratory animals afterpulmonary and dermalexposure to nanomaterials (NORA-HELD)Continue evaluationand characterizationof workplaces handlingnanomaterialsDevelopment of firmcardiovascular endpoints(NORA-HELD)Quantification of systemic nanoparticle concentrations in laboratoryanimals after pulmonaryexposure to nanospheresand nanofibers (NORAHELD)(Continued)



### 166Projected timeframe for addressing critical areasCalendar yearNIOSH10 critical areas20052006200720082009Epidemiology and surveillanceRisk assessmentPhase I—baselineinformation gathering(NTRC-DRDS)Preliminary QRA on TiO2from existing studies (EIDbase)Initiate collaborative research on lungmodel development andnanoparticle dose estimation (NTRC-EID)External review draftof CIB developed withseparate RELs for fineand ultrafine TiO2basedon NIOSH QRASurvey of uses andworkers (DRDS-DSHEFSunfunded)Phase I—baselineinformation gathering(NTRC-DRDS)Correlation of healtheffects with ultrafineaerosol exposures inauto workers (NTRCDART-DSHEFS pending)Perform QRA on otherfine and ultrafine materials from existing studies(EID base)Publish scientific paperson QRA methods fornanoparticles includingTiO2Develop lung depositionmodel enhancementsPhase I—baseline information gatheringPhase II—populationstudiesContinue QRA of fine andultrafine particles (EID)Initiate hazard/risk evaluation for nanomaterialsin workplace (EID)Extend and calibrate ratlung dosimetry model fornanoparticles (NTRC-EID)Start estimation ofnanoparticle depositionin nasopharyngeal region(NTRC-EID)Start evaluation andmodeling of CNT inhalability and lung deposition (NTRC-EID)Phase I—baseline information gatheringLevels of exposure androutesQRA for nanoparticlesusing new NIOSH data(EID pending)Validate rat dosimetrymodel for nanoparticlesusing new NIOSH data(NTRC-EID)Human lung model variability and uncertaintyresults (NTRC-EID)Nasopharyngeal deposition results (NTRC-EID)CNT inhalability modeling preliminary results(NTRC-EID)Use hazard/risk evaluation in NIOSH guidancedocument (EID-pending)Further correlation ofhealth effects with ultrafine aerosol exposures inauto workersExtend human lungdosimetry model fornanoparticle estimation(NTRC-EID)Initiate CNT human lungdosimetry model basedon preliminary results(NTRC-EID pending)Preliminary QRA for CNTbased on rodent data(EID pending)(Continued)



### 167Projected timeframe for addressing critical areasCalendar yearNIOSH10 critical areas20052006200720082009Measurement methodsEngineering controls andPPEFire and explosion safetyCommunication andeducationPilot studies of nanoparticles in the workplace(DRDS)Development of techniques for online surfacearea measurement(DART)Identification of key control issuesIdentification of key safety issues (DSR-NPPTL)Basic set of FAQs (NTRC,OD base)Web site updates (NTRCEID, OD, others base)Public presentations(NTRC and many divisions base)NIL pilot (SRL-DRDS)Measurement studiesof nanoparticles in theworkplace (DRDS andothers)Analyses of filter efficiency (NPPTL-DRDS)Evaluation of controlbanding options (NTRCEID-DRDS-DART)Initiate efforts to investigate fire and explosionhazards of nanomaterialsExpanded set of FAQs(DART, NTRC and manydivisions base)Web site updates (NTRC,EID, OD, others base)Public presentations(NTRC and many divisions base)NIL updates (SRL-DRDS)Established suite of instruments and protocols(NTRC-DRDS)Measurement studies ofnanoparticles in the workplace (DRDS and others)Further developmentof online and offlinenanoparticle measurement methods (DRDSDART)Testing controls in autoplants (DART-DSHEFS)Respirator performanceevaluations (NPPTL)Good safety handlingpractices (NTRC-DSRNPPTL)Web site updates (NTRC,EID, OD, others base)Public presentations(NTRC and many divisions base)NIL updates (SRL-DRDS)Viable and practicalworkplace samplingdevice for nanoparticles(affordable, portable,effective) (NTRC-DARTDRDS and others)Evaluation of controlimprovements in autoplants (DART-DSHEFS)Evaluation of clothingand otherWeb site updates (NTRC,EID, OD, others base)Public presentations(NTRC and many divisions base)NIL updates (SRL-DRDS)Performance results fornanoparticle measurement instruments andmethods (DRDS andothers)Summary of controlstrategies (NTRC-DART)Summary of nanotechnology safety experience(NTRC-DSR)Web site updates (NTRC,EID, OD, others base)Public presentations(NTRC and many divisions base)NIL updates (SRL-DRDS)(Continued)



### 168Projected timeframe for addressing critical areasCalendar yearNIOSH10 critical areas20052006200720082009Recommendations and External review of NIOSH Publication of TiO2CIB Good working practices New or updated Nano- New or updated NanoguidanceTiO2CIB (EID base) (EID base)guidelines (DART base) materials document materials document(NTRC base)(NTRC base)Nanomaterials document(NTRC base)ApplicationsNIOSH education series Roadmap up and runningPrioritizedlist of short Further r2pFurther r2pterm impact r2p*CIB=Current Intelligence Bulletin; CNT=carbon nanotube; DART=Division of Applied Research and Technol­Abbreviations:ogy; DEP=diesel exhaust particulate; DRDS=Division of Respiratory Diseases; DSHEFS=Division of Surveillance Hazard Evaluation and Field Studies; EID=Education and Information Division; FAQs=Frequently AskedQuestions; HELD=Health Eff ect Laboratory Division; ID=identifi cation; NIL=Nanoparticle Information Library;NIOSH=National Institute for Occupational Safety and Health; NORA=National Occupational Research Agenda;NPPTL=National Personal Protective Technology Library; NTRC=Nanotechnology Research Center; OD=Offi ce of theDirector; PPE=personal protective equipment; PRL=Pittsburgh Research Laboratory; QRA=quantitative risk assessment; r2p=research to practice; SNORA=Small National Occupational Research Agenda (on PPE); SRL=Safety Research Laboratory; TiO2=titanium dioxide.



### 169

# Appendix H Executive Summary Approaches to Safe Nanotechnology: An Information Exchange with NIOSH**Appendix H ■ Executive Summary: Approaches to Safe Nanotechnology NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



## Approaches to Safe Nanotechnology: An Information Exchange with NIOSH The Executive Summary is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. The draft document “Approaches to Safe Nanotechnology: An Information Exchange with NIOSH” has not been formally disseminated by CDC/NIOSH and should not be construed to represent any agency determination or policy. A copy of the draft document can be found at the NIOSH Web site: http://www.cdc.gov/niosh/topics/nanotech /


## Executive Summary Nanotechnology has the potential to dramatically improve the effectiveness of a number of existing consumer and industrial products and could have a substantial impact on the development of new applications ranging from disease diagnosis and treatment to environmental remediation. Because of the broad range of possible nanotechnology applications, continued evaluation of the potential health risks associated with exposure to nanomaterials is essential to ensure their safe handling. Nanomaterials are engineered materials having at least one dimension between 1 and 100 nanometers. Nanomaterials oftenexhibit unique physical and chemical properties that impart specific characteristics essential in making engineered materials, but little is known about what effect these properties may have on human health. Research has shown that the physiochemical characteristics of particles can influence their effectsin biological systems. These characteristics include particle size, shape, surface area, charge, chemical properties, solubility, and degree of agglomeration. Until the results from research studies can fully elucidate the characteristics of nanoparticles that may potentially pose a health risk, precautionary measures are warranted. NIOSH has developed this document to provide an overview of what is known
a b out nanomaterial toxicity and measures that can be taken to minimize workplace exposures. NIOSH is seeking comments from occupational safety and health practitioners, researchers, product innovators and manufacturers, employers, workers, interest group members, and the general public so thatappropriate existing safety and health guidance can be further refined and disseminated. Opportunities to provide feedback and information are available throughout the document.

172**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix H ■ E x**  **e c**  **u t**  **i v**  **e S u**  **m m**  **a r**  **y : A**  **p**

**p r**  **o a**  **c h**  **e s t**  **o S a**  **f**

**e N a**  **n o**  **t e**  **c h**  **n o**  **lo g** 

**y**



### The following is a summary of findings and key recommendations:

Potential Health Concerns



## ■ The potential for nanomaterials to enter the body is among several factors that scientists examine in determining whether such materials may pose an occupational health hazard. Nanomaterials have the greatestpotential to enter the body if they are in the form of nanoparticles, agglomerates of nanoparticles, and particles from nanostructured materials that become airborne or come into contact with the skin.



## ■ Based on results from human and animal studies, airborne nanomaterials can be inhaled and deposit in the respiratory tract; and based onanimal studies, nanoparticles can enter the blood stream, and translocate to other organs.



## ■ Experimental studies in rats have shown that equivalent mass dosesof insoluble ultrafine particles (smaller than 100 nm) are more potent than large particles of similar composition in causing pulmonary inflammation and lung tumors in those laboratory animals. However, toxicity may be mitigated by surface characteristics and other factors. Results from in vitro cell culture studies with similar materials are generally supportive of the biological responses observed in animals.



## ■ Cytotoxicity and experimental animal studies have shown that changes in the chemical composition, structure of the molecules, or surfaceproperties of certain nanomaterials can influence their potential toxicity.



## ■ Studies in workers exposed to aerosols of manufactured microscopic (fine) and nanoscale (ultrafine) particles have reported lung function decrements and adverse respiratory symptoms; however, uncertaintyexists about the role of ultrafine particles relative to other airborne contaminants (e.g., chemicals, fine particles) in these work environments in causing adverse health effects.



## ■ Engineered nanoparticles whose physical and chemical characteristics are like those of ultrafine particles need to be studied to determine if they pose health risks similar to those that have been associated with the ultrafine particles. Potential Safety Concerns



## ■ Although insufficient information exists to predict the fire and explosion risk associated with nanoscale powders, nanoscale combustible

173**Appendix H ■ Executive Summary: Approaches to Safe Nanotechnology NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### material could present a higher risk than coarser material with a similar mass concentration given its increased particle surface area and potentially unique properties due to the nanoscale.



## ■ Some nanomaterials may initiate catalytic reactions depending on their composition and structure that would not otherwise be anticipated from their chemical composition alone. Working with Engineered Nanomaterials



## ■ Nanomaterial-enabled products such as nanocomposites and surface coatings, and materials comprised of nanostructures such as integrated circuits are unlikely to pose a risk of exposure during their handling and use. However, some of the processes (formulating and applying nanoscale coatings) used in their production may lead to exposure to nanoparticles.



## ■ Processes generating nanomaterials in the gas phase, or using orproducing nanomaterials as powders or slurries/suspensions/solutions pose the greatest risk for releasing nanoparticles. Maintenance on production systems (including cleaning and disposal of materials from dust collection systems) is likely to result in exposure to nanoparticles if it involves disturbing deposited nanomaterial.



## ■ The following workplace tasks may increase the risk of exposure to nanoparticles: 	 Working with nanomaterials in liquid media without adequate p r otection (e.g., gloves) will increase the risk of skin exposure.	 Working with nanomaterials in liquid during pouring or mixin g o perations, or where a high degree of agitation is involved, will lead to an increase likelihood of inhalable and respirable droplets being formed.	 Generating nanoparticles in the gas phase in non-enclosed syst e ms will increase the chances of aerosol release to the workplace. 	 Handling nanostructured powders will lead to the possibility of
a e rosolization.	 Maintaining equipment and processes used to produce or fabr i cate nanomaterials or the clean-up of spills or waste material will pose a potential for exposure to workers performing these tasks.	 Cleaning of dust collection systems used to capture nanopartic l es can pose a potential for both skin and inhalation exposure.

174**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix H ■ E x**  **e c**  **u t**  **i v**  **e S u**  **m m**  **a r**  **y : A**  **p**

**p r**  **o a**  **c h**  **e s t**  **o S a**  **f**

**e N a**  **n o**  **t e**  **c h**  **n o**  **lo g** 

**y**



### 	 Machining, sanding, drilling, or other mechanical disruptions of materials containing nanoparticles can potentially lead to aerosolization of nanomaterials. Exposure Assessment and Characterization



## ■ Until more information becomes available about the mechanismsunderlying nanoparticle toxicity, it is uncertain as to what measurement technique should be used to monitor exposures in the workplace. Current research indicates that mass and bulk chemistry may be lessimportant than particle size and shape, surface area, and surface chemistry (or activity) for nanostructured materials.



## ■ Many of the sampling techniques that are available for measuring airborne nanoaerosols vary in complexity but can provide useful information for evaluating occupational exposures with respect to particle size, mass, surface area, number concentration, composition, and surface. Unfortunately, relatively few of these techniques are readily applicable to routine exposure monitoring.



## ■ Regardless of the metric or measurement method used for evaluatingnanoaerosol exposures, it is critical that background nanoaerosol measurements be conducted before the production, processing, or handling of the nanomaterial/nanoparticle.



## ■ When feasible, personal sampling is preferred to ensure an accurate representation of the worker’s exposure, whereas area sampling (e.g.,size-fractionated aerosol samples) and real-time (direct reading) exposure measurements may be more useful for evaluating the need for improvement of engineering controls and work practices. Precautionary Measures



## ■ Given the limited amount of information about the health risks associated with occupational exposure to engineered nanoparticles, it is prudent to take measures to minimize worker exposures.



## ■ For most processes and job tasks, the control of airborne exposure tonanoaerosols can be accomplished using a wide variety of engineering control techniques similar to those used in reducing exposure to general aerosols.



## ■ The implementation of a risk management program in workplaces where exposure to nanomaterials exists can help to minimize the potential for exposure to nanoaerosols. Elements of such a program should include the following:

175**Appendix H ■ Executive Summary: Approaches to Safe Nanotechnology NI**  **OS H N**  **a n**  **o t**  **e c**  **h n**  **o lo**  **g**

**y R e**  **s e**  **a r**  **c h C**  **e n**  **t e**  **r**



### 	 Evaluating the hazard posed by the nanomaterial based on available physical and chemical property data and toxicology or health effects data 	 Assessing potential worker exposure to determine the degree of risk 	 The education and training of workers in the proper handling
o f n anomaterials (e.g., good work practices) 	 The establishment of criteria and procedures for installing and
e va luating engineering controls (e.g., exhaust ventilation) at locations where exposure to nanoparticles might occur 	 The development of procedures for determining the need and
s e lection of PPE (e.g., clothing, gloves, respirators) 	 The systematic evaluation of exposures to ensure that control
m e asures are working properly and that workers are being provided the appropriate PPE



## ■ Engineering control techniques such as source enclosure (i.e., isolating the generation source from the worker) and local exhaust ventilation systems should be effective for capturing airborne nanoparticles. Current knowledge indicates that a well-designed exhaust ventilation system with a HEPA filter should effectively remove nanoparticles.



## ■ The use of good work practices can help to minimize worker exposures to nanomaterials. Examples of good practices include; cleaning of work areas using HEPA vacuum pickup and wet wiping methods, preventingthe consumption of food or beverages in workplaces where nanomaterials are handled, and providing facilities for hand-washing and showering and changing clothes.



## ■ No guidelines are currently available on the selection of clothing or other apparel (e.g., gloves) for the prevention of dermal exposure to nanoaerosols. However, some clothing standards incorporate testing with nanoscale particles and therefore provide some indication of the effectiveness of protective clothing with regard to nanoparticles.



## ■ Respirators may be necessary when engineering and administrative controls do not adequately prevent exposures. Currently, no specificexposure limits exist for airborne exposures to engineered nanoparticles although occupational exposure limits exist for larger particles ofsimilar chemical composition. The decision to use respiratory protection should be based on professional judgment that takes into account

176**NIOSH Nanotechnology Research Center A**  **p**

**p e**  **n d**  **ix H ■ E x**  **e c**  **u t**  **i v**  **e S u**  **m m**  **a r**  **y : A**  **p**

**p r**  **o a**  **c h**  **e s t**  **o S a**  **f**

**e N a**  **n o**  **t e**  **c h**  **n o**  **lo g** 

**y**



### toxicity information, exposure measurement data, and the frequency and likelihood of the worker’s exposure. Preliminary evidence showsthat for respirator filtration media there is no deviation from the classical single-fiber theory for particulates as small as 2.5 nm in diameter.While this evidence needs confirmation, it is likely that NIOSH certified respirators will be useful for protecting workers from nanoparticle inhalation when properly selected and fit tested as part of a complete respiratory protection program.
Occupational Health Surveillance



## ■ The unique physical and chemical properties of nanomaterials, the increasing growth of nanotechnology in the workplace, available information about biological and health effects in animals associated with exposures to some types of engineered nanoparticles in laboratory studies, and available information about the occupational health effects of incidental ultrafine particles all underscore the need for medicaland hazard surveillance for nanotechnology. Every workplace dealing with nanoparticles, engineered nanomaterials, or other aspects of nanotechnology should consider the need for an occupational health surveillance program. NIOSH is in the process of formulating guidance relevant to occupational health surveillance for nanotechnology.

177